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Abstract 
The Countermeasures Against Chemical Terrorism (CounterACT) Program, sponsored by 
the U.S. Department of Homeland Security, seeks to promote and support research aimed at 
finding new (therapeutics) pharmaceuticals that are antidotal toward toxicants considered likely to 
pose significant terrorist threat. More specifically, this means countermeasures to toxicants that 
can be easily prepared from readily available precursors in quantities suitable for inflicting mass 
casualties on civilian and/or military targets. The challenge to Public Health issued by the 
CounterACT program is to identify and develop antidotes to any such toxicants deemed to be of 
particular concern, including the mitochondrial poisons sulfide, cyanide and azide. Ideally, in 
addition to efficacy, the antidotes should be stable enough for stockpiling and safe enough for self-
administration. Herein, various biological systems mimicking some relevant aspects of acute 
poisonings in humans have been tested for their usefulness as experimental “models” suitable for 
examining toxic mechanisms and assessing the efficacies of putative antidotes. Larvae of the 
greater wax moth (Galleria mellonella) are shown to be a convenient and inexpensive invertebrate 
model for investigating the action of some mitochondrial poisons and their antidotes. The acute 
toxicities of sulfide, cyanide and azide have been studied together with the ameliorating effects of 
sodium nitrite and a cobalt-based scavenging agent. The results obtained with the larvae are 
 v 
compared to findings employing a cultured mammalian cell line (bovine pulmonary artery 
endothelial cells) and rodents (Swiss-Webster mice). The Galleria mellonella larvae are argued to 
be an extremely useful intact organism for (i) pre-screening putative antidotes for efficacy and (ii) 
circumventing any confounding effects that can arise in some studies of intracellular processes due 
to the presence of blood in intact vertebrates. 
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1.0 Introduction 
1.1 Mitochondria 
Human and environmental exposure to toxic chemicals can happen through accidental or 
intentional means and depending on the dose received, the exposures can pose a potential risk to 
human life. Currently, there are more than 80,000 chemicals registered for use in the United States 
that remain untested for potentially toxic exposures.1 According to the Environmental Protection 
Agency (EPA) each year approximately 2,000 new chemicals2 are introduced and the average 
person is exposed to more than 100 chemicals3 before getting to work in the morning. Unlike the 
extensive research that goes into pharmaceuticals, there are tens of thousands of chemicals 
(environmental, personal hygiene, cosmetics) that are not as extensively tested for toxicity and this 
includes their effect on mitochondria in humans.1, 4 
Mitochondria are the key organelles producing cellular energy in the form of adenosine 
triphosphate (ATP) through oxidative phosphorylation (OXPHOS).5-7 The Krebs cycle is the third 
step in the cellular respiration pathway, after glycolysis and pyruvate oxidation7, providing the 
electrons equivalents needed for oxidative phosphorylation.8 OXPHOS is the pathway by which 
nutrients are oxidized and energy, in the form of ATP, is produced.8 The electron transport system 
or ETS (see Figure 1) is made up of a collection of membrane-embedded proteins and organic 
molecules.2  Electrons produced by the transfer of NADH to NAD in complex I and electrons 
transferred from the reduction of FAD to FADH2 in complex II, flow sequentially into Q 
(ubiquinone) and on through complex III, cytochrome c and finally, into the terminal electron 
acceptor, cytochrome c oxidase,9 5, 6, 10 also known as complex IV. During OXPHOS, the flow of 
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electrons (Figure 1) through the ETS pumps protons across the inner membrane and into the 
intermembrane space5, 7, 10, 11 forming a gradient in the intermembrane space. During 
chemiosmosis, the energy stored along the gradient is used to make ATP.5 Protons are passed back 
through the inner mitochondrial membrane via a membrane protein called ATP synthase5, 9, 12 The 
flux of protons across this gradient generated by electron transfer causes inorganic phosphate (Pi) 
to bind ADP, forming ATP. 9, 12 
Healthy mitochondria under normal physiological conditions account for more than 90% 
of cellular ATP production.8, 13 The physiological functions and mechanisms of the complexes 
involved in OXPHOS, as well as their conformations and the inhibition sites by various inhibitors, 
are well known. Mitochondria are not only responsible for energy production; they are involved 
in several cellular processes, such as apoptosis, and control of the cell cycle5, 8, 14.  
Healthy mitochondrial function is critical to our survival and problems that arise from 
events such as chemical toxicity can adversely affect mitochondrial pathways, leading to 
dysfunction of the cell.15 If the mitochondria cease to function properly and oxygen turnover is 
inhibited, then death is the outcome.  This highlights the need for a rapid, effectual, and reliable 
screening procedure for evaluating any threat to public health posed by new chemical agents. 
 
 
 
 
 
 
 
3 
Figure 1. Electron Transport System. 
The electron transport system which is embedded in the mitochondrial inner membrane transfers electrons, from Krebs 
cycle products, NADH and FADH2, to the carrier molecules and uses them to concentrate hydrogen ions in the 
intermembrane space. The hydrogen ions then produce an electrochemical gradient that flows into the matrix through 
ATP synthase which then converts ADP to ATP. The flow of electrons through cytochrome c oxidase produces 
oxygen. This process can be inhibited by the toxicants binding the active site. 
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1.2 Cytochrome c Oxidase 
It can be argued that one of the most essential components of the mitochondrial electron 
transport system is complex IV or cytochrome c oxidase16. In eukaryotes the enzyme is located in 
the inner mitochondrial membrane and serves as the terminal electron acceptor in the ETS16. In 
mammals, cytochrome c oxidase is made up of 13 subunits with the catalytic core containing three 
mitochondrial DNA encoded subunits (I, II, III) that are synthesized in the mitochondrial matrix. 
9, 12, 13 Of the three, two play a key role in oxygen turnover (I and II); the function of subunit III is 
not entirely known12. The three subunit core is surrounded by smaller subunits encoded by the 
nuclear genome, that have been suggested to modulate the catalytic activity of the enzyme and to 
protect it from oxidative damage.12 Different organisms contain a variable number of cytochrome 
c oxidase subunits ranging in number from 4 to 13.12 The catalytic core subunits (I-III) are rather 
evolutionarily conserved and carry the heme and Cu+2 redox centers.12, 13, 17  It is significant to 
recognize that the cytochrome c oxidase enzyme is found in all organisms that utilize oxygen. 
Popovic et al,17 studied the similarities of cytochrome c oxidase in different organisms, and found 
that they are structurally similar, sharing the same key amino acid properties. 
Internal electron transport in cytochrome c oxidase is the rate limiting step of the 
respiratory chain under normal physiological conditions.13  Cytochrome c oxidase contains two 
heme a groups (a and a3) and three copper ions, arranged as two copper centers (Cu2+ A and Cu2+ 
B)12, 13.  Electrons are transferred from the CuA center to hemeb, and then to the active oxygen 
binding site, consisting of heme a3/CuB 5, 12, 13. This active site is a binuclear center for oxygen 
binding where electrons reduce molecular oxygen (the terminal electron acceptor) to water (4e- + 
O2 + 4H+  2 H2O).18 Four electrons (4e-) transferred from CuA in subunit 2 to the heme a3/CuB 
binding site in subunit 1, and 4H+, “scalar protons” are required to react with an oxygen molecule 
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to produce 2 water molecules13, 18. Cytochrome c oxidase activity directly affects mitochondrial 
function10 and this activity is an indicator of the oxidative capacity of the cell14, 16. Many 
xenobiotics have been shown to inhibit cytochrome c oxidase activity in a dose dependent manner 
leading to mitochondrial stress.19-21  The heme a3/CuB active site is the target of sulfide, cyanide 
and azide inhibition. If an inhibitor binds this site, it stops oxygen turnover, with potentially lethal 
consequences.  
1.3 The Inhibitors and the Putative Antidotes 
1.3.1  Sulfide, Cyanide and Azide 
To start, come clarification of terms “sulfide”, “cyanide” and “azide” is needed. Sulfide is 
a 50/50 combination of both H2S and the anion HS-,22 cyanide is almost all (98%) HCN,23 and the 
anion CN-, finally, azide is composed almost entirely of the anion N3-.24 All three are dangerous 
toxins with potential public health implications. It is widely accepted that the mechanism of action 
of these three toxicants is similar and the primary target is cytochrome c oxidase within the central 
nervous system.25-29 These mitochondrial toxicants bind the heme a3/CuB binding site, blocking 
oxygen turnover25-29. Upon inhibition of cytochrome c oxidase, death results from respiratory 
paralysis.25, 27, 30 Electron transfer activities of different cytochrome c oxidases are essentially 
independent of source tissue and or species.13 Inhibition constants (Ki) have been calculated for 
various inhibitors including the three mentioned above, sulfide: 0.45µM,27 cyanide: 0.2µM and 
azide: 22µM.31 The Ki is an indicator the inhibitors potency, the smaller the Ki the greater the 
binding affinity, and therefore, the smaller the amount needed to inhibit enzyme activity.32  
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Hydrogen sulfide poisonings mostly occur as occupational accidents, but there are other 
public health concerns. For years hydrogen sulfide has been infamous for its use in “detergent 
suicides” in both Japan and the United States33 with 75 cases of chemical suicide between 2008 
and 2015,34 80% of these cases resulted in first responder injury.34 In Japan, residents of an 
apartment building had to be treated for exposure when an individual committed suicide in an 
apartment and the hydrogen sulfide gas entered the ventilation system.33 The danger lies not only 
with the victims, but with first responders entering the scene. Even more serious than the chemical 
suicides is the potential of hydrogen sulfide to be used in a nefarious capacity, it has been 
mentioned in the Mujahedeen Poisons Handbook,35 where extremists provide information on its 
use in scenarios expected to lead to mass casualties.  
Hydrogen sulfide results from the breakdown of organic matter in the absence of oxygen; 
such is the case in swamps and it occurs naturally in natural gas, well water and volcanic gasses.33 
Most exposures stem from occupational means such as manure storage tanks and sewers33 (Table 
1). Sanitation workers are often exposed when cleaning or maintaining municipal sewers and 
septic tanks 36. This danger is also found in farm workers who can be exposed when cleaning 
manure storage tanks, and oil and natural gas drilling and refining employees who may be exposed 
when hydrogen sulfide is present in oil and gas deposits.36  
Sodium hydrosulfide (NaHS) has a distinct rotten egg smell. At 0.1 ppm sulfide quickly 
blocks the sense of smell (anosmia).37 At concentrations higher than 500 ppm the gas causes 
irritation to nose, throat and lung tissue resulting in pulmonary edema, and eventually, (at 
concentrations >800 ppm) death.35, 37, 38 Sulfide reacts with a wide variety of biological materials 
including hemoglobin making working with this toxin difficult.35, 38 Currently, there are no 
approved antidotes for hydrogen sulfide toxicity.  
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Sodium azide is a rapid acting, potentially deadly, compound used as a chemical 
preservative in laboratories and hospitals, explosives detonators, and as a pest control agent and 
soil fumigant in agriculture.37 Most notably azide is used as a fuel in automobile airbags.37 In 
airbags, a sodium azide pellet with an oxidizing agent is heated to about 300°C upon impact, 
decomposing to nitrogen, inflating the airbag and leaving a residue of sodium oxide.37 The 
potential impact of having azide in the inflators of vehicle airbags will be felt in the next few 
decades when these cars age. Accidental release of the azide into the environment could happen 
due to a lack of regulations requiring the detonation of airbags when a car is destroyed.39 Sodium 
azide was linked to the suicide of a UC Berkley professor in 2014.40  In 2010, sodium azide was 
added to an iced tea dispenser to poison customers of a local Dallas County, Texas restaurant.41 
(CDC). Sodium azide is also mentioned in the Mujahedeen Poisons Handbook.35 
In 1954 sodium azide’s toxicity was explained by Robertson and Boyer as the inhibition 
of heme-type enzymes such as catalase, peroxidase and cytochrome c oxidase.42  Hypotension is 
the most common health affect from exposure to low levels of sodium azide.37 Other effects 
include hypothermia, loss of vision, clonic seizures, pulmonary edema, coma, and death.43 Onset 
of symptoms can occur onset anywhere from an hour to several days depending on route of 
exposure.37 Both azide and cyanide are on the list of agents of concern with the Department of 
Homeland Security.44, 45 
Throughout history, cyanide (CN-) has been successfully used as a poison and as a warfare 
agent.46 The highly reactive cyanide salts are used for industrial applications, chemical synthesis, 
electroplating, agriculture, manufacturing, fumigants and pesticides.19 Cyanide can be found in 
cyanogenic food, 47, 48 and in waste products from mining. Most infamously, cyanide was used by 
the Germans in World War II in the gas chambers (Zyklon B) to carry out genocide.44 49-52 In 
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addition, the Japanese made frangible hydrocyanic acid grenades. In 2010, a dam at the Baia Mare 
gold mine overflowed and caused a flood of toxic cyanide 40km long down the River Tisza in 
northern Yugoslavia. This accident caused a tide of dead fish, spreading the poison further 
downstream into the Danube River.53  
Though occupational exposure is rare, there is a growing concern for fire fighters, as 
cyanide is a by-product of the combustion of polyurethanes.54 Cyanide readily enters the 
bloodstream, rapidly diffusing into tissues where it irreversibly inhibits cytochrome c oxidase, 
causing death within minutes55 (The estimated lethal dose in adults is 50-200 mg NaCN or 100-
300 ppm HCN55).  This rapid action is what makes cyanide so lethal. While cyanide is a potent 
toxicant (at pH 7 NaCN is 98% HCN23), there are mechanisms in the body to detoxify small 
amounts of CN-, for example, rhodanese is a mitochondrial enzyme that detoxifies cyanide (CN−) 
by catalyzing the cyanide-dependent cleavage of thiosulfate to form thiocyanate (SCN−) and sulfite 
(SO32-)56 (Rhodanese S2O32- + HCN  SCN- + HSO3-).  The thiocyanate is then excreted in the 
urine over a period of days.56 Unlike sulfide and azide, there are available antidotes for cyanide 
poisoning. 
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Table 1. Cytochrome c Oxidase Inhibitors. 
 
a Sulfide: Malone-Rubright, S., et al,  Nitric Oxide 17 (2017) 1-13 
b. ATSDR Agency for Toxic Substances and Disease Registry, Hydrogen Sulfide Carbonyl Sulfide, Last    updated: 
March 3, 2011, https://www.atsdr.cdc.gov/substances/toxsubstance.asp?toxid=67 
c PUBCHEM Hydrogen Sulfide. U.S. National Library of Medicine National Center for Biotechnology Information. 
https://pubchem.ncbi.nlm.nih.gov/compound/hydrogen_sulfide 
d Cyanide: Malone, S. et al, Toxicology of Cyanides and Cyanogens: Experimental, Applied and Clinical Aspects 
(2015) 368 
e ATSDR Agency for Toxic Substances and Disease Registry, Cyanide, last updated: March 3, 2011. 
https://www.atsdr.cdc.gov/substances/toxsubstance.asp?toxid=19 
f PUBCHEM Sodium Cyanide. U.S. National Library of Medicine National Center for Biotechnology Information. 
https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-cyanide 
g Azide: Chang, S. et al,  Int J Toxicol (2003) 22, 175-186 
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1.3.2  Putative Antidotes 
Two antidotes are available for use against cyanide poisoning in the United States. First, 
Nithiodote™,57 which consists of a  combination of sodium nitrite/sodium thiosulfate, is an off 
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label antidote that has been approved, but not FDA labeled, for use in humans.58 Nitric oxide (NO) 
is a messenger molecule that regulates physiological processes in mammals26 and multiple studies 
have shown that NO is an antagonist of cyanide, ameliorating its effect on cytochrome c oxidase 
enzyme activity 59, 60 61, 62. NO produces methemoglobin in this reaction: HbO2 + NO  Hb+ + 
NO3-.63 Then, methemoglobin can bind the toxicant of interest (e.g. Hb+ + CN-  HbCN).63 In 
addition, the enzyme rhodanese64 acts in concert with a sulfur donor, to convert cyanide to the less 
toxic metabolite, thiocyanate (SCN–). Pearce et al,59, 65 proposed that nitrite acts as a NO donor 
and not a methemoglobin former in the mechanism of antidotal action toward cyanide toxicity.  
The second available antidote is Cyanokit™,66 an FDA approved antidote that is a form of 
vitamin B12, or hydroxocobalamin, which binds cyanide and sequesters it for excretion, acting as 
a decorporation agent.66 Hydroxocobalamin was FDA Approved in 2006.66, 67  It has 6 ligands 
around cobalt atom, and only 1 available site (OH–) to substitute HS-, CN- or N3- ligands (Figure 
2A). It is a very large, complex molecule with a molecular weight of 1,346 g/mol.68 In addition to 
being large it is expensive, the average cost per gram is $180/g (making it nearly $1,000 for single 
adult intravenous dose)23, and patients may need a second dose. Because of the expense many 
ambulances that carry it, usually only carry one, most will carry Nithiodote™ instead. Again, it is 
effectively antidotal toward cyanide, but the antidotal effect for azide and sulfide remained 
inconclusive and until recently there are no approved antidotes for sulfide or azide.35  Due to 
similar mechanisms of toxicity between sulfide, azide and cyanide, however, existing cyanide 
therapies could be expected to be beneficial for sulfide and azide toxicity. 
Our group has sought to develop new (simpler) cobalt-containing compounds that were 
smaller, less complex structures that would increase solubility, reduce costs, and offer equal or 
better antidotal effect toward toxicants than hydroxocobalamin, especially in a mass casualty 
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situation.  A potential antidotal compound is CoN4[11.3.1] (a complex of cobalt (II) with the 
ligand2,12-dimethyl-3,7,11,17-tetraazabicyclo-[11.3.1]heptadeca-1(17)2,11,13,15-pentaene 
(CoN4[11.3.1])69 (Figure 2B) that, can bind two molecules of cyanide in a cooperative fashion with 
an association constant of 2.7 (±0.2) × 10(5).70  CoN4[11.3.1] or “the Busch compound”, was first 
synthesized by Darryl Busch in Ohio in 1967. (69 It is smaller, cheaper ($180/g), and might be 
easier to deliver in mass casualty applications. It provided good antidotal results when used in sub-
lethal cyanide intoxication assays on mice.23  
 
   A           B 
 
Figure 2. Structures of cobalt containing compounds. 
A) hydroxocobalamin (vitamin B12); and B) CoN4[11.3.1](cobalt(II/III)(2,12-dimethyl-3,7,11,17tetraazabicyclo-
[11.3.1]heptadeca-1(17)2,11,13,15-pentaene) 
1.4 Typical Models Used for Toxicological Experiments 
The reality is that animal studies and in vitro models are always going to be used for 
screening of toxic agents in order to identify and predict potential ill effects to humans, wildlife 
and the environment.71 We need an efficient method of screening dangerous chemical, prior to 
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their release into the community, before these chemicals impact public health while using fewer 
animals in toxicological testing. 
There are many models used for preliminary toxicological experiments, with mammals 
such as mice and rats being among those traditionally preferred.72 However, the use of mammals 
in research is expensive and requires ethical and regulatory oversight.73 Russell and Burch 
introduced the ‘Three R’s” in 1959, Replacement, Reduction and Refinement.74 These principles 
encourage the use of alternative models (i.e. invertebrate and cell models) in research 
investigations in place of mammals to reduce the number of mammals used in an investigation, 
thereby decreasing the incidence or severity of inhumane procedures applied to vertebrate animals 
that still need to be used. It is important to keep in mind that models used in these studies should 
mimic some aspects of human poisoning and/or treatment.74 Zebrafish, fruit flies and mammalian 
cells are just a few of the models that are currently utilized in preliminary investigations,71 all have 
pros and cons but all of these models serve as worthy alternatives to mammals in toxicological 
experiments.  
1.4.1   Cell Models 
Cells offer researchers many advantages for preliminary toxicological investigations 
(Table 3). In vivo assays are, in some cases, an excellent tool for these investigations and can 
provide quick, reliable data for proof of concept experiments.71 Investigations can be carried out 
in a controlled environment, studying just a part of an organism in great detail.71 Though one of 
the most important advantages of cell culture is that you can control the physiochemical 
environment,71 results from cells that have been isolated and grown in an artificial environment 
outside of the organism may not accurately predict the conditions inside of a living organism where 
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mechanisms of the toxicity may be acted on by other pathways.71 As well, the use of cells prevents 
knowledge of the behavioral patterns affected by these mechanisms.  
1.4.2  Drosophila melanogaster 
Invertebrate models, have proven very useful in the study of bacterial, fungal and parasitic 
pathogenesis and treatments thereof,43, 71, 73, 75-78 as well as advantageous candidates for 
preliminary chemical testing71. Drosophila melanogaster (Table 3), or the fruit fly, has been a very 
important model in many biological and biomedical studies and gained recognition as a tool to 
identify molecular genetic mechanisms of toxic substances71, 77. Many genes correspond to human 
genes and control the same biological functions; about 60% of genes are conserved between fruit 
fly and humans.77  Several fly models have been developed to study mechanisms of complex 
diseases such as Parkinson’s and Alzheimer’s due to the ease and cost effectiveness of producing 
transgenic flies to generate models of human diseases.71  Though the anatomy of the brain and 
other major organs within Drosophila differ from that of humans,77 fundamental cellular 
processes, genes and signaling pathways are conserved between them. The insect models not only 
save money (Table 3), they require very few ethical or regulatory restrictions (Table 3).78 These 
models have a rather short life cycle, and produce a large number of offspring in the lab setting. 
Multiple generations can be observed in a very short time span. Many larvae can be used in each 
experiment making data easy to obtain, more reliable and repeatable. However, Drosophila larvae 
are very tiny and, for instance, injections are almost impossible to accurately administer.77 Using 
fruit flies highlights some issues such the lack of an adaptive immune system, and different drug 
effects when compared to human studies.77 
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1.4.3  Zebrafish 
Zebrafish (Danio Rerio) have been used in many studies, evaluating the toxicity of 
agrochemical agents,71, 79, 80 but more recently, they have been used to assess toxicity of 
pharmaceutical compounds.71, 79, 80 Zebrafish are used to screen for effects of exposures on the 
cardiac system, central nervous system, the intestinal tract, auditory and visual functions, pro-
convulsant potential and bone formation.79, 80  Zebrafish are not only small, and easy to breed 
quickly, they share similar molecular pathways and physiology to humans.71 The zebrafish eggs 
are transparent (Table 3) and remain so throughout embryonic development. Because of the lack 
of pigment, little magnification is needed to view adverse effects of chemical exposure on 
development of the brain, notochord, and heart. Unlike mammalian embryological development 
the zebrafish embryo can be continually followed in live individuals rather than harvested embryos 
and fetuses. They are a powerful in vivo model used in high-throughput screens for toxicity testing, 
small-molecule screening, and drug discovery80. Their genome has been sequenced and they share 
70% of genes with humans79 (Table 3).  
Some drawbacks of zebrafish research include: they need to be kept in a clean tank, they 
have temperature and food requirements (Table 3) and aquatic vertebrate species are subject to 
existing regulatory oversight according to the Guide for the Care and Use of Laboratory Animals80. 
Most significantly, in relation to the present worn, zebrafish are not air breathing. 
1.4.4  Mouse Model 
Mice82 are the gold standard for toxicological studies because they have biological, 
physiological and behavioral characteristics that closely resemble those of humans, and many 
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symptoms of human conditions can be replicated in mice. They are indispensable in contributing 
to our understanding of the functions of genes, the etiology and mechanisms of different diseases, 
and the effectiveness and the toxicities of medicines and chemicals.72 Swiss-Webster mice are 
advantageous in toxicology because they are an outbred model, exhibiting variability between 
animals whereas inbred mice are effectively genetically identical, unlike humans. 72, 81 
Adult mice reproduce quickly (as often as every three weeks), and have a very short 
generation time (about 10 weeks) allowing for multiple generations to be observed at once.81 The 
life span is approximately two years which makes it easy to measure the effects of aging.  Mice 
are a preferred model for genetic research because they share 92% of their genes with humans72 
(Table 3) and their genome can be easily modified to present desired characteristics to simulate 
human disorders.72 Mouse models have aided in the progress of research and enabled the 
development of important new drugs and therapies in humans. They have been pivotal in studying 
naturally occurring diseases that affect complex biological systems found in humans, such as the 
immune, nervous system, and cardiovascular diseases. 72 
In toxicological studies, whole animals are often required to compare the effects of a toxic 
chemical in a living organism to that of a known human response. Laboratory tools and cells 
simply cannot duplicate these complicated phenomena. Whole animals are complicated and 
therefore simple systems are often required.  There are obvious differences between vertebrates, 
invertebrates and cells such as blood and biological structures (i.e. lungs, liver, and brain) that still 
require that a comparison be drawn between at least two models to glean a full understanding of 
any exposure. 71  
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1.4.5  Galleria mellonella 
Figure 3. Different developmental stages of Galleria mellonella. 
Approximately 30-day-old caterpillar (last instar larval stage), pupae, shed chrysalis and adult moth. 
 
 
Intact mammals are often too complicated for detailed niche studies where a different 
model is needed. There are over two million insects available for development as models for use 
in preliminary toxicological testing,82 and unlike vertebrate models, insects do not come with a 
high price tag or require special ethical and legal requirements associated with their use in the 
laboratory setting (Table 3). Galleria mellonella have been successfully used for the study of 
bacterial, fungal and parasitic pathogenesis83, 84 and treatments thereof, as well as for evaluating 
the efficacy of antimicrobial agents,75, 78 food additives85 and pesticides78. Along with Drosophila 
melanogaster, Galleria mellonella (L.) (Lepidoptera: Pyralidae) has emerged as a desirable model 
for such studies.86  
After employing G. mellonella larvae in bacterial infection investigations, the question 
arose as to whether or not the larvae could be beneficial in preliminary in vivo toxicological studies. 
G. mellonella larvae displayed many advantages over other models. They can be administered 
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toxins through routes similar to Drosophila (i.e., inhalation, feeding or topical applications)43 
(Table 3). Unlike vertebrate models such as mice and zebrafish, larvae have no special care 
requirements (Table 3), and they can be reared in temperatures ranging from 15°C through 37°C 
allowing researchers to mimic in vivo conditions. Research has established that there is a strong 
structural and functional similarity between the insect immune response and that of mammals, 
allowing the use of insects in place of, or in comparison to common toxicological models, such as 
mice87 in preliminary toxicity studies.  
Physiologically there are many similarities between insect and mammalian anatomy. 
Galleria mellonella have a heart with an aorta and a nervous system. Unlike mammals, the larvae 
do not have a brain, instead they have ganglia which are located in several places along the nerve 
cord, with a main ganglia acting as the primary brain-like structure.88  
The insect fat body is an organ that functions in a metabolically similar fashion to the 
mammalian liver and adipose tissue.10, 88, 89 Consisting of a network of lobes, it is a delicate 
connective-tissue membrane that stores fat reserves, glycogen and protein. The cells are laden with 
mitochondria and are as diverse in enzymes as the mammalian liver.88 A number of antioxidant 
enzymes produced by the fat body such as superoxide dismutase, catalase and glutathione-s-
transferase are highly conserved between the species.90 
 The Malpighian tubes function similar to the mammalian kidney.10, 88 These simple tubular 
glands which open at the junction between the midgut and hindgut are the main excretory organs. 
The cytoplasm of the Malpighian tubes is rich in mitochondria.88 Finally, the digestive system of 
G. mellonella is a relatively simple, straight-through type of gut, consisting of a foregut, midgut, 
hindgut and anus.88, 89 Where they are similar to humans, is in the midgut, which is lined with 
epithelial cells similar to the intestinal cells of the mammalian digestive system.89 
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The G. mellonella circulatory system differs from that of humans as it is open.10, 88, 89 There 
is little distinction between hemolymph and interstitial fluid, and the hemolymph circulates freely 
throughout the body cavity,89 the closed tubular heart circulates hemolymph primarily by the 
contractile action of a dorsal vessel, which is divided into an abdominal heart and a thoracic aorta88. 
Dissolved substances circulate by diffusion.10 The insect respiratory system does not include lungs; 
instead spiracles are located on the lateral sides of the larvae. These spiracles are openings that 
allow for gas (O2, CO2) exchange through the trachea. The trachea branch off into tracheole, which 
branch to touch every cell, allowing for oxygen transport within the body without an oxygen carrier 
molecule such as hemoglobin.89  
The hemolymph is a functional analogue of mammalian blood,91 (Table 2) though it does 
not function in the transport of gasses, primarily oxygen, the hemolymph contains hemocytes 
which function in the immune defense of the larvae.10, 89 Additionally, hemolymph bathes all cells 
in the body and accounts for 50% total body water. It produces a high pressure hydrostatic skeleton 
giving the larvae its body shape and allowing it to move. Hemolymph has pH of 6.4-6.8 (Table 2) 
and a buffering capacity (bicarbonate, inorganic phosphate, carboxylic and amino acids). Human 
neutrophils and insect hemocytes exhibit many similarities92 including the ability to produce 
superoxide by a functional NADPH oxidase complex.93 
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Table 2. Difference between mammalian blood and larval hemolymph. 
 
 
Insect electron transport is similar to that of many vertebrates and invertebrates.94 On the 
other hand, glycolysis in insect flight muscles is always aerobic and can persist for prolonged 
periods of time.10 This is due to the extensive tracheole system which is capable of supplying 
sufficient oxygen for totally aerobic oxidation during flight.10, 88 While glycolysis is a reasonable 
source of energy for cellular metabolism, electron transport is where most of the ATP production, 
specifically oxidative phosphorylation is generated in the insect larvae. 
 Like mammals, the NADH dehydrogenase enzyme-CI complex is bound to the inner 
membrane, however, the glycerol-3-phosphate dehydrogenase, (located on the outer portion of the 
inner membrane) is linked to a flavoprotein other than NAD+.10 The metabolic water that is formed 
at the end of the chain is an important source of water for insects,10, 88 especially for the larvae that 
are not eating in the last instar. It has been noticed that after being exposed to sulfide, cyanide, and 
azide the larvae would eat the paper towel circle in the petri dish and there would be an increase 
            Insect Physiology and Biochemistry, second edition, 2008 
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in excrement left in the dish. This was not observed in the sentinels or in larvae treated with only 
PBS, cobalt, or nitrite.  
 
Table 3. Current Toxicological Study Models. 
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1.5 Overall Objective of the Dissertation 
In addition to the thoughtful identification of candidate compounds, the rational design of 
improved toxicant-specific antidotes requires at least some understanding of the molecular 
mechanisms of both the toxicant and potential antidotes. In obtaining this information, it was 
necessary to conduct studies involving synthesized compounds, isolated biochemicals, cultured 
cells, excised tissues, and intact organisms. For some time our research group has focused on 
mitochondrial (electron transport system) toxicants and their amelioration utilizing these 
experimental systems.  
It is widely accepted that the mechanism of action of sulfide,95, 96 cyanide,19 and azide 37 is 
similar, and that cytochrome c oxidase located primarily within the central nervous system is their 
primary target for inhibition, resulting in death from respiratory paralysis. Cyanide is apparently 
the only one of the three toxicants for which there are known antidotes. Following the earlier work 
of our group concerning the discovery and improvement of antidotes to cyanide, we began attempts 
to evaluate the significance of the possible antidotal effects of the nitric oxide donor, sodium 
nitrite,59, 60 and the anionic ligand scavenger, CoN4[11.3.1],23, 69 on sulfide and azide, toxicities 
using mice. 22   
While useful information was obtained, some experimental limitations became apparent 
during these studies. First, there was the confounding/interfering role of hemoglobin in the 
biochemistry being studied led to some ambiguity in interpretation of the results. Second, the mice 
exhibited a variation in response to the three toxicants, resulting in different experimental 
paradigms for exposure and recovery assessments having to be developed for each toxicant. This 
prompted a need for multiple behavioral assessments to be developed and implemented, making 
straightforward comparison of the effectiveness of any given potential antidote toward multiple 
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toxicants extremely challenging. Initially, in an effort to circumvent these issues, a study with 
cultured mammalian endothelial cells was undertaken (Section 2). Unfortunately, some toxicants 
of interest to our research group, as well as some of the potential antidotes to be tested, interfered 
directly with many of the molecular (indicator) probes that are typically used to monitor cellular 
functions. For this, as well as other reasons, the cultured cells presented practical experimental 
difficulties that were at least comparable to those observed with the intact mice.  
Our group was interested in finding a non-hemoglobin invertebrate organism that would 
be a useful toxicological model system for preliminary screening of antidotes and some early-stage 
mechanistic investigations. The already widely used fruit fly (Drosophila melanogaster) and zebra 
fish (Danio rerio) approaches were quickly discounted as inadequate for intended application so 
we turned to another readily available organism, the larval (pre-pupation) stage of the greater wax 
moth (Galleria mellonella) commercially available as “wax worms”, commonly used as fishing 
bait, reptile treats, and commonly used, roasted, as the “protein” content in some commercial bird 
feeds. 
Since their immune systems seemingly share some similarities with ours, the wax worms 
have started to become accepted as a model for bacterial infections.43 In some preliminary 
investigations (not published) we had looked at the effect of antidotes such as sodium nitrite 
on Escherichia coli infections in G. mellonella.  Knowing that the wax worms are able to be 
injected accurately and display no negative effects when inoculated with nitrite made us 
hypothesize that maybe these larvae would be a suitable non-hemoglobin model to investigate the 
mechanism of sodium nitrite amelioration in sulfide, cyanide and azide toxicities.  In a similar 
manner, we wanted to investigate amelioration of the effects of the three 
toxicants in the G. mellonella caterpillars by CoN4[11.3.1].  We anticipated that comparison of 
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the findings with the cultured cell and mouse data might be of assistance in the further 
interpretation of the results from the mammalian systems.  To date, there is only one 
other published study exploring the use of G. mellonella as a viable model for preliminary 
toxicological studies – also from our group.97  
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2.1 Abstract  
Bovine pulmonary artery endothelial cells (BPAEC) respond in a dose-dependent manner 
to millimolar (0–10) levels of sodium sulfide (NaHS). No measurable increase in caspase-3 
activity and no change in the extent of autophagy (or mitophagy) were observed in BPAEC. 
However, lactate dehydrogenase levels increased in the BPAEC exposed NaHS, which indicated 
necrotic cell death. In the case of galactose-conditioned BPAEC, the toxicity of NaHS was 
increased by 30% compared to that observed in BPAEC maintained in the regular glucose-
containing culture medium, which indicated a link between mitochondrial oxidative 
phosphorylation and the mechanism of toxicant action. This is consistent with the widely held 
view that cytochrome c oxidase (complex IV of the mitochondrial electron-transport system) is the 
principal molecular target involved in the acute toxicity of “sulfide” (H2S/HS–). In support of this 
view, elevated NO (which can reverse cytochrome c oxidase inhibition) ameliorated the toxicity 
of NaHS and, conversely, suppression of endogenous NO production exacerbated the observed 
toxicity. Respirometric measurements showed the BPAEC to possess a robust sulfide oxidizing 
system, which was able to out-compete cytochrome c oxidase for available H2S/HS– at micromolar 
concentrations. This detoxification system has previously been reported by other groups in several 
cell types, but notably, not neurons. The findings appear to provide some insight into the question 
of why human survivors of H2S inhalation frequently present at the clinic with respiratory 
insufficiency/pulmonary edema, while acutely poisoned laboratory animals tend to either succumb 
to cardiopulmonary paralysis or fully recover without any intervention. 
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2.2  Introduction 
There is still no approved antidote for hydrogen sulfide poisoning and, unhelpfully, a better 
clarification of the mechanism(s) of acute toxicity remains a stumbling block to the rational 
development of effective therapies.  While it is widely accepted that the principal molecular target 
for the acute toxicity of hydrogen sulfide (H2S) and/or its mono-anion hydrosulfide (HS–) is 
mitochondrial cytochrome c oxidase (complex IV of the electron-transport system)38, 96, 98-101 the 
evidence for this in vivo remains circumstantial and, consequently, ambiguous, or even 
contradictory.  For instance, it is not clear how to reconcile the observation that free H2S/HS– 
seemingly only persists for a matter of seconds in the bloodstream102-105 yet onset of symptoms 
presumably associated with cytochrome c oxidase inhibition by H2S/HS– occurs at 2 minutes after 
injection of the toxicant dose.38  Confounding matters further, it is noteworthy that significant 
numbers of human victims of H2S inhalation arrive at the clinic exhibiting compromised 
respiratory function 30 minutes or more after exposure and frequently succumb hours later.96, 100, 
106-108 We began the present study with the expectation that employing cultured cells as the 
experimental system would enable us to at least demonstrate inhibition of cytochrome c oxidase 
by H2S/HS– in the intact cellular environment, free of any potential experimental interference from 
factors in the bloodstream and, subsequently, go on to investigate possible reversal of this 
inhibition by putative antidotes to the toxicant.  Since the lung is reported to be particularly 
sensitive to H2S/HS– 100, 109-113 we selected bovine pulmonary artery endothelial cells (BPAEC) as 
the principal experimental system.  BPAEC seem additionally appropriate because pulmonary 
edema is a lethal consequence of H2S inhalation106, 114, 115 and most non-cardiogenic pulmonary 
edemas (of varying underlying cause) appear to be associated with endothelial barrier 
dysfunction.116, 117 
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The first acid dissociation constant (pKa1) for H2S is 7.04, and the second (pKa2) is not 
accessible in water.118  Consequently, irrespective of whether inhaled as H2S gas or injected as a 
NaHS solution, in vivo, the toxicant is ~30% H2S and ~70% HS– prior to any biochemical 
modification – in keeping with common practice in the biochemical/toxicological literature, we 
subsequently refer to this aqueous mixture as “sulfide.”  In a previous study, we showed that the 
NO-donor species sodium nitrite could significantly ameliorate acute sulfide toxicity in mice if 
given prophylactically.38  These earlier findings are at least consistent with nitrite-derived NO 
reversing the inhibitory effect of sulfide bound to cytochrome c oxidase as we have previously 
argued in the case of cyanide poisoning.61, 62  Here, we begin by showing that slow infusion of 
sulfide solution directly into the bloodstream of mice through the tail vein leads to a syndrome in 
which death results from respiratory collapse seemingly due to cardiopulmonary paralysis.  The 
results indicate that this acute pattern of intoxication does not conform to Haber’s law and suggest 
a plausible explanation of why, if the administration of toxicant is slow enough, some laboratory 
animals (and human poisoning victims) reportedly succumb to a post-acute syndrome involving 
pulmonary edema rather than cardiopulmonary failure.  We then go on to examine the effects of 
sulfide on mitochondrial function in cultured BPAEC and reversal of sulfide-dependent inhibition 
by the nitric oxide (NO) donor sodium nitrite.  The findings provide further insight into the possible 
role of endothelial dysfunction/pulmonary edema in post-acute sulfide toxicity and suggest an 
approach to developing practical antidotal protocols. 
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2.3  Experimental Procedures 
2.3.1  Chemicals  
Unless stated to the contrary, reagents were ACS grade, or better, and used without further 
purification. Sodium hydrogen sulfide was obtained as NaHS•xH2O (Sigma) where x was 
determined to be 2.5 essentially following titration procedures described by Koltoff et al.119  
Briefly, concentrations of HS- were determined by quantitative reaction with excess iodine (2HS- 
+ I2 → S + 2H+ +2I-) followed by titration of the liberated iodide119 (as I- + I3-) with silver nitrite 
(precipitating AgI + AgI3) using an Ag+ sensitive ion-selective potentiometric electrode (Accumet 
Silver/Sulfide Combination SIE 13-620-511) to detect the end point.38  Sodium hydrogen sulfide 
solutions were freshly prepared for all experiments by dissolving NaHS in septa-sealed (Suba-
Seal) tubes with minimal head space. All volumetric transfers were made with gas-tight syringes. 
2.3.2  Animals and Sulfide Exposure 
All animal procedures were approved by the University of Pittsburgh Institutional Animal 
Care and Use Committee (Protocol Number 13092637).  Veterinary care was provided by the 
Division of Laboratory Animal Research of the University of Pittsburgh.  Male Swiss Webster 
(SW) mice weighing 35-40 g were purchased from Taconic, Hudson, NY.  Adult animals were 7-
8 weeks old and were housed four per cage.  The mice were allowed access to food and water ad 
libitum.  Experiments commenced after the animals were allowed to adapt to their new 
environment for one week.  All sulfide solutions were prepared in septa-sealed vials, by dilutions 
into sterilized saline, using gas-tight syringes for any transfers. Mice were placed in a Tailveiner 
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Restrainer for mice (Braintree Scientific, Inc., Braintree, MA) for the duration of tail vein injection 
using a mechanically driven Hamilton syringe to introduce sulfide at a rate of 10-6 µL/min 
(dependent on mouse weight) to achieve the desired dose of sulfide. To monitor the progress of 
injections, a small amount of Evans blue dye was added to sulfide solutions to induce darkening 
of the tail vein. Blue coloration in the ears and nose confirmed efficient delivery of the solution 
over the times indicated. In general, a group of at least 3 mice were tested for each experimental 
point.  At the end of exposures and tests, mice were euthanized with CO2 and subsequent cervical 
dislocation. 
2.3.3  Cells and Cell Culture  
Bovine pulmonary artery endothelial cells (BPAEC) were purchased from Cell 
Applications, Inc. (San Diego, CA 92121) and used at passages 5-8. BPAEC were grown in Opti-
MEM complete media supplemented with 10% fetal bovine serum, 5 mM L-glutamate, 100U/mL 
penicillin and 100 µg/mL streptomycin under 5% CO2 and 3% oxygen (92% N2) and minimally 
handled. Cells were grown to ~80% confluence prior to being plated and were harvested by 
trypsinization. Cell numbers were determined using a hemocytometer. The culture media and 
supplements were purchased from Life Technologies (Carlsbad, CA) or Sigma (St. Lois, MO).  
2.3.4  Hydrogen Sulfide Toxicity in BPAEC 
 Hydrogen sulfide solutions were prepared by dissolving NaHS in tubes sealed with 
minimal head space and septa-seal caps to minimize leakage. All volumetric transfers were made 
with Hamilton gas-tight syringes. Hydrogen sulfide toxicity in BPAEC was measured by 
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employing cells grown in 6 well plates, seeded at a density of 4 x 105 cells/well, reaching ~80% 
confluence in two days in Opti-MEM media. On test day, Parafilm was placed over the wells to 
reduce the loss of hydrogen sulfide during exposures. Sulfide solutions were prepared in media 
and were injected into the wells while lightly shaking the plate. After injections, a second layer of 
Parafilm was placed over the plate and smoothed down onto the plate surface. The plate was then 
incubated at 37°C in 3% oxygen for one hour.  
2.3.5  Cellular Assays 
Propidium Iodide was used to detect cell death in BPAEC exposed to sulfide. Briefly, cells 
were treated with NaHS (see above) and subsequently, propidium iodide (15 μM final 
concentration) was added to each well in order to determine cell death. SYBR Gold (1:10,000 
dilution) was used according to the manufacturer’s (Life Technologies) instructions to determine 
the live cell count. The plate was incubated for 15 minutes (3% oxygen, 37°C) and cell 
fluorescence (PI, λex = 535 nm; λem = 617 nm; SYBR Gold, λex = 495 nm; λem = 537 nm) was 
observed. Annexin V-Cy3 assays were performed using a kit from BioVision (Milpitas, CA) where 
the manufacturer’s protocol was followed. BPAEC were seeded at passage 6-8 at a density of 
approximately 4 x 104 cells/mL in Opti-MEM in 6 well plates (2mL/well).  To compare the 
influence of glucose versus galactose on cells exposed to NaHS, the media was removed from all 
plates and replaced with either 5mM glucose or 10 mM galactose media and incubated (3% 
oxygen, 37°C) for 3 hours prior to addition of NaHS. Cells were then scraped, spun down and 
counted, the pellet resuspended in binding buffer and finally, the annexin antibody was added. For 
comparison, other BPAEC were exposed to L-NAME (N (ω)-nitro-L-arginine methyl ester), nitrite 
and sulfide prior to annexin V-Cy3 assay. L-NAME (0.5 mM) was prepared using nano-pure 
 31 
water, added to wells and incubated for 1 hour at 37°C.  Plates were covered in Parafilm prior to 
5 mM NaHS solution being injected into wells while shaking the plate slightly. The plate was 
covered again with a second layer of Parafilm and returned to the incubator for a second 1 hour 
incubation. Sodium nitrite solutions (0.5 mM) were prepared using phosphate-buffered saline 
(PBS). The sodium nitrite solutions were injected into the cell media of wells while shaking the 
plate slightly. After 2 minutes, 5 mM sodium hydrogen sulfide solution was injected into the wells 
through Parafilm. Fluorescent cells were counted using a fluorescent microscope, divided by the 
number of total cells in the field of view and the percent cell death for the sample was calculated. 
Caspase activity was determined using the protocol for the Molecular Probes (Eugene, OR) 
EnzChek caspase 3 assay kit from Invitrogen (ThermoFisher Scientific, Waltham MA). 
Staurosporine (1µM) was used as a positive control for apoptosis. Prior to the assay, protein 
concentrations of the samples were determined using the Pierce BCA assay kit (ThermoFisher 
Scientific, Waltham MA). 
Nitrotyrosine levels were determined using the ELISA protocol from Millipore (Temecula 
CA). A 3-nitrotyrosine standard curve was generated for each assay.  
Lactate dehydrogenase (LDH) activity of the BPAEC supernatant was measured in the 
presence of NAD+ and lactate following exposure to 5 mM NaHS. The increase in absorbance, 
due to the appearance of NADH, at 340 nm was measured over a 10 minute time span and 
compared to controls.  
2.3.6   Western Blotting 
BPAEC were lysed in radio immunoprecipitation assay buffer (150 mM NaCl, 0.5% 
sodium deoxycholate, 0.1% SDS, 50 mM Tris, 1 mM EDTA) containing a protease inhibitor 
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cocktail mixture (Roche). Protein concentrations of the samples were determined using the Pierce 
BCA Protein Assay Kit (ThermoFisher Scientific, Waltham, MA) and probed, subsequently, for 
β-actin and/or LC3-β (goat polyclonal IgG#SC-1615/#SC-16755; Santa Cruz Biotechnology, Inc., 
Santa Cruz CA). Proteins were separated on 14% tris-gycine gels and transferred to a 
polyvinylidene difluoride membrane blocked with 3% nonfat milk according to a protocol by 
Tanida et al.120 Blots were incubated with primary antibodies (1:1000) overnight at 6°C, rinsed 
and then incubated with horseradish peroxidase (donkey anti-IgG HRP conjugated; Santa Cruz 
Biotechnology, Inc., Santa Cruz CA) (1:5000) for one hour at room temperature. Photolytic ladder 
(Ladder generously provided by Karla Wasserloos, University of Pittsburgh) was used to visualize 
standards. 
In an analogous manner, Western blots were carried out to detect mitophagy in BPAEC 
using β-actin and/or PINK1 primary antibodies (H-300 rabbit polyclonal Ig3, Santa Cruz 
Biotechnology, Inc. #SC-33796).  (Beta Actin and chemiluminescence detection reagents were 
generously provided by Alexis Carter, University of Pittsburgh).   
2.3.7  Respirometric Experiments 
An Oxygraph O2k polarographic instrument (Oroboros, Innsbruck, Austria), equipped 
with a Clark-type electrode for high-resolution respirometry was used to measure oxygen fluxes 
and concentrations. BPAEC, at an average density of 2.5 x106 cells/mL, suspended in DMEM 
media were loaded into the sample chambers and equilibrated (sealed from the atmosphere) at 
37°C for 20 minutes. Solutions for additions (10-50 µL volumes) of 1 mM sodium nitrite and/or 2 
mM hydrogen sulfide were prepared in nano-free water and were added by gas-tight syringes into 
the sealed sample chambers.  Data analysis was carried out with the DatLab software provided by 
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Oroboros.  (Note:  the sensitivity of this system is such that adding a deoxygenated solution to the 
more oxygenated Oxygraph chambers can erroneously register as an increase in oxygen 
consumption.  Helmy et al.121 have described this artifact as a dilution effect.  Conversely, of 
course, adding an oxygenated solution to the Oxygraph chambers containing less oxygenated 
solutions can register as a decrease in oxygen consumption (see Supplemental Data).  In practice, 
one usually avoids such effects by adding small reagent volumes of a few microliters to the 
chambers (2.0 mL total volumes) and ignoring any minor erratic signals in the traces obtained 
during the first couple of minutes after any additions.) 
2.3.8   Instrumentation  
Fluorescence measurements were carried out using a BMG Labtechnology FLUOstar 
Galaxy microplate reader, a Zeiss IM 35 Fluorescent microscope with Infinity Analyze camera 
software or the Shimadzu RF-5301 PC spectrofluorophotometer. Electronic absorption 
measurements were performed using Shimadzu UV-2501PC and UV-1650PC 
spectrophotometers. 
2.3.9   Data Analysis  
Statistical comparisons were carried out using one way analysis of variance (ANOVA) and 
student t-tests.  Values are expressed as means +/- standard errors. A p-value ≤ 0.05 was considered 
significant and statistical analyses were performed with KaleidaGraph. 
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2.4 Results and Discussion 
2.4.1  Intact Mice 
In previous experiments with mice we have employed single-shot intraperitoneal injections 
to administer sulfide solutions.38  This experimental paradigm, in which the animals either 
significantly recover or succumb within 4 minutes, does not reflect the consequences of real-world 
poisonings in at least two important aspects.  First, unlike human victims, none of the surviving 
animals exhibited any symptoms persisting longer than a few minutes following cessation of the 
toxicant dose.  Second, upon autopsy, the tissues of non-surviving animals did not show any of the 
green discoloration due to the formation of sulfhemoglobin reported in the case of human 
fatalities.122-125 In the few cases where this information is available, the durations of human 
exposures (by H2S gas inhalation) resulting in unconsciousness and some deaths are from a few 
minutes up to about 15 minutes.126-129  Consequently, anticipating some possible experimental 
advantage to administering the toxicant dose over several minutes rather than by single-shot 
injection, we began to explore slower intravenous infusion through the tail vein. 
Injection methods (as opposed to inhalation) allow for more precise control of dose 
delivered, but importantly, the animals must not be sedated, since there are some well-documented 
(if incompletely understood) confounding effects associated with anesthesia.62, 130, 131  Briefly, 
physically restrained Swiss-Webster males (6-8 weeks old, 25-35 g) were infused through 
catheters inserted into their tail veins with NaHS dissolved in saline (10-30 mg/kg in maximally 
0.1 mL solution per mouse) employing mechanically-driven Hamilton-type syringes and times 
until death (cessation of breathing) were observed.  The results turned out to be highly reproducible 
with a remarkably linear relationship between lethal dose and the duration required for its infusion 
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(Figure 4).  Clearly, the present data do not obey what has become known as Haber’s law132 in 
which the lethal dose would be a constant given by the concentration administered times the 
duration of the dose.  Instead, the lethal dose is highly variable (Figure 4) being proportional to 
the duration of the dose, or inversely proportional to the concentration administered.  Deviations 
from Haber’s law are not that unusual, but in the context of the present study, it is noteworthy that 
earlier authors administering inhaled H2S to rats (at much lower concentrations than here) did 
observe adherence to Haber’s law when the dose durations were several hours.114  Immediately, 
after absorption, the composition of the sulfide toxicant is the same (~30% H2S and ~70% HS–) 
irrespective of whether it is delivered as H2S or NaHS.  Therefore, observation of adherence to 
Haber’s law at relatively slow delivery of low levels of toxicant as opposed to non-adherence to 
Haber’s law at faster delivery of the same toxicant at higher concentrations is strongly indicative 
of there being two quite distinct mechanisms of toxicity and/or antagonistic (i.e. protective) tissue 
responses under the two regimens. 
Figure 4. Slow intravenous infusion of NaHS into mice. 
Un-sedated, but physically restrained, Swiss Webster males (6-8 weeks old) were injected through catheters inserted 
into their tail veins with NaHS dissolved in saline (maximally 0.1 mL per mouse, employing mechanically-driven 
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Hamilton-type syringes) and time until death (cessation of breathing) recorded.  Broken line:  linear regression fit to 
data (R = 0.995); (solid black circle) indicates individual data points; (solid black square) indicates two superimposed 
data points. 
 
At all dose rates examined (Figure 4) the mice were rendered unconscious as the lethal 
doses were approached; but if the dose was terminated before death, the animals recovered righting 
ability within 30-60 seconds.  Full recovery of normal neuromuscular function – as determined by 
the ability of animals to remain on a rotating cylinder (RotaRod testing, data not shown) – was 
evident by 15 minutes following cessation of the toxicant infusion.  These surviving animals 
exhibited normal behavior for up to 3 days after their intoxications, at which time they were 
sacrificed.  In our previous study employing intraperitoneal injections of sulfide solutions38 the 
mice began to show signs of intoxication (slow, irregular movement and raised hackles) about 2 
minutes after receiving the dose.  For purposes of comparison, extrapolating the data of Figure 4 
to the 2-minute dose duration indicates a lethal dose of ~5 mg/kg, whereas the lethal dose 
determined in the earlier study was actually greater than 20 mg/kg.38  Together, these observations 
seem to indicate that only about 25% of the sulfide given intraperitoneally ends up entering the 
bloodstream, presumably with the majority of the toxicant dose having been metabolized within 
the peritoneum.  This observation is suggestive of at least one way in which slow delivery of low 
H2S doses by inhalation114 might present such a different toxic response to infusion of higher 
sulfide concentrations directly into the bloodstream (Figure 4) namely, metabolism of the toxicant 
within the pleural membrane might present a significant barrier to sulfide entry into the 
bloodstream.  Since functionally similar endothelial cells are present in both membranous 
structures, the decision was made to further investigate sulfide metabolism in a cultured pulmonary 
endothelial cell line since pulmonary cells are presumably those most impacted during actual (H2S 
gas) poisonings. 
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Curiously, while we have verified (data not shown) that purified mouse hemoglobin can 
readily be manipulated to undergo the same conversion to green sulfhemoglobin as the human 
protein, the tissues of mice lethally exposed to sulfide have (to date) never exhibited any evidence 
of green discoloration, irrespective of whether the toxicant were given by single-shot 
intraperitoneal injection38 slow tail vein infusion (as in Figure 4) or by H2S inhalation (data not 
shown).  This marked difference in outcome between human victims122-125 and the animal models 
remains to be understood. 
2.4.2  Cultured Cells 
Proliferating (sub-confluent) bovine pulmonary artery endothelial cells (BPAEC) provide 
a means of investigating changes in mitochondrial function within the cellular environment – as 
we have previously shown in studies examining the effects of ionizing radiation133 and acute 
cyanide toxicity60 – without any potentially confounding effects due to the presence of hemoglobin 
and other bloodstream constituents.  Culturing cells and performing experiments at 3% (v/v) 
oxygen ensures that any “oxidative stress” experienced by the BPAEC is not artificially elevated 
beyond that to be expected in vivo.  In the past, we have successfully employed the metabolic 
indicator dye AlamarBlue® to monitor cell proliferation60, 133 but, more recently, have found this 
to undergo direct reduction by sulfide warranting a switch to a propidium iodide-based method for 
assaying cell death.38  As equilibrated aqueous sulfide is about 30% H2S at pH 7.4, it is rapidly 
lost to the atmosphere from unsealed containers.  To prevent this, cell cultures were covered with 
Parafilm and inoculations of reagents made by injections through the covering.  Undoubtedly, 
however, there were some losses and the concentrations of sulfide administered to the BPAEC in 
the following experiments should be read as the instantaneous sulfide concentrations just after the 
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inoculations.  To obtain a reproducible dose-response after 1 hour, it was found necessary to 
employ millimolar concentrations of sulfide in the cell media, irrespective of whether death was 
estimated by the propidium iodide method (Figure 5A) or by annexin V binding (Figure 5B).  The 
extent of cell death determined by either method never exceeded ~25%, most likely attributable to 
H2S (g) being lost under the conditions employed, with a maximum dose being achieved at ~5 mM 
NaHS in solution. 
BPAEC treated with toxic levels of sulfide appeared to be blebbing (not shown) which can 
be associated with a number of phenomena, including cell death by apoptosis and/or necrosis.  The 
annexin V-Cy3 assay is sensitive to the translocation of phosphatidyl serine to the cell exterior, or 
the presence of plasma-membrane fragments;134 hence it may be indicative of both apoptosis and 
necrosis.  The appearance of lactate dehydrogenase (LDH) activity in the medium following 
sulfide treatment, however, suggests the cell death to have been mostly necrotic (Figure 5C).  
While the propidium iodide and annexin V dose response curves are not completely 
superimposable, they are the same within the experimental uncertainty, again indicating necrosis 
to have been the predominant mechanism of cell death. 
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Figure 5. Hydrogen sulfide toxicity in BPAEC assessed by propidium iodide, annexin V Cy-3 and lactate 
dehydrogenase. 
BPAEC (at 80% confluency, grown in 3% oxygen at 37°C, in OptiMEM media) were exposed for 1 hr to increasing 
levels of NaHS (1-10 mM). BPAEC were subsequently treated with either propidium iodide (A) or annexin V Cy-3 
(B) (see Experimental Procedures for details). * p < 0.01 for BPAEC treated with 1-10 mM NaHS compared to the 
control cells. Lactate Dehydrogenase (LDH) activity (C) was determined in BPAEC with and without NaHS exposure 
(5 mM, 1 hr) * p <0.05. All p-values were determined by one way ANOVA using KaleidaGraph. 
 
 
Interestingly, there was clearly increased death in the case of cultures grown in a galactose-
containing medium compared to those grown in a glucose-containing medium (Figure 6A).  Cells 
conditioned to galactose rely more heavily on mitochondrial oxidative phosphorylation for their 
ATP production compared to cells maintained in glucose which rely more on glycolysis for their 
energy requirements.135, 136 Therefore, the present data clearly support the consensual viewpoint 
suggesting the principal target for sulfide toxicity to be mitochondrial.  In both the galactose-
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conditioned cells and the glucose-maintained cells, the addition of the NO-donor species55, 137 
sodium nitrite ameliorated sulfide-induced cell death and the addition of the NO synthase inhibitor 
L-NAME exacerbated the sulfide-induced cell death.  These findings concerning the effects of NO 
were confirmed in the case of glucose-maintained cells employing the propidium iodide assay 
(data not shown).  In summary, the results (Figure 6A) suggest that delivery of NO reverses the 
mitochondrial-linked toxicity of sulfide, while suppression of endogenous NO production 
exacerbates the toxicity.  We have previously demonstrated that NO is able to reverse the inhibition 
of cytochrome c oxidase by cyanide59, 60 and shown that this seemingly results in sodium nitrite 
being an effective cyanide antidote in mice.61, 138 Similarly, we have more recently shown sodium 
nitrite to have significant antidotal activity in mice toward sulfide intoxication.38  Consequently, 
the present findings (Figure 6A) are entirely consistent with the idea that inhibition of cytochrome 
c oxidase by sulfide is the principal molecular mechanism of toxicity and that the inhibition can 
be antagonized by NO.  
To further clarify the mechanism of sulfide-induced cell death, we performed a caspase-3 
activity assay (Figure 6B).  Irrespective of whether the BPAEC were galactose-conditioned or 
glucose-maintained, there was no measureable caspase-3 activation, demonstrating that sulfide 
does not induce apoptosis in this particular cell line and, consequently, the cell death observed in 
the other experiments (i.e. Figures 5A & B, 6A) was, unambiguously, almost entirely necrotic.  
Staurosporine causes apoptosis by an extrinsic mechanism and was used here as a positive control 
(Figure 6B). 
 
 
 
 41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Autophagy and 3-nitrotyrosine levels in glucose/galactose-conditioned BPAEC exposed to NaHS 
and/or NaNO2. 
BPAEC were grown in 3% oxygen at 37°C and either maintained in 5 mM glucose media (DMEM) or conditioned in 
10 mM galactose-media (DMEM) for 3 hours prior to further treatments.  A: Annexin V-Cy3 binding. BPAEC were 
treated either with 5 mM NaHS (1 hr), 0.5 mM sodium nitrite (added 5 min prior to NaHS), 0.5 mM L-NAME (added 
1 hr prior to NaHS), or combinations thereof. p –values measured between *sulfide treated and sulfide/nitrite treated 
BPAEC grown in 10 mM glucose by one way ANOVA.  p –values were also measured between #sulfide treated and 
sulfide/L-NAME treated BPAEC grown in 10 mM glucose by one way ANOVA.  Similar p-values were observed 
between sulfide, nitrite/sulfide and L-NAME/sulfide treated galactose-conditioned (5 mM) BPAEC.  B: Caspase-3 
activity.  BPAEC were treated with either 5 mM NaHS (1hr) or 1µM staurosporine (STAU) (30 min) and analyzed 
for caspase-3 activity (normalized to protein concentrations) p < 0.01 for the BPAEC controls versus the *glucose-
maintained and #galactose-conditioned cells. C: 3-Nitrotyrosine levels.  3-Nitrotyrosine levels (normalized to protein 
concentrations) in BPAEC treated with similar concentrations of 0.5 mM nitrite (10 min) and 5 mM NaHS (1 hour) 
were determined using an ELISA (see Experimental Procedures for details). *p <0.01 between the glucose- and 
galactose-conditioned controls.  All p-values were determined by one way ANOVA using KaleidaGraph  
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NO is clearly a modulator of sulfide toxicity in BPAEC (Figure 6A) and sulfide inhibition 
of cytochrome c oxidase should lead to oxygen accumulation and accompanying elevated 
production of superoxide (O2–).  Since NO in the presence of superoxide results in the diffusion-
limited generation of peroxynitrite (NO + O2– → ONO2–) we should consider whether peroxynitrite 
might be involved here.  Evidence for the production of peroxynitrite is most readily obtained 
through determination and quantification of its biomarker species 3-nitrotyrosine.139-141  Three-
nitrotyrosine levels were increased in galactose-conditioned BPAEC compared to glucose-
conditioned cells – to a greater extent than the effects of adding sulfide, nitrite, or both (Figure 
6C).  Note in particular that addition of nitrite alone did not result in any measurably significant 
increase in 3-nitrotyrosine levels, consistent with superoxide being the limiting reagent in the 
peroxynitrite formation.  Compared to glucose-maintained BPAEC, the galactose-conditioned 
cells have a higher rate of oxygen turnover due to a greater reliance on mitochondrial oxidative 
phosphorylation to generate ATP (see below).  Consequently, the present results (Figure 6C) are 
consistent with the widely held view that mitochondria can be a major source of superoxide in 
cells.  Compared to untreated controls, neither galactose-conditioned nor glucose-maintained 
BPAEC exhibited any significant increase in peroxynitrite production in response to sulfide, 
nitrite, or a combination of the two.  Thus, there does not appear to be any role for peroxynitrite in 
the antagonistic interplay between NO and sulfide within these cells. 
A Western blot analysis (Figure 7A) showed that cells conditioned in 10 mM galactose for 
3 hours prior to harvesting exhibited increased levels of LC3 II (lane 1) compared to those grown 
in 5 mM glucose (lane 3).  A decreased level of actin in the galactose-conditioned cells (lane 1) 
compared to those maintained on glucose (lane 3) is consistent with increased cellular degradation 
through autophagy in the former.  Interestingly, the addition of 5 mM NaHS to the galactose-
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conditioned cells 1 hour before harvesting resulted in decreased autophagy (lane 2) compared to 
the toxicant-free controls (lane 1).  Addition of 5 mM NaHS to the glucose-maintained cells did 
result in a slight increase in autophagy (lane 4) compared to the toxicant-free controls (lane 3).  
Overall, however, it is clear that the net rate of autophagy observed in BPAEC exposed to NaHS 
is similar in both media (compare lanes 2 and 4) and cannot account for the increased sulfide 
toxicity evident in galactose-conditioned BPAEC (Figure 6A). 
The mitochondrially targeted serine/threonine kinase, PINK1, has been shown to provide 
protection against mitochondrial dysfunction during cellular stress by helping to clear depolarized 
mitochondria via selective autophagy (i.e. mitophagy).142  Changes in PINK1 levels of galactose-
conditioned and glucose-maintained BPAEC following exposure to NaHS were determined by 
Western blot analysis (Figure 7B).  Again, actin levels were also followed as a check on cellular 
integrity. Compared to the galactose-conditioned cells (lanes 1 and 2) the glucose maintained 
BPAEC showed clearly elevated PINK1 levels (lanes 3 and 4) indicative of increased mitophagy.  
This result is fully consistent with the glucose maintained cells being more dependent on 
glycolysis, rather than oxidative phosphorylation, to meet their ATP requirements.  Addition of 
NaHS does not appear to have much impact on the observed results in either growth medium and, 
therefore, mitophagy does not contribute to the increased sulfide toxicity evident in galactose-
conditioned BPAEC (Figure 6A).   
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Figure 7. Western Blot analysis of LC3-I/II and PINK1. 
BPAEC were grown in 3% oxygen at 37°C and either maintained in 5mM glucose media (DMEM, lanes 3&4) or 
conditioned in 10mM galactose-media (DMEM, lanes 1&2) for 3 hours prior to treatment with NaHS (lanes 2&4). 
Either LC3 –I/II or PINK1 levels are shown with actin levels for comparison and normalized by protein concentration. 
Protein standards are shown on the far left-hand side of both blots. A: LC3-I/II.  BPAEC were poisoned with 5 mM 
NaHS for 1 hour (in either glucose or galactose) prior to harvesting for western blot analysis. B: PINK1. BPAEC were 
poisoned with 5 mM NaHS for 1 hour (in either glucose or galactose) prior to harvesting for western blot analysis 
(See Experimental Procedures for details of the Western blots). 
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2.4.3   Respirometric Measurements 
High-resolution respirometry was performed with an Oroboros Oxygraph O2k equipped 
with a Clark-type oxygen-sensing electrode for polarographic measurements. Using analogous 
equipment, Bouillaud and colleagues have shown143, 144 that rat heart mitochondria have a robust 
set of oxidizing enzymes that are able to detoxify sulfide (Figure 8) and that this system is lacking 
in neuronal mitochondria.  We took the trouble to briefly confirm these observations using minced 
mouse ventricular tissue and whole brain (data not shown). The first enzyme in this sulfide 
oxidizing unit is associated with the mitochondrial inner membrane and passes two electrons into 
the electron-transport system while converting hydrosulfide anion (HS–) to protein-bound 
persulfide (cys-S-SH).58, 145 This is a crucial step in the overall process and important for 
interpretation of the respirometric data; specifically, for sulfide to be catabolically eliminated 
through sulfide oxidation, the electron-transport system must be functioning.  If sulfide is bound 
and, therefore, inhibiting cytochrome c oxidase, then formation of the persulfide intermediate by 
the sulfide-quinone reductase and the subsequent oxygen-dependent steps cannot occur.  
Administration of aqueous sulfide into the medium of galactose-conditioned BPAEC (4 and 8 µM) 
led to a rapid but transient increase in the rate of oxygen consumption (Figure 9A, increased “O2 
flux”) commensurate with protection of mitochondrial function through oxidation of the sulfide.  
In this respect, the BPAEC appear to be more like cardiomyocytes than neurons. 143, 144  At 16 µM 
NaHS there was a more prolonged elevation in the oxygen consumption rate, suggesting that the 
sulfide-oxidizing unit may have been saturated for several minutes, but there was never any 
detectable net inhibition of electron transport (i.e. no sulfide-dependent decrease in oxygen 
consumption rate was observed).  Therefore and, most importantly, the sulfide-oxidizing system 
was able to efficiently outcompete cytochrome c oxidase for the available sulfide!  Repeating these 
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experiments with glucose-maintained BPAEC yielded unsurprising results (Figure 9B).  Using 
samples normalized by cell count (106 cells in each case), the overall oxygen-consumption rates 
were slower in the glucose-maintained BPAEC (~40%) and the increased oxygen uptake rates in 
response to sulfide additions were more modest.  Again, there was no evidence for inhibition of 
electron transport and, accordingly, addition of the NO-donor species sodium nitrite did not impact 
on the respirometric results (data not shown).  Note, however, that the sulfide concentrations used 
in these experiments were about two orders of magnitude less than the concentrations used to 
demonstrate the mitochondrial link to sulfide-induced death (Figure 6A).  Unfortunately, at sulfide 
concentrations approaching 50 µM and in the absence of any cells in the sample chambers, the 
Clark electrodes exhibited a variable (sulfide-dependent) basal oxygen flux (see Supplemental 
Data) and this interference prevented meaningful respirometric studies at higher sulfide 
concentrations where inhibition of electron transport might be observable. 
Figure 8. Sulfide Oxidizing Unit (SOU) in Mitochondria.
Adapted with permission from John Wiley and Sons, Inc. from FEBS J. Three enzymatic activities catalyze the 
oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria; Hildebrandt, T.M. and Grieshaber, 
M.K.; Vol. 275; Copyright 2008; permission conveyed through Copyright Clearance Center, Inc. [57]
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Figure 9. Respirometric Analyses. 
Oxygen consumption was assessed in BPAEC (3 x 106 cells/mL) conditioned in either (A) 5 mM glucose or (B) 10 
mM galactose 3 hours prior to testing. BPAEC were allowed to equilibrate for ~10 minutes prior to sequential 
additions of NaHS (final concentrations of 4, 8 and 16 µM). Oxygen concentration is shown on the right axes (dashed 
lines) and oxygen flux on the left axes (solid lines).  Galactose treated BPAEC turned over oxygen at a rate of 90(±10) 
pmole/(s mL) versus 60(±10) pmole/(s mL) for the rate of the glucose-condition cells.  The default settings of block 
temperature, 37°C; stir bar speed, 400 rpm and data recording, 2 s were used.  
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2.5 Conclusion 
2.5.1  Post-Acute Toxicity 
As we previously observed with mice given single-shot intraperitoneal injections of NaHS 
in saline38 slower infusion of the toxicant solution into the tail vein (Figure 4) also resulted in death 
through cessation of respiration.  While in a rat model it appears that death is due to cardiac 
failure,105 in both cases the animals recover quickly if infusion of toxicant is stopped before they 
succumb.  In keeping with the widely held view96, 101, 146 that the central nervous system is the 
critical target for acute sulfide toxicity (at least in these experimental systems) we suggest that it 
is probably reasonable to think of all these findings falling under the single category of death 
through some kind(s) of cardiopulmonary paralysis.  Certainly, this seems reasonable given the 
observation, with which we concur, that neuronal mitochondria are less able to detoxify sulfide 
than myocardial mitochondria.143, 144  Some of the reported cases of human poisonings reflect these 
experimental findings – death can be very rapid, or unconscious individuals can recover without 
medical intervention.  Significant numbers of human victims of H2S inhalation, however, arrive at 
the clinic exhibiting compromised respiratory function, most frequently with pulmonary edema, 
30 minutes or more after exposure and may only succumb hours later.96, 100, 106-108 
It now seems quite clear that surviving human victims of sulfide poisoning, who do not 
spontaneously recover and present with respiratory insufficiency, cannot possibly be subject to the 
same mechanism(s) of toxicity as experimental animals that have been infused/injected with the 
toxicant.  In particular, we suggest the following scenario that plausibly explains the critical 
differences.  Virtually all cases of human sulfide poisonings involve inhalation of H2S gas, which 
necessarily means that systemic levels of the toxicant species must be lower than that experienced 
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by the pulmonary tissue.  Given the ability of endothelial cells to oxidize sulfide (Figure 9) it 
appears that the lung may be able to protect other tissues, especially those of the central nervous 
system, from the inhaled toxicant.  Therefore, victims exhibiting rapid knockdown and/or death 
around the time of exposure to the gas must have experienced H2S levels high enough to result in 
saturation of the sulfide detoxifying capabilities of their pulmonary tissue and/or received some of 
the dose through nasal tissues by-passing the lung.  At lower levels of H2S exposure, the central 
nervous system may never be enough affected to result in cardiopulmonary paralysis, but if the 
dose continues for at least several minutes, then pulmonary tissue damage including necrosis of 
endothelial cells (Figures 5 and 6) will ensue.  Since death in response to sulfide exposure has also 
been demonstrated in pulmonary smooth muscle cells,147 it is to be anticipated that the sulfide-
induced endothelial barrier dysfunction leading to lung edema may involve at least these two cell 
types.  It follows that lethality in the “post-acute” timeframe (i.e. an hour or more after the toxicant 
exposure) appears to be due principally to respiratory insufficiency secondary to the lung edema. 
2.5.2   An Approach to Antidotes? 
A virtue of the above discussion is that it does offer an explanation as to why application 
of cyanide antidotes to the treatment of sulfide intoxication might be ineffective.  Cyanide and 
sulfide have generally been thought to be similar mitochondrial poisons, exhibiting essentially 
indistinguishable inhibitory effects towards cytochrome c oxidase.98  However, while cyanide 
antidotes like sodium nitrite (protective of mitochondrial function) are effective if given after the 
toxicant dose61, 62 they tend to only work prophylactically as sulfide antidotes.38  Whether by 
inhalation of HCN, ingestion of cyanide salts, or other cyanogenic compounds, in acute cases 
significant toxicant reaches the central nervous system and death results from cardiopulmonary 
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paralysis.148, 149  Therefore, one is drawn to conclude that in order to be effective the available 
cyanide antidotes must ameliorate these toxic effects on the central nervous system.  As discussed 
above, victims of sulfide poisoning reaching the clinic alive are probably no longer experiencing 
any acute toxicity where cardiopulmonary paralysis is a significant problem and, consequently, 
one should not necessarily expect cyanide antidotes to be of much use for therapeutic application 
to sulfide poisoning cases. 
In developing new therapies for sulfide poisoning, it seems most reasonable to assert that 
the focus should be on treating the post-acute pulmonary edema.  Our present findings show that 
NO is antagonistic towards sulfide-induced damage in endothelial cells (Figure 6A) and others 
have previously shown that NO donors are cytoprotective towards sulfide damage in pulmonary 
smooth muscle cells.147  While there are probably many more examples in the literature of 
deleterious or even causative effects of NO in relation to lung injury, during the past decade or so, 
there have been multiple reports of the efficacious application of NO delivery in the treatment of 
a variety of pulmonary edemas in both animal models150-152 and human subjects.153-155  
Undoubtedly, the extent of the edemas in question and the precise dose of NO to be employed are 
critical matters that remain to be satisfactorily explored.  Nevertheless, in our opinion, there is now 
already enough evidence to suggest that an NO-inhalation therapy approach to the treatment of 
sulfide poisoning should be considered a promising area for further research.  
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2.6 Supplemental Materials and Figures 
 
 
 
 
 
 
 
 
 
 
Figure 10. Cultured cell-free respirometric data. 
Solid trace:  To initially aerobic PBS (2.0 mL in the sample chamber, at 25°C) additions of anaerobic buffer (2, 5, 10, 
25, 50, 100 µL at 25°C) were made with gas-tight syringes at two-minute intervals.  The trace shows the response of 
the system to decreasing levels of oxygen following the introduction of anaerobic solution.  If cells were present, this 
type of response can mistakenly be taken for oxygen consumption (increased respiration).  Dotted trace:  2.0 mM 
aerobic NaHS was prepared in a septum-sealed container and titrated (2, 5, 10, 25, 50, 100 µL at 25°C; each 1 µL 
addition resulting in a 1 µM increase in NaHS concentration) into initially aerobic PBS (2.0 mL in the chamber, at 
25°C) with a gas-tight syringe.  The trace shows the response of the system to increasing levels of oxygen following 
introduction of aerobic solutions – indicating that there must have been a net lowering of the oxygen level in the 
sample chamber during the course of the experiment that was probably due to slow oxidation of added sulfide.  In 
addition, however, following the additions of 25-µL and greater volumes of the NaHS solution, the apparent basal 
oxygen consumption began to rise, also probably due to slow oxidation of added sulfide.  Again, if cells were present, 
this type of response could be misinterpreted as cellular oxygen consumption (increased respiration).  It is not clear if 
the observed oxidation of sulfide was occurring at the electrode surface, or in free solution; but there was no 
irreversible change in the system’s behavior, simply rinsing out the sample chamber resulted in a return to initial 
behavior.  There is, however, clearly a potentially serious artifact detected during the collection of respirometric data 
at 25 µM and higher added NaHS. 
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Figure 11. SHSY-5Y neuronal cells  exposed to successive concentrations of NaHS. 
SHSY-5Y neuronal cells were exposed to successive concentrations of NaHS, injected into the chamber in µL 
additions (5, 50, 100, 200). NaHS was prepared in an airtight container with a suba-seal and injections were done with 
a Hamilton gastight syringe, at 37°C. Final NaHS concentration in the chamber, 1 µL = 1 µM.  
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3.0 Results of Toxicant/Antidote Testing in a Mouse Model 
3.1  Introduction 
The following results offer an abridged review of the antidotal activity in Swiss-Webster 
mice exposed to each of the three toxicants (sulfide, cyanide or azide) and treated either 
prophylactically or therapeutically with NaNO2 or CoN4[11.3.1] through ip injection. For each of 
the studies reviewed, recovery of righting ability in the mice was measured following a 
simplification of a procedure originally used by Crankshaw et al,156 defined as the time it took 
from the initial administration of the toxicant until the mouse flipped from a supine position (on 
back) to a prone position (on feet) in a plastic, critter tube. Treatment efficacy was established by 
a decrease in the timed recovery of righting ability after receiving injections of both the antidote 
and toxicant, compared to mice treated with the toxicant alone. Interestingly, we were able to 
produce a similar unconscious or “knockdown” response in the Galleria mellonella larvae exposed 
to the three toxicants. The duration of said recovery of righting (minutes) differed among the two 
species; as did the dose that elicited the knockdown response. It was interesting to our group to 
draw a comparison of the G. mellonella larvae data to that of the mouse data.  
3.1.1  Sulfide Toxicity Testing 
Sulfide poisoning and amelioration in mice was examined by Cronican et al, 201838 
(Appendix A) in both 16–18 week old adult, male Swiss-Webster mice (40-59 g) and 6-8 week 
old juvenile male Swiss-Webster mice (25-35 g).  Briefly, the mice were exposed to an LD40 (16 
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mg/kg (adult) or 18 mg/kg (juvenile) aqueous dose of NaHS through an intraperitoneal (ip) 
injection resulting in 57% survival in adult and a 67% survival in juvenile male mice (Table 4). In 
the case of sulfide, the knockdown/recovery of righting ability was variable and short. The mice 
that did not die within 5 minutes of receiving the toxicant were fully recovered within 15 minutes. 
Since a significantly larger number of animals would have been required to demonstrate the effects 
of the antidotes through righting recovery, efficacy of the NaNO2 amelioration of NaHS toxicity 
had to be validated through percent survival. (Appendix A) 
We observed a different response in the G. mellonella poisoned by sulfide. We were able 
to administer an intrahaemocoel (ih) injection of NaHS (72mg/kg) into the G. mellonella larvae 
and produce a repeatable 10 minute unconscious state (Section 4.4.4; FIGURE 16A). During the 
unconscious state the larvae were placed on their backs, similar to the mice, and the recovery of 
righting was able to be timed (from the initial administration of the toxicant until the larvae turned 
onto their feet).  
In the Swiss-Webster mice, the prophylactically administered NaNO2 (24 mg/kg dose), 
five minutes before, was highly protective against acute toxic effects of the NaHS (LD40) in both 
adult (16 mg/kg) and juvenile mice (18 mg/kg) increasing the percent survival from 57-67% to 
93–94% (Table 4), respectfully. Not surprisingly, in a preliminary study using juvenile mice, 
CoN4[11.3.1] (26 mg/kg) was administered prophylactically 2 minutes before NaHS (18 mg/kg), 
this dose was antidotal toward the sulfide poisoning (92% survival) (Table 4). G. mellonella larvae 
were also treated with both NaNO2 (5 mg/kg) and CoN4[11.3.1] (8 mg/kg) therapeutically, one 
minute after NaHS. The length of the knockdown was cut in half when the antidotes where 
administered, from 10 minutes to ~5 minutes (Section 4.4.4; Figure 16A).  
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The dose given to mice (16/18 mg/kg) was much smaller than the dose given to G. 
mellonella (72 mg/kg). The apparent difference in the response to sulfide (pKa ~7.1) could be due 
to the difference in pH of the two systems. In mice hemoglobin, (pH 7.4) NaHS is a 30:70 mixture 
of H2S/HS-.38  Whereas, in the larvae hemolymph (pH 6.8), the NaHS is a 70:30 mixture H2S/HS-
33. In the G. mellonella larvae system, more sulfide is present in the gaseous form (H2S) (Section 
4.5.2) so small gaseous molecules like H2S could easily be lost from the small larval body by 
passive diffusion. This explanation may account for the larger dose of NaHS having to be used in 
G. mellonella.
Table 4. Antidotal activity of sodium nitrite and CoN4[11.3.1] against sulfide toxicity in Swiss-Webster mice. 
 
3.1.2   Cyanide Toxicity Testing 
In the next study, Cambal et al157 exposed adult, male Swiss-Webster mice to 5 mg/kg 
doses of NaCN by ip injection. The percent survival of the cyanide exposed mice was 66% and 
after a subsequent dose of NaNO2 (12 mg/kg), 2 minutes after NaCN (5 mg/kg), the percent 
survival increased to 82% and recovery time was dropped from 24 minutes to 6-9 minutes (Table 
All agents given in saline solutions by ip injection. Antidotes administered prophylactically 
* Data not published
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5). Expanding on the Cambal cyanide study, Andrea Cronican, et.al23, (Appendix B) went on to 
examine the ameliorative effects of four cobalt-containing complexes, including CoN4[11.3.1], on 
cyanide poisoning in 7-8 week old juvenile, male Swiss-Webster mice. The percent survival of the 
juvenile mice exposed to NaCN (5 mg/kg) only, was greater than that of the adults in the Cambal 
et al157 cyanide study, 80% versus 66% (Table 5), however, the recovery of righting time was 
similar (24 minutes).  When the mice received an ip dose of CoN4[11.3.1] (50 µmol/kg) one minute 
after the ip cyanide, survival was increased to 92% and the recovery of righting time decreased to 
4 minutes (Table 5).  In the juvenile mice cyanide study, 23 the mice administered CoN4[11.3.1] 
exhibited a noteworthy improvement compared to other cobalt-containing compounds tested, but 
did not offer the same measurable impact when administered 5 minutes after. This study suggests 
that within five minutes after the cyanide dose, the toxicant had bound the active site of cytochrome 
c oxidase and was unable to be removed.  
A comparable study was completed in the G. mellonella larvae (Section 4.4.4.). 
CoN4[11.3.1] (8 mg/kg) was  given one minute after NaCN similar to the mouse cyanide data 
(Section 4.4.4). G. mellonella were injected intraheamocoelly (ih) with 7.5 mg/kg NaCN, a dose 
similar to the 5 mg/kg dose the mice received. In the larvae, the recovery time for the toxicity of 
cyanide was cut in half with both the NaNO2 and the CoN4[11.3.1] when administered one minute 
after the toxicant (from 11 minutes to ~5 minutes) (Figure 16B). The similarity here suggests that 
insect and mammalian cyanide toxicity models may not be very different.  
 
 
 
 
57 
Table 5. Antidotal activity of sodium nitrite and CoN4[11.3.1] against cyanide toxicity in Swiss-Webster mice.
3.1.3  Azide Toxicity Testing 
Finally, a preliminary study was done by our group to examine the effects of NaNO2 (not 
published) and CoN4[11.3.1] 24 on 16-20 week old adult, male Swiss-Webster mice poisoned by 
azide. The mice exposed to a 26 mg/kg (adult) ip dose of sodium azide had an 88% survival, with 
an approximate 40 minute righting recovery time (Table 6). A 24 mg/kg dose of NaNO2 was not 
particularly effective at ameliorating NaN3 therapeutically in adult mice, only decreasing recovery 
time by 2 minutes with similar survival (Table 6). However, therapeutic injection CoN4[11.3.1] 
five minutes after NaN3 produced a 100% survival, and a decrease in the righting recovery time 
from 40 minutes to 12 minutes (Table 6). Next, G. mellonella were treated with 5 mg/kg NaNO2 
or 8mg/kg CoN4[11.3.1] (Figure 16C) one minute after a 14 mg/kg dose of NaN3 (Section 4.4.4). 
In G. mellonella treated with NaNO2 the recovery of righting ability improved from 33 minutes in 
larvae treated with azide alone to ~19 minutes; even more impressive, the larvae that received the 
CoN4[11.3.1] one minute after showed an improvement in righting recovery from 33 minutes to 
11 minutes (Figure 16C). Recovery with the Busch compound was more significant than the 
NaNO2 (p ≤ 0.001).  
All agents given in saline solutions by ip injection. Antidotes administered prophylactically 
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After reviewing the results in the G. mellonella study (Section 4.4.4), we made the decision 
to re-examine the NaNO2 in the mice. (Submitted to Chem Res Toxicol) This time we investigated 
the effects in juvenile, male Swiss-Webster mice (6-8 weeks old; data not published). The mice 
received a therapeutic dose of 24 mg/kg NaNO2 or a 70 µmol/kg ip dose of CoN4[11.3.1], five 
minutes after a 27mg/kg dose of NaN3. Of the mice that received NaNO2, 2 of the 6 mice knocked 
down and recovered righting ability within ~23 minutes of receiving the azide injection (Table 6). 
We went on to inject CoN4[11.3.1] five minutes after the NaN3, and again there was a 100% 
survival in these mice and recovery time was cut in half from 38 minutes to 16 minutes (Table 6). 
Again, we injected a small sample of the adult mice (12 weeks old) and were surprised to see that 
the adult mice did not regain recovery of righting ability faster than mice receiving azide alone 
(data not shown). This supported the adult mouse data reported earlier where the NaNO2 was not 
shown to be helpful in adult mice.  
 
Table 6. Antidotal activity of sodium nitrite and CoN4[11.3.1] against azide toxicity in Swiss-Webster mice. 
All agents given in saline solutions by ip injection. Antidotes administered prophylactically 
* Data not published 
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3.2 Summary  
We were able to observe a comparable ameliorative response to both the NaNO2 and 
CoN4[11.3.1] in the mouse and G. mellonella models. It was of interest to compare the results of 
mouse and G. mellonella studies conducted in our laboratory since the similarities in response to 
the toxicants/antidotes suggests that insects and mammalians may not be very different. We know 
that the cytochrome c oxidase is conserved between the species17 and there is a significant 
difference related to blood and hemolymph in the two organisms. Due to the promising nitrite data 
in the cell (Section 2.4.2), G. mellonella (Section 4.4.4) and mice, this putative antidote appears to 
be promising for future studies. Finally, CoN4[11.3.1] significantly reduced the righting recovery 
in both G. mellonella (Section 4.4.4) and mice. The similarity found in this data suggests that for 
comparative purposes, in preliminary screening, G. mellonella larvae may be an acceptable model 
for prescreening antidotes ahead of mammalian studies. 
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4.0 Assessing Modulators of Cytochrome c Oxidase Activity in Galleria mellonella Larvae 
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4.1 Abstract 
Caterpillars of the greater wax moth, Galleria mellonella, are shown to be a useful 
invertebrate organism for examining mitochondrial toxicants (inhibitors of electron transport) and 
testing putative antidotes.  Administration of sodium azide, sodium cyanide, or sodium (hydro) 
sulfide by intra-haemocoel injection (through a proleg) results in a dose-dependent paralyzed state 
in the larvae lasting from <1 to ~40 min.  The duration of paralysis is easily monitored, because if 
turned onto their backs, the larvae right themselves onto their prolegs once they are able to move 
again.  The efficacy of putative antidotes to the three toxicants can routinely be assessed by 
observing shortened periods of paralysis with larvae given toxicant and antidote compared to 
larvae administered only the same dose of toxicant.  The validity of the approach is demonstrated 
with agents previously shown to be antidotal towards cyanide intoxication in mice; namely, 
sodium nitrite and CoN4[11.3.1] (cobalt(II/III) 2,12-dimethyl-3,7,11,17-tetraazabicyclo-[11.3.1]-
heptadeca-1(7)2,11,13,15-pentaenyl cation).  These same compounds are shown to be antidotal 
towards all three toxicants in the G. mellonella caterpillars; findings that may prove important in 
relation to azide and sulfide poisonings, for which there are currently no effective antidotes 
available.  The observation that sodium nitrite ameliorates cyanide toxicity in the larvae is 
additionally interesting because it unambiguously demonstrates that the antidotal action of nitrites 
does not require the involvement of methemoglobin, contributing to the resolution of an ongoing 
controversy. 
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4.2 Introduction 
Any compounds entering mammalian blood, whether deliberately introduced in the diet, 
as pharmaceuticals, or inadvertently absorbed environmental agents, will encounter millimolar 
concentrations of blood proteins, particularly hemoglobin and serum albumin. From an 
experimental perspective, this can be problematic, because the broader effects that a xenobiotic 
may have on the other systemic cells/tissues can be masked by overwhelming interactions with the 
blood proteins present at anomalously high levels compared to most non-structural biochemical 
molecules.  In addition, reactive small bioinorganic molecules, secondary derivatives of oxygen 
and nitric oxide competent to modify many organic compounds, can be generated in the 
bloodstream. The comparative experimental use of invertebrates to investigate the mechanistic 
biological effects that chemical agents may have in the absence of a confounding mammalian 
vasculature is, therefore, of some value. 
The larvae (caterpillars) of the greater wax moth Galleria mellonella (commonly called 
“wax worms”) (Figure 12) have been proposed as a model organism for screening potential 
therapeutics for microbial infections 73, 75, 77 and investigating the safety of food additives 158.  More 
generally, of course, the application of such larvae could reduce considerably the number of 
mammals otherwise required for preliminary toxicological testing of any new commercial 
compounds.  For many experimental applications, the G. mellonella larvae (average length: 2 cm; 
average weight: 250 mg) display advantages compared to the common insect model Drosophila 
melanogaster (average length: 3 mm; average weight: 0.5 mg).  For instance, while administration 
of reagents through routes similar to those used with Drosophila such as inhalation, feeding, or 
topical application 159 is possible, the larger G. mellonella larvae can also routinely be given 
reagents through intra-haemocoel injection (ih) allowing precise control of the dose administered.  
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The inexpensive G. mellonella larvae are available commercially in large numbers, facilitating 
good statistical analyses.  Unlike vertebrate models, such as mice and zebra fish, the larvae have 
no special care requirements, do not need feeding, can be reared at temperatures ranging from 
15°C through 37°C and are easily housed in plastic containers with perforated lids and some wood 
shavings.  G. mellonella larvae are also devoid of any of the ethical and legal requirements 
associated with the experimental use of mammals. 
 
 
 
 
 
Figure 12. G. mellonella. 
Diagram and scaled picture of the Galleria mellonella (Lepidoptera: Pyralidae, the greater wax moth) 
 
 
In our laboratory, interest in G. mellonella larvae arose in relation to screening potential 
antidotes to mitochondrial toxicants. Most importantly, for this purpose, the larvae contain 
functioning mitochondria and, since they are air breathing, exposure to gaseous compounds of 
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interest is possible.  Physiologically, the fat body contained in G. mellonella larvae is an organ that 
functions in a metabolically similar fashion to the mammalian liver and adipose tissue, containing 
a number of cytochrome P450, glutathione- and sulfo- conjugation enzymes which are involved 
in drug detoxification.76, 158  The hemolymph is an analogue of mammalian blood 91 though it does 
not function in the transport of gasses and has no hemoglobin, or other oxygen carrier.  The 
hemolymph does, however, participate in the immune defense of the larvae 89, 160.  The insect larval 
midgut epithelial cells also share similar physiological phenotypes to the intestinal cells of 
mammalian digestive systems 73, 161.   
In the current study, we have examined the susceptibility of G. mellonella larvae to the 
mitochondrial toxicants azide, cyanide and sulfide.  All three seem to inhibit the insect cytochrome 
c oxidase, the terminal electron acceptor of the mitochondrial electron transport system, in a 
manner similar to the results previously reported for the mammalian enzyme.  At this time, there 
is no available antidote and/or reliable protocol for treating acute azide or sulfide poisoning and 
only a single FDA-labeled treatment for cyanide toxicity (Cyanokit®, containing 
hydroxocobalamin).  Another off-label cyanide antidote is available (Nithiodote®, containing 
nitrite and thiosulfate) but this two-component cocktail continues to be a source of controversy.  
Specifically, it was believed for decades that sodium nitrite functioned as a cyanide antidote by 
virtue of its methemoglobin generating capability, resulting in cyanide scavenging through 
formation of cyanomethemoglobin.  Quite recently, the validity of this hypothesis has been 
seriously challenged 61, 62, 162, 163, but the older erroneous explanation for the efficacy of sodium 
nitrite continues to persist in the literature 164-166.  Herein, we seek to further discredit the 
cyanomethemoglobin-formation hypothesis by demonstrating the effectiveness of sodium nitrite 
as a cyanide antidote in G. mellonella larvae which do not contain any hemoglobin.  In total, we 
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have studied the ameliorative capabilities of sodium nitrite and a cobalt-containing 
hydroxocobalamin mimic towards azide, cyanide and sulfide in the larvae.  Through comparison 
with the reported analogous data for mammalian systems, the results provide valuable insights into 
the mechanisms of action and proof-of-concept data that will assist in the design of improved 
antidotes to these and similar mitochondrial poisons for use in humans and livestock. 
4.3 Materials and Methods 
4.3.1  Reagents  
Unless stated to the contrary, all reagents were ACS grade or better, purchased from either 
Sigma-Aldrich or Fisher Scientific and used without further purification.  The composition of the 
sodium hydrosulfide (NaSH•xH2O) as supplied was determined by a previously described titration 
method.38  Sodium azide (NaN3), sodium cyanide (NaCN) and sodium hydrosulfide solutions were 
prepared immediately prior to use for injection into G. mellonella in phosphate-buffered saline 
(PBS) followed by filtration (22 µm) into septum-sealed vials with minimized headspaces.  
Subsequent volumetric transfers were made with gas-tight syringes.  At pH 7.4, a mixture of ~30% 
H2S and ~70% HS– exists in aqueous solution.  In keeping with what seems to be a common 
convention, we refer to this mixture at physiological pH as “sulfide.”  Although greater than 98% 
of HCN is present at physiological pH, the combination of HCN + less than 2% CN– is referred to 
as “cyanide.”  Very little HN3 is found at physiological pH and, therefore, the term “azide” for 
solutions prepared from the sodium salt is unambiguously appropriate. Cobalt(II/III)2,12-
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dimethyl-3,7,11,17-tetraazabicyclo-[11.3.1]-heptadeca-1(7)2,11,13,15-pentaenyldibromide 
(CoN4[11.3.1]) was synthesized and characterized as previously reported.70 
4.3.2  G. mellonella Larvae Exposures 
Sixth instar G. mellonella larvae (order Lepidoptera, family Pyralidae, the greater wax 
moth) were purchased from Vanderhorst Wholesale, Inc. (Saint Mary’s, Ohio).  The larvae were 
shipped overnight and, upon arrival, incubated in their shipping containers, at 30°C, in complete 
darkness.  The larvae were allowed to acclimate for two days from the date of delivery and were 
then used within 10 days.  Larvae were handled minimally and carefully to avoid stress; feeding 
was unnecessary.  Preceding intra-haemocoel injections, gastight syringes were washed with 10% 
bleach solution (2x), followed by 100% ethanol (2x), water (3x) and finally PBS (1x); repeating 
the washing after every 10 larvae and again between each group.  Larvae were counted, measured 
(2-2.5 mm), weighed (250-300 mg) and placed in a holding dish.  During manipulation, the larvae 
were held between thumb, forefinger and index finger, cleaned with 70% ethanol using a cotton 
swab and injected into the hemocoel through the last left pro-leg using a 10 µL syringe.  Each 
subsequent injection into the same larva was into a different leg by rotating to the right and the 
larvae were then transferred to a Petri dish containing a piece of paper towel, to observe time until 
knockdown (in the case of toxicants) and recovery.  Once larvae recovered and began crawling 
around again they were relocated to a clean Petri dish with a new piece of paper towel.  The dishes 
were taped, labeled and incubated at 30°C overnight. 
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4.3.3  Righting-Recovery Testing 
Following toxicant injections of sodium azide (5.7-22.5 mg/kg), sodium cyanide (1.5-20 
mg/kg), or sodium hydrosulfide (18-140 mg/kg), the larvae exhibited a state of paralysis (became 
motionless) and were able to be placed on their backs in the supine position.  The duration of time 
required for the larvae to turn back over onto their legs/prolegs to the prone position, and remain 
so, was measured and recorded.  For each individual, the time between the onset of paralysis and 
the larva flipping back onto its legs/prolegs was taken as the righting-recovery time, similar to the 
procedure we have previously employed with mice.38, 61  The caterpillars were then returned to the 
Petri dish and observed for 48 hours for any adverse reactions, of which there were none. 
4.3.4  Antidote Testing 
Solutions of antidotes (5 mg/kg sodium nitrate or 8 mg/kg CoN4 [11.3.1]) were prepared 
fresh for each experiment in sterilized PBS.  The potential toxicity of the putative antidotes was 
tested by injecting the larvae (n = 20/group) with a 5 µL intra-hemocoel injection through the 
proleg.  Larvae were placed in a Petri dish within an incubator at 30°C observed for 48 hours, 
during which time no adverse reactions were observed.  Subsequently, nitrite or CoN4[11.3.1] 
solution was injected into G. mellonella larvae 5 min prior to 14 mg/kg NaN3, 7.5 mg/kg NaCN, 
or 72 mg/kg NaHS and the righting recovery times were measured. 
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4.3.5  G. mellonella Tissue Collection 
Approximately 20 larvae were put into a Petri dish and placed in the refrigerator (4°C) for 
twelve minutes.  The larvae were then transferred to a weighing boat on ice with 1 mL cold 
mitochondrial isolation buffer (154 mM KCl, 1 mM EDTA; pH adjusted to 6.8) 159 and chopped 
with scissors.  The minced tissue was poured into an ice-cold tissue grinder with 5 mL cold 
mitochondrial particle extraction buffer and gently homogenized using a 15-mL conical tissue 
homogenizer with a glass pestle (80 strokes up and down).  The homogenate was poured into a 15 
mL conical tube through cheesecloth to collect the liquid, which was centrifuged (1500 x g; 4°C) 
for 8 minutes (Beckman Coulter Allegra X-12R centrifuge).  The supernatant was discarded and 
the pellet washed with 200 µL mitochondrial isolation buffer (1500 x g; 4°C) for 2 minutes.  The 
pellet was finally suspended in 100 µL mitochondrial isolation buffer plus 100 µL 10% dodecyl 
maltoside solution and incubated on ice for 30 min prior to cytochrome c oxidase activity assays.  
Alternately, for respirometric measurements, the final tissue pellet was resuspended in 200 µL 
mitochondrial isolation buffer prior to being stored on ice subsequent to use (see below).   
4.3.6  Cytochrome c Oxidase Assays 
Ferrocytochrome c:O2 oxidoreductase activity was spectrophotometrically determined by 
employing a method similar to Sinjorgo et al.167  After incubation, the G. mellonella tissue was 
diluted 1:10 with mitochondrial assay buffer (115 mM KCl, 10 mM KH2PO4, 2 mM MgCl, 3 mM 
HEPES, 1 mM EGTA, BSA 0.2%; pH adjusted to 6.8)159, ferrocytochrome c (5-30 µM) was added 
and the change in absorbance at 550 nm was measured over time in 0.25 mM oxygen at 25°C.  All 
kinetic time courses for ferrocytochrome c oxidation were essentially linear in the range 10−60 s.  
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Where required, rates were estimated from the linear-region slopes of ferrocytochrome c 
concentration versus time plots.  Azide and cyanide inhibition of cytochrome c oxidase was 
determined using 0.1 mM azide, 1.0 mM azide, 7 µM cyanide and 14 µM cyanide, varying the 
initial concentration of ferrocytochrome c.  The assays were performed using Shimadzu UV-
1650PC and UV-2501PC spectrophotometers. 
4.3.7  Respirometric Experiments 
An Oxygraph O2k Polarographic instrument (Oroboros Instruments, Innsbruck, Austria), 
equipped with a Clark-type electrode for high-resolution respirometry was used to measure oxygen 
fluxes and concentrations.  Mitochondrial respirometer solution, MiR05,168(0.5 mM EGTA, 3 mM 
MgCl2, 60 mM lactobionic acid, 10 mM KH2PO4, 20 mM HEPES, 110 mM D-Sucrose, 1g/l BSA) 
35 (2.1 mL) was added to each chamber and equilibrated for 20 minutes prior to the addition of ~50 
µL tissue homogenate (prepared as described above) into the Oxygraph chambers (sealed from the 
atmosphere) at 25°C.  Mitochondrial electron transport was observed with the addition of NADH 
oxidase substrate precursors, pyruvate (final concentration: 5 mM), malate (final concentration: 
0.5 mM) and glutamate (final concentration: 10 mM) to the respirometer.  A determination of the 
state of coupling of the mitochondrial tissue was evaluated by the addition of CCCP (final 
concentration: 0.05 µM) and cytochrome c (final concentration: 10 µM) to the respirometric 
chamber.  Oxygen turnover was examined by the addition of succinate (final concentration 10 
mM) and NADH (0.5 mM). Rotenone (final concentration: 0.5 µM) and antimycin A (final 
concentration: 2.5 µM) were added to inhibit complex I and complex III, respectively.  Each of 
the following cytochrome c oxidase inhibitors were added as small volumes of unbuffered 
solutions in deionized water:  sodium azide (pH 7.0, final concentration: 1.25 mM), sodium 
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cyanide (pH 11.3, final concentration: 15 µM) or sodium hydrogen sulfide (pH 10.0, final 
concentration: 15 µM) by gas-tight syringe into the sealed Oxygraph chambers.  Respirometric 
data analysis was carried out with DatLab 7 software provided by Oroboros.  
4.3.8   Numerical Analysis   
Statistical comparisons were carried out using one-way analysis of variance (ANOVA) and 
student t-tests.  Values are expressed as means +/- standard errors.  A p-value ≤ 0.05 was 
considered significant and statistical analyses were performed with KaleidaGraph® (Synergy 
Software). 
The subunit sequences (CO1, CO2 and CO3) encoded in the mitochondrial DNA of 
cytochrome c oxidase from H. sapien, M. musculus, B. taurus and G. mellonella species were 
compared using UniprotKB (https://www.uniprot.org/).  A BLASTp search was done to find 
sequence similarity between H. sapien (H9RLZ4) and G. mellonella (A0A0S1YCX8) protein 
sequences for subunits 1-3 (CO1, CO2, CO3), based on E-value data.  The E-values for the 
comparison of the G. mellonella to H. sapiens cytochrome c oxidase subunits 1-3 were the 
following:  CO1 gene (D8VVZ2_GALME vs H9RLZ4_HUMAN) was 6.1e-47, for CO2 
(COX2_GALME vs COX2_HUMAN) 4.7e-87 and for CO3 (A0A0S1YD76_GALME vs 
COX3_HUMAN), 1.6e-139.  These E-values showed a significant relationship between the two 
sequences compared in all subunits. BLAST also provided a quantitative measurement of the 
similarity between the two sequences with related species having a higher percent identity than 
more distantly related species. For CO1 there was an 83% identity, for CO2 a 55% and CO3 a 
65.8% respectfully. Finally, Clustal Omega Alignment was used to view the characteristics of the 
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four species alongside each other to observe the relationships between ligands for prosthetic groups 
within the CO1 and CO2 subunits of cytochrome c oxidase. 
4.4 Results 
4.4.1  Cytochrome c Oxidase Turnover and Inhibition Kinetics in Tissue from G.mellonella   
Homogenized G. mellonella tissue extracted with lauryl maltoside was examined for 
cytochrome c oxidase activity using a method similar to Sinjorgo et al, 167 but working at pH of 
6.8, the in vivo pH of G. mellonella.  Inhibition of the reaction in the presence of azide (at 0.1 and 
1.0 mM, Figure 13A) and cyanide (at 7 and 14 µM, Figure 13B) was measured (Figures 13A and 
13B, respectively).  This same turnover approach could not be used in the case of sulfide inhibition, 
as it directly reduces ferricytochrome c back to ferrocytochrome c, interfering with the assay.  The 
azide inhibition constant, Ki(azide), determined from the turnover kinetics was found to be 22(±4) 
µM, the identical result to that originally reported by Petersen 31 for the beef heart cytochrome c 
oxidase (monitoring oxygen-consumption kinetics).  The close similarity of the present result and 
earlier findings is not surprising as several groups, including our own, have previously shown that 
the electron-transfer activities of different cytochrome c oxidases are essentially independent of 
source tissue and/or species 167, 169.  The cyanide inhibition constant, Ki(cyanide), was determined in 
the present study to be 4(±1) µM for the G. mellonella enzyme, 20 times larger than the 0.2 µM 
previously reported for the beef enzyme 31. It follows from the observations with azide, that we 
probably should not necessarily simply attribute this 20-fold discrepancy to any intrinsic difference 
in the cyanide-inhibition characteristics of the insect larval and mammalian cytochrome c oxidases.  
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A more plausible explanation might be that some insects have significant levels of enzymatic 
activities that deactivate cyanide, such as rhodanese and β-cyanoalanine synthase, making them 
unusually resistant to cyanide toxicity.170-172  Additionally, it is to be noted that the cyanide content 
of neutral aqueous solutions is ~99% molecular HCN, which can rapidly be lost by partitioning 
into the gas phase.  The extent of loss depends upon the ratio of head space to solution volume and 
the rate of loss on the surface tension, which in turn depends upon a complicated set of 
experimental variables including ionic strength and detergent/lipid content.   
 
 
Figure 13. Turn-over analysis: cyanide and azide inhibition of cytochrome c oxidase extracted from G. 
mellonella tissue. 
Sodium azide (A) and sodium cyanide (B) inhibition of cytochrome c oxidase during turnover at 25°C, in 
mitochondrial assay buffer (115 mM KCl, 10 mM KH2PO4, 2 mM MgCl, 3 mM HEPES, 1 mM EGTA, BSA 0.2%; 
pH adjusted to 6.8). The concentration of cytochrome c was varied from 5-30 µM.  Twenty five µL of extracted 
cytochrome c oxidase (see Materials and Methods for details) was used in each assay.   
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4.4.2  Respirometric Analysis of G. mellonella Tissue 
In addition to the cytochrome c oxidase (complex IV) assays, mitochondrial electron 
transport in the G. mellonella tissue extracts was also examined by high-resolution respirometry 
(Figure 14).  Any observed variations in oxygen consumption rates (broken traces) are typically 
slight and difficult to follow, so the slope of the raw data (oxygen flux) is also shown (solid 
traces).  Since the flux as presented is actually –d[O2]/dt, increases in the ordinate values of the 
solid traces should be interpreted as indicating increased oxygen consumption rate.  It is also to 
be understood that the Oroboros system is quite sensitive, enough that >5 µL additions of fully 
aerated (or fully de-aerated) reagent solutions register as changes in measured oxygen flux.35  Any 
troughs appearing in the solid traces during the first minute following reagent additions (Figure 
14) are the result of fully aerated additions detected as decreases in oxygen consumption (i.e. 
increases in oxygen concentration) – the experimentally meaningful consequences of reagent 
additions follow these artifacts.  Using high salt to isolate mitochondrial particles all but insured 
that the electron transport system would be disrupted and hence, uncoupled.  The following 
titrations of substrates and inhibitors into the mitochondrial tissue during respirometric 
experiments generated a series of observations (data not shown) indicating that the isolated 
particles were indeed uncoupled but contained the competent electron-transport system:  additions 
of an uncoupler, CCCP, to the G. mellonella tissue did not affect the oxygen flux, while ADP 
gave only a very modest increase in oxygen consumption; additions of cytochrome c (replacing 
that lost through disruption) measurably increased the oxygen flux and was therefore added to all 
other experiments; additions of succinate to this cytochrome c-replenished preparation resulted 
in a sharp increase in the rate of oxygen consumption confirming the presence of complex II 
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(succinate dehydrogenase) and inhibition of oxygen consumption following addition of antimycin 
A confirmed the presence of complex III (cytochrome c reductase). 
Addition of NADH to a cytochrome c-replenished preparation also resulted in a sharp 
increase in the rate of oxygen consumption (Figure 14A) confirming the presence of complex I 
(NADH dehydrogenase) – as expected, this could be reversed by the addition of either rotenone 
(complex I inhibitor) or antimycin A (data not shown).  NADH-driven electron transport was 
readily blocked by inhibition of the terminal oxygen acceptor, cytochrome c oxidase, with either 
azide (Figure 14B) or cyanide (Figure 14C) in keeping with the spectrophotometric results (Figure 
13).  The findings for the inhibition of electron transport by added sulfide were more complicated 
(Figure 14D) as following a temporary decrease in oxygen flux (the large “dip” at ~35 min, a 
previously described artifact due to direct interaction of sulfide with the electrode system 35) a 
non-transient decrease in oxygen flux was observed (from 36-40 min) discernibly slower than in 
the case of azide or cyanide.  Mammalian cytochrome c oxidase is known to undergo several 
reactions with sulfide including turnover and slow inhibition 27, 173-175 that are never observed for 
reactions of the same enzyme preparations with azide or cyanide.  Therefore, in the present case, 
the findings are still commensurate with cytochrome c oxidase being the site of inhibition of 
electron transport by sulfide in the G. mellonella mitochondria.   
 
 
 
 
 75 
 
 
Figure 14. Respirometric Analysis from Ground-up G. mellonella Tissue. 
Oxygen consumption was assessed in homogenized G. mellonella tissue diluted in MiR05 respirometric solution (see 
Materials and Methods for details).  The tissue (2.1 mL) was allowed to equilibrate in chamber for ~10 minutes prior 
to measuring electron flow. Default respirometric settings of block temperature, 25°C; stir bar speed, 400 rpm and 
data recording, 2 s were used. All regents/substrates amounts are given as final concentrations.  Oxygen turnover 
(oxygen concentration, left y-axis; oxygen flux right y-axis) by G. mellonella tissue was followed after additions of 
cytochrome c (10 µM) and NADH (0.5 mM): (A) control, (B) plus NaN3 (1.25 mM), (C) plus NaCN (14 µM) and (D) 
plus NaHS (15 µM).  
 
 
4.4.3  Cytochrome c Oxidase Inhibitors Induce a “Knockdown” State in G. mellonella 
  The cytochrome c oxidase inhibitors, sodium azide, sodium cyanide and sodium 
hydrosulfide, were independently administered by intra-hemocoel (ih) injections through 
the proleg (see Experimental Methods for details) of the G. mellonella larvae.  The initial 
dose of each toxicant given to the caterpillars was the same dose that we had previously found to 
induce “knockdown” (unconsciousness) in mic.38, 61 Subsequently, the doses were increased/
decreased in 2-5 mg/kg increments to obtain dose-response curves and find final working 
doses that produced a state of paralysis (larvae became motionless) for a reproducible and 
suitable time period (>10 minutes) without causing death.  The reported recovery times are the 
durations from the initial injection of toxicant into the larvae until they “righted” themselves 
and began to move again when touched following the period of “knockdown” (or state of 
paralysis).   
When sodium azide was administered to G. mellonella larvae (5-25 mg/kg) and 
the recovery time monitored, a dose-response curve was obtained exhibiting saturation at a 
recovery time of 80 min using the LD40 dose of 25 mg/kg (Figure 15A).  Increasing the dose to 
28 mg/kg sodium azide resulted in 100% deaths.  A “knockdown” or unconscious response of 
38 min to sodium azide was observed in the G. mellonella larvae at the IC50 dose (ih) of 15(±1) 
mg/kg (fit to the data in Figure 15A).  In comparison, a brief preliminary study with mice 
showed that a 27-28 mg/kg (ip) sodium azide dose (~LD40) induced a “knockdown” state of 
40(±8) min in surviving animals (see Supplemental Material) and 30 mg/kg (ip) sodium 
azide proved lethal.  After administration of azide doses, the larvae immediately became 
rigid and could then be placed on their backs where they remained motionless until they turned 
over. This was in contrast to cyanide and sulfide G. mellonella intoxications, where approximately                     
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15 seconds elapsed prior to the larvae showing any signs of succumbing to the does. After the 
larvae recovered from azide intoxication, they seemed unusually sensitive if touched along 
their backs with a cotton swab, but remained lethargic for hours if not disturbed. 
The dose-response (recovery time) curve obtained for sodium cyanide exposures in G. 
mellonella larvae also exhibited saturation, but with maximum recovery time of ~40 min at 
the LD40 dose of 20 mg/kg (Figure 15B).  An 8 mg/kg (ih) dose of sodium cyanide induced a 
state of paralysis within fifteen seconds with a recovery time of 20(±3) min and a 100% survival 
rate.  In comparison, mice given a 5 mg/kg (ip) dose of NaCN exhibit a “knockdown” state with 
a 24(±7) min recovery time and an 80% survival rate.61, 62  The similarity of dose-response 
findings for the larvae and the mice is intriguing – suggesting that, in vivo, the insect and 
mammalian electron-transport systems cannot be very different, contrary to the 20-fold variation 
in the Ki (cyanide) values between the insect and mammalian enzymes found above. 
Sodium hydrogen sulfide administered to G. mellonella larvae exhibit a dose-response 
curve without any apparent asymptote in the practically accessible dose range (Figure 15C).  A 
dose of 108 mg/kg (ih) NaHS caused a state of paralysis lasting 25(±3) min with an LD30.  
In contrast, a dose of 16 mg/kg of NaHS created a “knockdown” state lasting 4 (± 1) min with 
only a 57% survival rate in a mouse model.176  Thus, there is an apparent large difference 
(~7-fold) between the response of the G. mellonella larvae and mice for the mitochondrial 
toxicant sulfide. 
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Figure 15. Dose-response data for azide, cyanide and sulfide. 
Toxicants (azide, cyanide and sulfide) or phosphate buffered saline (PBS) (5-10 µL) were injected into the proleg of 
G. mellonella larvae using a gas-tight syringe. The time from which the larvae ceased movement until movement 
began again was recorded (recovery time). Larvae injected with PBS (5 µL) were used as controls and showed no 
inhibition of movement.  (A) Sodium azide (NaN3) was injected at the following doses: 5.6, 11.2, 14, 16.8, 22.4 mg/kg, 
and the recovery time observed. The IC50 was determined to be 15(±1) mg/kg with an average time until recovery of 
40(±10) min.  (B) Sodium cyanide (NaCN) was injected at the following doses: 1.5, 3, 4.5, 6, 7.5, 9, 11.3 mg/kg, and 
the recovery time observed. The IC50 determined to be 8.3(±0.3) mg/kg with an average time until recovery of 20(± 
3) min.  (C) Sodium hydrogen sulfide (NaHS) was injected at the following doses: 14.4, 28.8, 43.2, 57.6, 72, 86.4, 
108, 120, 140 mg/kg, and the recovery time observed. The IC50 determined to be ~108 mg/kg with an average time 
until recovery of 24(± 3) min.  
 
4.4.4  Evidence for Amelioration of Cytochrome c Oxidase Inhibition in G. mellonella 
Larvae by Putative Antidotes 
Previous work has shown that both sodium nitrite and several cobalt complexes, including 
CoN4[11.3.1], can act through different mechanisms to ameliorate cyanide toxicity in mice.61, 62, 
70, 176-178  These same compounds are not significantly antidotal towards sulfide in mice unless 
given prophylactically 35, 38 and the limited available literature suggests they might be ineffective 
as azide antidotes 179.  G. mellonella larvae were administered (ih) sub-lethal doses of either 
sodium azide (8 mg/kg), sodium cyanide (7.5 mg/kg), or sodium hydrosulfide (72 mg/kg), 
resulting in mean knockdown durations of 33 min, 11 min and 10 min respectively (Figures 16A, 
16B & 16C).  When given either sodium nitrite (5 mg/kg, i.h.) or Co(II)N4[11.3.1] (8 mg/kg), 1 
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min after the toxicant, the azide injected larvae recovered significantly more quickly (~19 min & 
11 min respectively) than the controls given no antidote (Figure 16A).  In the case of larvae injected 
with cyanide or sulfide solutions, administration of either sodium nitrite or Co(II)N4[11.3.1] 1 min 
later resulted in an approximate halving of the recovery durations compared to controls given no 
antidote (Figures 16B & 16C respectively).  In all groups treated with either nitrite or 
Co(II)N4[11.3.1], the larvae survived (100%) post injections with no side effects noted, some going 
on to pupate within 96 hours similar to sentinel-type controls.  
 
 
Figure 16. Amelioration of toxicants (sulfide, cyanide and azide) by CoN4[11.3.1] or sodium nitrite. 
Larvae were injected with each of the three toxicants either alone, or received subsequent injections of 5µL PBS, 5µL 
sodium nitrite (5mg/kg) or 5µL CoN4 [11.3.1] (8 mg/kg) one minute after the initial injection. The time until recovery 
was significantly decreased by the injection of both the sodium nitrite and the cobalt compound (* p ≤ 0.001).  
*(Graph shows the distribution of the samples, specifically, the median of each sample (line) within the interquartile 
range or “box” containing 50% of the sample, with the “whiskers” extending from the top (Q3) and bottom (Q1), these 
values show the maximum and minimum of the sample. 
4.4.5  The Conserved Nature of the Cytochrome c Oxidase Active Site 
Since we are interested in the possible use of G. mellonella as an invertebrate model for 
modulation of the activity of mammalian cytochrome c oxidase by various inhibitors and their 
potential antidotes, a comparison of the subunits encoded by mitochondrial DNA (CO1, CO2 and 
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CO3) from the human, bovine, murine and G. mellonella species seemed highly appropriate.  
Subunit 1 (CO1) contains the active site prosthetic groups, heme a3 and CuB, where oxygen is 
reduced to water. The first subunit also contains heme a, which functions to funnel electrons to the 
heme a3/CuB active site.  Subunit 2 (CO2) contains CuA, a copper complex that transfers electrons 
to heme a.  The third subunit (CO3) encoded by mitochondrial DNA is thought to maintain the 
structural integrity of the first and second subunits 180.  These 3 subunits form the functional core 
of the enzyme, including the ability to pump protons.  A comparison of the protein sequences of 
G. mellonella CO1, CO2 and CO3 subunits 181 with those from human showed that these subunits 
were quite similar (see Materials and Methods).  Most importantly, all the ligands to the prosthetic 
groups (heme a, heme a3, CuA and CuB) were identical between species (Figure 17) indicating the 
highly conserved nature of the essential functional unit. 
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Figure 17. Partial comparison of cytochrome c oxidase amino acid residues in subunits CO1 and CO2 from 
human, bovine, mouse and G. mellonella. 
Conserved amino acid sequences (*) are represented by amino acid residues, highlighted in grey. Similar amino acid 
residues (for example, V and L) are marked with double dots (:) and dissimilar residues are marked with a single dot 
(.).  The ligands for heme a and heme a3 are marked with red and green boxes, respectively. The ligands for CuA and 
CuB are marked with blue and gold boxes, respectively.  See Material and Methods for details. 
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4.5 Discussion 
4.5.1  Comparison of Structure and Function in Cytochrome c Oxidases 
It has been known for some time that, except for one non-physiological reaction with 
carbon monoxide, the functional (electron-transfer) properties of eukaryotic cytochrome c 
oxidases do not measurably vary between tissues 167 or species 169.  Furthermore, this strong 
similarity even seems to extend to bacterial examples 17 and so, it is not surprising that the enzyme 
from G. mellonella also contains essentially the same active site characteristics (Figure 17).  These 
observations provide a solid foundational argument for the further development of the larval 
system as a functional model for the mammalian enzyme in a variety of experimental 
circumstances. 
4.5.2  Observed Paralysis in G. mellonella Larvae Secondary to Cytochrome c Oxidase 
Inhibition 
The ligands azide (N3–), cyanide (CN–) and sulfide (HS–) are all known inhibitors of 
mitochondrial respiration, blocking the heme a3/CuB oxygen-reduction site of cytochrome c 
oxidase.31, 98  Accordingly, the respirometric experiments showed that in mitochondrial particles 
extracted from the G. mellonella larvae, oxygen turnover was inhibited by all three of these heme 
ligands (Figures 13 & 14).  In mammals, intoxication with azide, cyanide, or sulfide typically 
results in loss of consciousness and, if the toxicant dose is lethal, death is widely accepted to follow 
through collapse of the nervous system supporting cardiopulmonary function.  The response of the 
larvae to the toxicants appears to be somewhat analogous, with the observed paralysis (Figure 14) 
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clearly implicating dysfunction of the nervous system, presumably due to depletion of available 
ATP following inhibition of oxidative phosphorylation. 
With the G. mellonella larvae, all three toxicants act rapidly, resulting in paralysis within 
about 15 s of injection (ih).  In contrast, while the action of cyanide and sulfide are rapid in mice, 
knockdown/death occurring within 3-4 min of injection (ip), the onset of symptoms following 
azide administration is significantly slower – knockdown after 10 min and deaths at 30 min to 
several hours post intoxication (ip).  Also, the larvae seem to exhibit measurable effects due to 
azide at lower doses than the mice, whereas in the case of cyanide and sulfide the larvae require 
higher doses than mice for comparable effects.  In short, the larvae were observed to be 
unexpectedly sensitive to azide compared to cyanide and sulfide.  The vertebrate blood-brain 
barrier might provide a plausible explanation for these observations.  At physiological pH, azide 
exists almost exclusively in its anionic form (N3–) and, consequently, is probably restricted from 
crossing the blood-brain barrier.  Cyanide and sulfide on the other hand exist as anions in 
equilibrium with molecular forms (HCN and H2S) at physiological pH and are, therefore, able to 
cross the blood-brain barrier by passive diffusion.  Thus, the slower onset of azide toxicity in mice 
can readily be understood.  Insects also possess protective neural barriers, but it presently remains 
unclear exactly how functionally similar they are to the vertebrate systems 182, 183.  The rapid onset 
of azide effects we report here may suggest that, at least in the case of G. mellonella larvae, the 
neural barrier must be significantly more permeable to azide anions than its vertebrate counterpart. 
The IC50 for sulfide (~108 mg/kg NaHS) was ten times larger than that found for cyanide 
(11 mg/kg NaCN) in the G. mellonella larvae (Figure 14) indicating the sulfide to be an order of 
magnitude less toxic.  In mice, we have previously found sulfide to be only about three-to-four 
times less toxic than cyanide 38.  The caterpillars contain no oxygen carrier/storage molecule in the 
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hemolymph, gas exchange being accomplished through spiracles located on the sides of the larval 
body, these in turn attached to a tracheole system delivering oxygen directly to all cells 88, 161.  
Thus, even when paralyzed, small gaseous molecules like H2S could conceivably be efficiently 
lost from the small larval body by passive diffusion. In the mice, although compromised, 
pulmonary function does continue prior to death, so H2S can be exhaled during intoxication.  A 
plausible explanation for the lower toxicity of sulfide in the caterpillars compared to mice may be 
attributable to the different pH characteristics of blood compared to hemolymph. The normal pH 
of murine blood is 7.4, just to the alkaline side of the first acid dissociation constant of H2S (pKa 
~7.1) while the pH of the G. mellonella hemolymph is 6.8.  This dictates that “sulfide” in 
mammalian blood is an approximately 30:70 mixture of H2S/HS– 33 whereas in the hemolymph 
“sulfide” will be a 70:30 mixture of H2S/HS–.  Thus, in the G. mellonella larvae, 70/30 times more 
administered sulfide will be present in the easily lost gaseous molecular form than in the mice.  So, 
if sulfide is 70/30 times more easily lost from the larvae and is 3-4 times less toxic than cyanide in 
mice, we can most simply predict that sulfide should be ~8 times (i.e. 70/30 x 3.5) less toxic than 
cyanide in the G. mellonella larvae.  The predicted value of 8 compares rather favorably with the 
factor of 10 that we actually found.  Such simple considerations, however, appear misleading in 
relation to the observed toxicity of cyanide.  In activity studies of isolated preparations of 
cytochrome c oxidase, the inhibitory characteristics of cyanide and sulfide tend to be 
experimentally indistinguishable 98 and, with a pKa of ~9.3, “cyanide” is >98% HCN throughout 
the pH 6.8-7.4 range.  Consequently, it is unclear why cyanide is not more readily lost and, 
therefore, of lower toxicity than sulfide in both the caterpillars and mice.  Thus, not surprisingly, 
it is apparent that satisfactory quantitative comparisons of the relative toxicities require detailed 
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knowledge of the toxicodynamics/kinetics (i.e. delivery and elimination rates) in addition to the 
intrinsic inhibition characteristics at the target enzyme site. 
4.5.3  G. mellonella Larvae as a Potential Model for Screening Antidotes 
An objective of this study was to demonstrate the usefulness of G. mellonella larvae as a 
model for screening potential antidotes for mitochondrial toxicants, specifically cytochrome c 
oxidase inhibitors.  To this end, the practical approach of finding an easily monitored toxic 
response (righting recovery) and establishing a convenient experimental time frame on a trial-and-
error basis, thereby avoiding any need to rigorously understand the mechanisms of toxicity and 
antidotal action, has been achieved (Figure 16).  The two antidotes selected, sodium nitrite and 
CoN4[11.3.1], have previously been tested in animals for efficacy against cyanide, so the inclusion 
of these results here (Figure 16B) is, in part, as positive controls for proof of principle.  While the 
two antidotes are both clearly effective against sulfide intoxication in the larval experiments 
(Figure 16C) they are unlikely to ever become of any practical value in real poisonings. This is 
because surviving victims of sulfide poisoning typically reach the clinic presenting pulmonary 
injury, including edema, but no longer experiencing potentially reversible sulfide inhibition of 
mitochondrial function33.  The findings regarding azide intoxication and its amelioration by both 
sodium nitrite and CoN4[11.3.1] (Figure 16A) are the most interesting of this particular set. There 
is presently no available antidote for azide poisoning and the very limited available literature 
suggests that at least sodium nitrite might be of no therapeutic benefit.  The present results clearly 
indicate that the possible efficacy of sodium nitrite as an azide antidote should be more fully re-
investigated and that CoN4[11.3.1] represents a candidate lead compound for further development 
as a potential therapeutic.  More generally, these results lend support to the assertion that G. 
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mellonella caterpillars offer an inexpensive alternative to rodents for simple preliminary 
investigations identifying harmful chemical exposures and approaches to their amelioration.   
4.5.4  Methemoglobin Formation is not Required for the Antidotal Action of Nitrites 
The belief that nitrites are antidotal towards cyanide intoxication primarily by virtue of 
their methemoglobin-forming ability continues to persist in the literature.164-166. It has even been 
suggested that enough nitrite to result in 20-30% methemoglobin formation might be optimum for 
amelioration of cyanide toxicity 184 – an alarming recommendation, given that the patients in 
question will likely already be presenting with cyanide-compromised respiratory function.  Strong 
evidence has already been reported showing that neither inorganic 61, 62 nor organic 162, 163 nitrites 
depend on methemoglobin formation to account for their efficacy as cyanide antidotes.  The 
present findings unambiguously confirm this fact, since the G. mellonella larvae contain no 
hemoglobin, yet sodium nitrite is clearly antidotal in the caterpillars (Figure 16B).  Our group has 
previously postulated 61, 62 that the nitric oxide (NO) donor capability of nitrites is primarily 
responsible for their antidotal activity towards cyanide, as NO is an efficient antagonist of cyanide 
inhibition at cytochrome c oxidase 59, 60.  Further support for the critical role played by NO in 
amelioration of cyanide inhibition of cytochrome c oxidase has recently emerged during studies in 
which administration of a neuronal NO synthase inhibitor attenuated the protective effect of 
hyperbaric oxygen treatment on cyanide-intoxicated rats 185. 
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4.6  Supplemental Materials and Figures 
Approval for the mouse protocol was obtained from the University of 
Pittsburgh Institutional Animal Care and Use Committee (Protocol Number 16088947). The 
Division of Laboratory Research of the University of Pittsburgh provided veterinary care. 
All animal experiments complied with the National Institutes of Health guide for the 
care and use of Laboratory animals (NIH Publications No. 8023, revised 1978).  Swiss-
Webster (CFW) mice weighing 35-45 g from Charles River Laboratories, Wilmington, MA, 
were 10-12 weeks old and housed four per cage. The mice were allowed access to food and 
water ad libitum. Experiments commenced after the animals were allowed to adapt to their new 
environment for one week.  
The righting recovery method for determining the effectiveness of azide antidotes has been 
routinely used in our laboratory for almost a decade.  Upon loss of consciousness (“knockdown”), 
approximately 10-12 min following administration of sodium azide (NaN3, 26-30 mg/kg ip), 
mice were placed in a transparent but dark colored plastic tube in the supine position.  The time 
duration from the NaN3 injection until the mouse flipped from the supine to the prone position in 
the plastic tube was taken as the end point (“recovery time”).  Toxicant and Antidotal 
experiments with G. mellonella caterpillars are described in the Materials and Methods. 
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 Table 7. Caterpillar (Galleria mellonella) Toxicant Dose Response Data. 
 
Table 8. Mouse (Mus musculus) Sodium Azide Dose Response Data. 
Larva # Righting Recovery Time (min) 
Sodium azide (mg/kg) Sodium cyanide (mg/kg) Sodium hydrosulfide (mg/kg) 
5.6 11.2 14 22.4 28 3 4.5 6 7.5 9 11.3 16.2 19.8 28.8 43.2 57.6 72 86.4 108 120 138 
1 1 5 18.5 80 * 4 5 8.5 13 24 36 36 43 1.5 3 5 8 20 24.5 40 45 
2 1 8 31.5 40 * 3 6 8 12 26 34 37 43 1.5 3.5 5 12 14 22.5 41 40 
3 0.5 6 31 80 * 3 8 7 15 25 33 38 44 2 3.5 4.5 11 18 28 38 42 
4 3 7 36 69 * 5 6 8.5 15 27.5 35 36 45 1.25 3 4.5 10 13.5 22 * * 
5 2 12 33 72 * 4 8 7.5 12 25.5 34 34 50 2.5 3 5 12 17 24.5 * * 
6 1 6 34 75 * 3 7 8 13 26 33 39 43 1.5 3.5 4.5 10 15.5 25 * * 
7 1 12 35 50 * 3 7 8 12 25 35 * * 1.5 3.5 4.5 12.5 16 26 * * 
8 2 5 24 * * 5 8 8 15 27 * * * 2 3 4.5 8 15 * * * 
9 1 7 35 * * 5 6 8.5 15 25.5 * * * 1.5 2.5 5 10 19.5 * * * 
10 1 8 35 * * 4 6 7 15 25.5 * * * 2 3.5 5 13 * * * * 
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Std Dev 0.75 2.55 7.84 15.5 0 0.88 1.06 0.57 1.9 1.01 1.11 1.75 2.73 0.38 0.35 0.26 2.17 2.3 2.04 1.53 2.52 
Std 
Error 
0.24 0.81 1.75 5.87 0 0.28 0.34 0.18 0.43 0.32 0.42 0.71 1.12 0.12 0.11 0.08 0.48 0.77 0.77 0.88 1.45 
 
      
  
                
 
              
 *  Caterpillar succumbed to the dose 
                
 
Mouse     
# 
Righting Recovery Time (min) 
Sodium azide (mg/kg) 
30 28 27.5 27 26 
1 * 30 30.5 30.5 20 
2 * * 60 52 20.5 
3 * 26 45 * 20 
4 * * 
 
45 10 
5 * 25 
  
13.5 
6 * * 
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7 * * 
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Mean 0 35.2 45.167 42.5 19.385 
Std Dev 0 25.014 14.751 10.966 9.0073 
Std 
Error 
0 11.187 8.5163 6.3311 2.4982 
 
      
  
 *  Mouse succumbed to the dose 
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Table 9. Caterpillar (Galleria mellonella) Antidote Data 
Larva # 
Righting Recovery Time (min) 
Sodium azide (8 mg/kg) Sodium cyanide (7.5 mg/kg) Sodium hydrosulfide (72 mg/kg) 
Control NaNO2 (5mg/kg) 
CoN4[11.3.1]  
(8 mg/kg) Control 
NaNO2  
(5mg/kg) 
CoN4[11.3.1]       
(8 mg/kg) Control 
NaNO2         
(5mg/kg) 
CoN4[11.3.1]            
(8 mg/kg) 
1 10 5 5 9 6 4 18.5 16.5 12.5 
2 11 5 3.5 11 6 7 31.5 14.5 9.5 
3 10 5.5 6 11 12 4 31 20 14 
4 12 7 4 9.5 7.5 7 36 12 11.5 
5 11 4 3 12.5 11 7.5 33 20 11 
6 12 5.5 4 10 5 7 34 20.5 10.5 
7 15 8 5 10.5 6 4 35 16 6.5 
8 10 3 5 9 8 5.5 24 23 14 
9 10 4 6 10 10 7 35.5 21.5 6 
10 7.5 2.5 4.5 8 9 5.5 35 20 8.5 
11 7 5.5 6 7 4 5 42 23 13 
12 10 5.5 5.5 12 4 6 37 24 9 
13 11 6 4.5 8 9 7 20 25 12 
14 7 6 4.5 8 5 6 36 20 14 
15 11.5 5 3.5 14 6 8 34 20 12.5 
16 11.5 7.5 3 12 10 6.5 34 16 12 
17 9 5 5 10 7 7.5 28 12 16 
18 10 5.5 5 7 14 5.5 34 24 24 
19 5 4.5 5.5 16 6.5 6 60 24 13 
20 9 2 3.5 10 4 5.5 19 23 12 
21 7   10   23 26  
22 8   9.5   24 16.5  
23 10   16   25 20  
24 8   8   30 10  
25 9   14   30 17  
26 8   15   38 16  
27 12   16   41   
28 14   7   37   
29 9   16   42   
30 7   11   34   
31 8   15      
32 7   12      
33 10   13      
34 13   11      
35 11   12      
36 8   11      
37 11   14      
38 10   7.5      
39 12   10.5      
40 8   11      
41 8   10      
42 10   10.5      
43 8   12      
44 9   9      
45 9   8      
46 9   9.5      
47 10   15      
48 10   8.5      
49 8   8.5      
50 15   9      
51 7   11.5      
52 8   12      
53 8   13      
54 15   13      
55 9.5   10      
56 10   15      
 90 
57 9   13      
58 10   8.5      
59 7   9.5      
60 13   10.5      
61    10      
Mean 9.7000 5.1000 4.6000 10.984 7.5000 6.0750 32.717 19.250 12.075 
Std 
Dev 
2.1613 1.5183 0.96791 2.4949 2.8238 1.2061 8.2990 4.3064 3.7811 
Std 
Error 
0.27902 0.33950 0.21643 0.31944 0.63141 0.26969 1.5152 0.84455 0.84548 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9 Continued 
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5.0 Conclusions 
Improving toxicant-specific antidotes is even more important in today’s world where 
people are becoming increasingly concerned about the numerous chemicals agents that are 
“thought-to-be-safe” making news. Some examples include, the weed killer Roundup™ 
(glyphosate),186 beauty product additive, triclosan,187, 188 and about twelve ingredients in 
sunscreens189 that are harming humans and the environment. Consumers are approaching the 
government to mandate better screening of dangerous products prior to their release into the 
community where the chemicals can impact public health.4, 82, 190, 191 Additionally, the release of 
toxicants into the public domain, either accidentally or through nefarious means, necessitates the 
need for the development of antidotes for protection from poisonings. Finding a reliable, practical 
organism that can be used to screen ahead of testing in rodents and other mammals, cutting down 
the number of animals used, and thereby simplifying assessments is a very worthwhile, but 
considerable task. Ideally, the organism must be inexpensive, fairly robust, not as complex as a 
mouse, yet have a more developed physiology than a cell model for simple, preliminary, in vivo 
toxicity studies. There are a number of non-mammalian organisms that fit some of these criteria. 
Cells, mice, and G. mellonella larvae are the primary systems used by our group for 
assessing cytochrome c oxidase inhibitors and putative antidotes. Bearing in mind Russell and 
Burch ‘s Three R’s, (replacement, reduction and refinement74), all of our models mimicked some 
aspects of human poisoning and/or treatment, and each model introduced advantages and 
disadvantages. The advantages of cell and mouse studies (Section 1.4) have been widely 
documented in many peer reviewed journals. Unfortunately, for the purpose of our assessments, 
cell and mouse studies take considerable time and were quite costly. BPAEC needed to be 
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purchased, cultured, treated and maintained in precise conditions. When using sulfide in the cell 
model, it was difficult to control the loss of H2S to the environment even with Parafilm™ covering 
the wells, thereby affecting the reproducibility of the toxicant dose taken up by the cell. Like the 
cells, there are disadvantages to animal studies; first, we are limited to the minimal sample size 
necessary to achieve significance for each condition in our preliminary study due to the expense 
involved with purchasing, housing and care of the mice. The most important drawback to animal 
studies is that the mice require regulatory oversight and protocols must be carefully followed, 
limiting experimental flexibility.  
While these are not the only models used for toxicological screening, others also offer 
drawbacks, for instance, zebrafish (Danio rerio) and fruit flies (Drosophila melanogaster). 
Typically, zebrafish embryos are placed into the wells of plates and measured aliquots of reagent 
solutions are added to the media, as in cultured cells, the dosage is merely an estimation. The 
embryos are very small and a microscope must be used to visualize changes. Prior to beginning 
any experiments, unhealthy embryos must be removed from the sample, emerging problems are 
sometimes not clearly apparent. Reproducibility of dose between individuals is a particular 
problem with fruit flies. Drosophila larvae are so small it is difficult to accurately inject them, 
even with experience, and very time consuming. The alternate approach of feeding the larvae with 
toxin also results in significant variation in the individual doses. This is the same issue as 
quantifying the dose that was broached in the cell studies with sulfide and cyanide toxicity (Section 
2). Zebrafish, fruit flies and mammalian cells are just a few of the alternative models that are 
currently utilized in preliminary toxicological investigations and are worthy alternatives to the 
more expensive mouse model but all demonstrate issues with the final concentration of the dose 
taken up into the system.   
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In addition to being useful organisms for bacteriological studies, our non-mammalian, 
invertebrate model demonstrated many advantages in toxicological assessments.  G. mellonella 
allowed us to by-pass many of the burdens we faced with the cells and mice used in our laboratory. 
They require no regulatory oversight, after a 48 hour acclimation they are ready to use, and a 
hundred or more larvae can be easily and accurately injected in a day at very minimal cost (500 
larvae for $14, plus shipping), increasing the statistical significance of the study. They are 
delivered in a bait container filled with wood shavings which was placed in a box with air holes 
allowing the larvae a dry, dark area to acclimate; since they are in their last instar, they require no 
food or water. G. mellonella breathe air, though they have no lungs they take in air through the 
spiracles and diffuse the oxygen through a vast tracheole system that delivers oxygen to each cell, 
and removes CO2. Using the larvae allowed us to observe the toxicants without significant loss of 
the gasses to the air, as seen in the cells. Galleria mellonella are not only commercially available 
and a robust and economical model, that can be easily and accurately injected, they can also be 
used at or near human physiological temperatures. We were able to assure an accurate dose in a 
similar fashion to the ip injection of the mouse by injecting into the hemocoel (ih injection) of the 
G. mellonella larvae. The larvae are a whole organism and exhibit behaviors, such as the 
“knockdown” response that was used to quantify the toxicity and produce dose response 
relationships, as well as demonstrate amelioration of the toxicants by the antidotes. Respirometry 
data for G. mellonella generated for this study was easily obtained from crushing the larvae and 
using the isolated mitochondrial homogenate proving that cytochrome c oxidase was inhibited by 
each of the toxicants. 
In the past, many procedures for investigating cytochrome c oxidase in our laboratory have 
involved isolation from sources such as beef heart. This is a complicated preparation that is both 
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labor and time intensive. The procedure developed for isolating the mitochondria from the larvae 
was considerably easier and less time consuming than the procedure for isolating mitochondria 
from beef heart. Cytochrome c oxidase turnover in the G. mellonella mitochondrial homogenate 
exhibited the same inhibition constant (Ki) for azide that Petersen et al found (22 ± 4 µM) for azide 
in beef heart cytochrome c oxidase. Though the Ki for cyanide (4 ± 1 µM) was 20 times larger 
than the 0.2 µM reported for beef enzyme,31 insects tend to have higher levels of rhodanese and β-
cyanoalanine synthase, perhaps, making them more resistant to cyanide. Although I could not find 
any data on the G. mellonella specifically, β-cyanoalanine synthase activity has been detected in 
gut protein extracts, and rhodanese is present in detectible quantities in both larvae and adults, of 
multiple Lepidoptera species. Also, sulfide was not able to be tested in the turnover analysis 
because it is such a strong reductant, it directly reduced ferrocytochrome c back to ferricytochrome 
c interfering with the assay. Using the Oroboros O2k high- resolution respirometer we were able 
to run assays on the G. mellonella mitochondrial homogenate confirming the toxicants were 
inhibiting cytochrome c oxidase in real time. Sulfide was a problem in many aspects of our studies 
with the cells, including respirometry. The inability to add enough sulfide (millimolar 
concentrations) to the cells in the chamber to see inhibition without interacting with the electrode 
was a complication. However, in the larvae mitochondrial homogenate we were able to see 
inhibition at micromolar concentrations (Figure 14). In the past we have employed the metabolic 
indicator dye AlamarBlue, however, we were unable to use the indicator dye to assess viability in 
cells poisoned with sulfide as it reduced the indicator dye immediately. This was also the case with 
the lactate dehydrogenase assay, the indicator dye used was reduced by the sulfide. The wax worms 
circumvented issue with the indicator dyes and offered another example of the advantages of this 
invertebrate in testing the effectiveness of antidotes in a whole organism. Again, there are obvious 
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differences between mice, cells and larvae such as blood and biological structures (i.e. lungs, liver, 
and brain) that still facilitate a comparison be drawn between at least a couple of models to glean 
a satisfactory understanding of any exposure.  
The usefulness of this particular invertebrate system as a model for prescreening was that 
we were able to confirm that all three of the toxicants inhibited cytochrome c oxidase, and both 
sodium nitrite and the Busch compound were antidotal to all three toxicants in the wax worms.  It 
was exciting that the sodium nitrite worked so well in the G. mellonella with azide, as this was 
previously not the case with the 16-20 week old Swiss-Webster mice that were originally tested. 
There is presently no available antidote for azide poisoning and the very limited literature suggests 
that sodium nitrite might be of no therapeutic benefit. Because of the G. mellonella data, we went 
back and examined the sodium nitrite in both 6-8 week old male juvenile and 12 week old adult, 
mice. We discovered that the sodium nitrite was antidotal in both the larvae and the juvenile mice, 
but not in the adult mice. This study illustrated that effects can easily be found in the G. mellonella 
that may initially be missed in the mice.   
It was previously thought that the antidotal effect of nitrite toward cyanide was through the 
production of methemoglobin (Hb+), perhaps by secondary NO: HbO2 + NO  Hb+ + NO3-. The 
methemoglobin produced then binds the toxicant of interest, i.e., cyanide (e.g. Hb+ + CN-  
HbCN). As already stated previously, (section 2; page 48) our group has hypothesized 61, 62 that 
NO has been shown to be an efficient antagonist of cyanide by displacing CN– from the heme 
a3/CuB binding site of cytochrome c oxidase, restoring its oxygen binding capability thus restoring 
oxygen turnover.59, 60  We suggest that nitrite acts as a NO donor but not a methemoglobin former 
in the antidotal mechanism antagonizing cyanide toxicity. Again, our current results support this 
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hypothesis, since the G. mellonella larvae do not have any hemoglobin, and yet sodium nitrite was 
antidotal in the larvae (Figure 16).  
So far G. mellonella have been shown to be a useful organism for preliminary toxicological 
screening, mimicking vertebrate toxicology in certain respects. Our group began a study looking 
at potential phosphine antidotes.97 We implemented the G. mellonella in a preliminary inhalation 
study examining if Au (I) complexes could be beneficial phosphine-scavenging compounds. Three 
Au (I) compounds were studied and auro-sodium bis-thiosulfate (AuTS) proved to be the best 
therapeutic agent in the G. mellonella and was subsequently tested in mice. Mice given AuTS (50 
mg/kg) 1 min after a similar phosphine exposure, demonstrated a modest improvement in 
behavioral testing over untreated phosphine exposed mice. Similar to azide, we were able to test 
antidotal effects in the larvae prior to beginning an animal study decreasing the amount of mice 
needed, saving time and money. 
The importance of toxicological testing is vital, and no doubt, mice will remain the gold 
standard for toxicological investigations because of the genetic, biological, physiological and 
behavioral characteristics they share with humans. However, the data shared here establishes that 
G. mellonella are useful for pre-screening mitochondrial toxins and a solid tool in the toxicological 
model arsenal.  
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Abstract 
There are currently no FDA-approved antidotes for H2S/sulfide intoxication.  Sodium 
nitrite, if given prophylactically to Swiss Webster mice, was shown to be highly protective against 
the acute toxic effects of sodium hydrosulfide (~LD40 dose) with both agents administered by 
intraperitoneal injections.  However, sodium nitrite administered after the toxicant dose did not 
detectably ameliorate sulfide toxicity in this fast-delivery, single-shot, experimental paradigm.  
Nitrite anion was shown to rapidly produce NO in the bloodstream as judged by the appearance of 
EPR signals attributable to nitrosylhemoglobin and methemoglobin, together amounting to less 
than 5% of the total hemoglobin present.  Sulfide-intoxicated mice were not helped by the 
supplemental administration of 100% oxygen, nor were there any detrimental effects.  Compared 
to cyanide-intoxicated mice, animals surviving sulfide intoxication exhibited very short 
knockdown times (if any) and full recovery was extremely fast (~15 min) irrespective of whether 
or not sodium nitrite was administered.  Behavioral experiments testing the ability of mice to 
maintain balance on a rotating cylinder showed no motor impairment up to 24 hr post-sulfide 
exposure.  It is argued that antagonism of sulfide inhibition of cytochrome c oxidase by NO is the 
crucial antidotal activity of nitrite rather than formation of methemoglobin.  
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Introduction 
Methods for generating hydrogen sulfide gas (H2S) from household chemical products 
obtainable at multiple retail outlets have been publicized through the Internet and suicide by H2S 
inhalation is an emerging trend in some countries.192, 193  Significantly, it appears that neighbors 
not in the immediate vicinity of the release site, or emergency responders, were sometimes 
affected/injured194, 195 leading to a growing realization that H2S might find application as a 
weapon.192  Additionally, there are approximately 102 known commercial sources of H2S, resulting 
in thousands of occupational exposures per year in the US alone, including individuals engaged in 
paper pulping, tanning, vulcanizing, management of animal waste, sewer maintenance, heavy 
water production196, 197 and, especially, natural gas mining.198  Preventable deaths of inadequately 
protected would-be rescuers, both coworkers and emergency personnel, have been reported. 127  It 
is, therefore, of concern that no FDA-approved antidote, or reliable protocol, for treating acute 
H2S intoxication is currently available.96  Emergency medicine bulletins/pamphlets issued by 
several international, federal and state authorities 146, 199-204 suggest the use of cyanide antidote kits 
containing nitrite-thiosulfate, or cobalamin, but the basic science that would justify this approach 
is lacking.  Moreover, there are conflicting anecdotal case reports attesting to both the success and 
failure of cyanide therapeutics administered in situations where H2S was known or suspected to 
be the toxic agent.205  More seriously, we have recently shown that the production of hydrosulfide 
(HS-) in the blood from thiosulfate administered as a cyanide antidote is measurably toxic.61  
Therefore, the suggested use of the nitrite-thiosulfate combination as a therapy for H2S poisoning 
is alarming.  Certainly the toxicology of H2S shares features in common with that of cyanide; for 
instance, both toxins are highly efficient disruptors of mitochondrial electron-transport chain 
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function 95, 99, 174 with approximately identical inhibition constants (Ki) for cytochrome c oxidase.61, 
98  It follows that in developing potential therapies for treating acute H2S intoxication, initial efforts 
should be directed toward overcoming inhibition of cytochrome c oxidase and the associated rapid 
cardiopulmonary collapse.96 
The first pKa of H2S is 6.9-7.0 (37-25 ºC), the second pKa being inaccessible in water 206, 
207 which results in aqueous solutions of approximately 30-25% H2S and 70-75% HS– at pH 7.4, 
irrespective of whether initially introduced as the molecular gas, or as a salt (e.g. NaHS).  In 
keeping with what seems to be a common convention, we refer to this mixture at physiological pH 
as “sulfide” (and do not mean to imply S2– at any time herein).  Haouzi et al102  have recently 
shown that, at sub-lethal levels, intravenously administered aqueous sulfide becomes converted to 
other forms in the bloodstream of sheep and rats within 1 minute of infusion.  This seems to be 
incompatible with the findings of Truong et al208 who reported that cobalamin given 
intraperitoneally greatly increases the survival rate of sulfide toxicity in mice when administered 
2 min after the toxicant.  Curiously, these latter authors report death following sulfide intoxication 
in a zero-to-24-hr window with no mention of the rapid effects that we describe below.  To further 
confound matters, suspected human victims of H2S inhalation reaching the clinic have been 
reported to succumb to the poisoning hours after the exposure95, 106 possibly indicating additional 
slower mechanisms of toxicity subsidiary to cytochrome c oxidase inhibition.  In this study, we 
attempt to resolve these puzzling observations with regard to the acute toxicity of sulfide. 
Sodium nitrite has periodically been mentioned as a possible antidote for H2S for over 30 
years,95, 209-211 based upon the assumption that detoxification would result from nitrite-induced 
generation of methemoglobin (metHb) followed by binding of sulfide to form 
sulfidomethemoglobin (metHbSH).96  However, we propose this widely held mechanistic belief to 
 101 
be erroneous.  The matter is a critical issue to be overcome, because concerns that increased metHb 
levels (methemoglobinemia) would further challenge the oxygen utilization capabilities of already 
sulfide-compromised individuals have almost certainly hindered the rational investigation of 
nitrite as a possible frontline antidote.  In the related case of acute cyanide intoxication, we have 
shown that there need be no significant methemoglobinemia following administration of sodium 
nitrite (< 2% metHb61) as the principle antidotal action is to generate nitric oxide (NO) that 
ameliorates inhibition of cytochrome c oxidase function.59, 60  Herein, we have examined the 
antidotal activity of sodium nitrite towards sulfide toxicity and the potential ameliorating effects 
of supplemental oxygen, employing a combination of behavioral assessments on mice and 
spectroscopic (EPR) measurements on drawn blood.  A variety of sequelae, secondary to sulfide 
poisoning, have been anecdotally reported in humans, including neurological defects.   
Accordingly, we have performed some neuromuscular assessments on mice following recovery 
from sulfide intoxication to determine if any improved survivability observed with nitrite 
administration might also be associated with undesirable neurological consequences. 
 
Experimental Methods 
Chemicals.  All reagents were ACS grade, or better, used without further purification and 
unless stated to the contrary, were purchased from Fisher or Sigma-Aldrich.  Argon, carbon 
dioxide, nitric oxide, nitrogen and oxygen gases were purchased from Matheson Incorporated and 
with the exception of nitric oxide (see Enzyme Preparation and Cell Culture) used without further 
purification.  Sodium hydrosulfide or sodium cyanide solutions were prepared in septa-sealed vials 
with minimized headspaces immediately prior to use and volumetric transfers made with gas-tight 
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syringes.  Sodium hydrosulfide was obtained as NaHS•xH2O (Sigma) where x was determined to 
be 2.5 essentially following procedures described by Koltoff et al.119  Briefly, concentrations of 
HS– were determined by quantitative reaction with excess iodine (2HS– + I2 → S + 2H+ + 2I–) 
followed by titration of the liberated 2I– (as I– + I3–) with silver nitrate (precipitating AgI + AgI3) 
using an Ag+ sensitive ion-selective potentiometric electrode (Accumet Silver/Sulfide 
Combination ISE 13-620-551) to detect the endpoint. 
Animals, Exposure and Blood Collection.  All animal procedures were approved by the 
University of Pittsburgh Institutional Animal Care and Use Committee (Protocol Number 
13092637).  Veterinary care was provided by the Division of Laboratory Animal Research of the 
University of Pittsburgh.  Male Swiss Webster (CFW) mice weighing 40-50 g were purchased 
from Taconic, Hudson, NY.  Adult animals were 16-18 weeks old and were housed four per cage.  
The mice were allowed access to food and water ad lib.  Experiments commenced after the animals 
were allowed to adapt to their new environment for one week.  A series of experiments testing the 
efficacy of sodium nitrite as a sulfide antidote were performed.  All solutions were prepared by 
dilutions into sterilized saline in septa-sealed vials using gas-tight syringes for all transfers and 
administered through ~0.1 mL intraperitoneal (ip) injections.  In general, a group of at least 6 mice 
were tested for each experimental point.  At the end of exposures and tests, mice were euthanized 
with CO2.  Juvenile male Swiss-Webster mice 6-8 weeks old, 25 – 35 g, supplied by Taconic, were 
treated in the same fashion. 
For collection of blood samples, mice were first euthanized in an atmosphere of carbon 
dioxide and blood drawn by cardiac puncture into a 1-mL syringe containing 25 µL of 500 mM 
EDTA.  The blood was expelled into the bottom of a quartz EPR tube containing an argon 
atmosphere, then frozen by immersion in liquid nitrogen.  This entire process could comfortably 
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be completed in 2 min.  The cryogenically preserved sample was stored in liquid nitrogen and 
subsequently transferred to the EPR spectrometer without ever having been thawed.  Samples of 
heart tissue were also collected.  Euthanized animals were perfused with 5ml of PBS by cardiac 
puncture, then the hearts were removed and immediately frozen in liquid nitrogen.  After storage 
at -80°C, individual hearts were thawed, homogenized in 1 mL PBS and a 200-µL aliquot of this 
homogenate was introduce into an EPR tube and frozen in liquid nitrogen before subsequent 
transfer to the spectrometer. 
Righting-Recovery Testing.  Lengths of time required for recovery of righting ability in 
mice were determined based on some of the recommendations of Crankshaw et al212 regarding 
their measurement of the righting reflex, but adopting a simpler procedure.  Following ip 
administration of toxicant (±NaNO2) mice were placed in a transparent but dark green-colored 
plastic tube (Kaytee CritterTrail, available from pet stores) in a supine position.  The time duration 
from the toxicant injection until the mouse flipped from the supine to a prone position in the plastic 
tube was taken as the endpoint.   
RotaRod Testing.  To assess motor skill learning and recovery following intoxication, we 
used the accelerating RotaRodTM (Coulbourn Instruments, Whitehall, PA) – a rotating cylindrical 
apparatus (4 to 40 r.p.m.) on which the mice were placed.  The animals were evaluated for 3 trials 
per time point on three consecutive days, with a resting time of 30 s between each trial.  An 
individual trial was considered ended when the mouse either fell off or had remained on the 
rotating cylinder for 60 s.  Latency to fall, and highest speed reached were recorded for each trial.  
Mice were trained for 8 trials on the first day by placing them on an accelerating RotaRod for 60 
s, during which time the rotation rate was varied linearly from 4 to 11.2 r.p.m.  On the day of the 
toxicity experiments (day 2), animals were tested for a single set of three trials, with the same 
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parameters as during training to establish a baseline performance, before injection.   Trained 
animals were tested at fifteen min intervals after toxicant administration for 2 hrs and an additional 
time 24hrs after injection, by placing them on an accelerating RotaRod for 60 s, accelerating from 
4 to 22 r.p.m.  Motor performance was determined to be the highest rotation speed reached before 
the animal fell off the apparatus, determined from the mean r.p.m. in three trials for each mouse at 
each experimental time point.  For comparison between groups the mean performance in pre-
injection testing for a group was used to normalize all the other experimental points of that group. 
Enzyme Preparation and Cell Culture.  Bovine pulmonary artery endothelial cells (BPAEC) 
were purchased from Lonza and used at passages 4-8.  Cells were grown in Opti-Mem media supplemented 
with 10% fetal bovine serum, 5 mM glutamate, penicillin and streptomycin under 5% CO2.  Cytochrome c 
oxidase was prepared as previously described59 from intact bovine heart mitochondria using a modified 
Harzell-Beinert procedure (without the preparation of Keilin-Hartree particles).  The enzyme was 
determined to be spectroscopically pure if the 444 nm to 424 nm absorbance ratio for the reduced enzyme 
was 2.2 or higher.  Derivatives were prepared in 50 mM potassium phosphate, 1 mM in sodium EDTA and 
0.1% in lauryl maltoside, pH 7.4-7.8, to concentrations of 10-80 µM (in enzyme).  Enzyme concentrations 
were determined as total heme a using the differential extinction coefficient of ∆ε604 = 12 mM-1cm-1 for the 
reduced minus oxidized electronic absorption spectra.213  Concentrations throughout are given on a per 
enzyme concentration basis (NOT per [heme a]).  Ferrocytochrome c:O2 oxidoreductase activity was 
determined spectrophotometrically employing the high ionic strength method of Sinjorgo et al.214  
Electronic absorption spectra were measured and photometric determinations made using Shimadzu UV-
1650PC and UV-2501PC spectrophotometers.  Nitric oxide (for reactions with cytochrome c oxidase) was 
scrubbed with water and KOH pellets prior to use, bubbled through anaerobic buffer (prepared by bubbling 
argon through the solution) and added to enzyme samples volumetrically with gas-tight syringes.  Buffered 
solutions never exhibited any significant change of pH (i.e. < 0.05 pH units) following NO additions. 
 105 
Electron Paramagnetic Resonance (EPR).  X-band (9 GHz) EPR spectra were recorded 
on a Bruker ESP 300 spectrometer equipped with an Oxford Instruments ESR 910 flow cryostat 
for ultra-low-temperature measurements.  Access to this instrument and the software (SpinCount) 
used to analyze the EPR spectra were provided by Professor Michael Hendrich, Carnegie Mellon 
University.  Quantification of EPR signals was performed by simulating the spectra using known 
(or determined) parameters for each sample in question.  Simulations employed a least-squares 
fitting method to match the lineshape and signal intensity of a selected spectrum.   Simulated 
spectra were expressed in terms of an absolute intensity scale, which could then be related to 
sample concentration through comparison with a CuII(EDTA) spin standard of known 
concentration. 
Data Analysis.  Statistical data was analyzed using Graph Pad Prism 6 software by t-test.   
A p-value of ≤ 0.05 was considered statistically significant. 
 
Results 
Comparison of Sulfide and Cyanide Toxicities.  It is frequently noted that there are 
parallels between the acute toxicities of H2S versus HCN and it will be instructive to explore this 
comparison further (e.g. Table 10).  In our procedures, where the toxicants are given to mice as ip 
injections of sodium salts in saline solutions at approximately LD50 doses, those animals that 
succumb typically do so within 2-4 min, in keeping with the well-documented rapid action of these 
poisons.  In the particular case of sulfide, we have to date observed deaths in excess of 200 animals 
– more than 98% of these occurring within 5 min of the toxicant dose, 2 individuals died in the 5-
10 min period, and only 1 individual in the 10 min to 24 hr window.  Consequently, we are very 
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surprised by the methodology and observations of Truong et al208 who report returning mice to 
their cages after giving similar ip doses of aqueous NaHS to record deaths 24 hr later, with no 
mention of any fatalities in the first few minutes following administration of the toxicant.  The 
antidotal regimen adopted by these same authors involved ip administration of hydroxycobalamin 
solutions at 2 min following the toxicant dose and not at any later times in the 24-hr experimental 
window before deaths were recorded.  A time delay of only 2 min between the toxicant and antidote 
doses for efficacy suggests to us that these authors were probably dealing with the same kind of 
acute response as we now report (i.e. the majority of deaths within a few minutes of the toxicant 
dose) but for some reason left this unclear. 
 
Table 10. Summary of HCN and H2S Toxicological Observations in Mice. 
 
A period of unconsciousness, or “knockdown,” is a common acute symptom of exposure 
to both sulfide 96 and cyanide.148  With a simplified modification of a procedure developed by 
Crankshaw et al212 we have previously assessed sub-lethal cyanide intoxication in mice and its 
antagonism using the observed duration of knockdown to indicate extent of incapacitation and 
 NaCN/HCN39 
(~99% HCN at pH 7.4, 37°C) 
NaHS/H2S 
(~25% H2S at pH 7.4, 37°C) 
   
Strain/Sex Swiss-Webster/Males Swiss-Webster/Males 
Supplier Charles River Taconic 
Age 17 weeks 17 weeks 
Median weight 40 g 43 g 
Mean weight 39.8±6.6* g 43.0±4.0* g 
Toxicant dose 5.0 mg/kg (LD33 – LD50) ip 16 mg/kg (LD40) ip 
Total knockdowns 100% 71% (20 of 28) 
Knockdown duration 30.5±8* minutes 3.5±1.4* minutes 
Survival with knockdown 50 – 67% 40% (8 of 20) 
Mode of death Respiratory paralysis Respiratory paralysis 
Time to full recovery < 2 hours ~15 minutes 
*The quoted uncertainties are standard deviations 
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recovery 61, 62, 177.  Injection of mice with 0.1 mmol/kg (5 mg/kg, ip) NaCN in saline results in loss 
of consciousness, with clear indication of the onset of narcosis (animals stagger or are motionless) 
beginning at around 1 min following administration of the toxicant.  Shortly thereafter, the animals 
may be placed on their backs (supine position) and observed until they regain consciousness, at 
which time they turn themselves to an upright (prone) position.  The observed “righting-recovery 
time” generally lasts around 30 min with about 60% survival in the case of cyanide intoxication at 
the stated dose.  The method has proven suitable for demonstrating the efficacy of putative 
antidotes given before, or up to 20 min after the cyanide.61  Unfortunately, however, the same 
method proved impractical for use with respect to sulfide as the toxicant.  Mice that experienced 
sulfide-induced knockdowns were more likely to die than to survive and, in fact, only about one 
quarter of all surviving animals experienced knockdown (Table 10).  Furthermore, using 0.29 
mmol/kg (16 mg/kg, ip) NaHS in saline we found that a 16 mg/kg dose (57% survival) caused a 
knock-down duration of only 3.5 ±1.4 min (n = 28).  Increasing the dose incrementally did not 
lead to any significant lengthening of knockdown times observed and at 20 mg/kg all the mice 
injected (n = 6) died within 5 min.  That is, in the case of sulfide intoxication, knockdown/righting-
recovery was the atypical response, variable and short – necessitating that an unreasonably large 
number of animals would have been needed to demonstrate any beneficial effects of putative 
antidotes by this method.  Therefore, we reluctantly investigated the efficacy of NaNO2 toward 
antagonism of NaHS toxicity using death or survival (observed at 15 min and 24 hr) as the 
endpoint. 
In addition to the clear differences in frequency of response and knockdown duration noted 
above with sulfide- and cyanide-dosed mice, the recovery times were also found to be quite 
distinct.  Following a toxicant dose (~LD40) with no antidote given, sulfide-intoxicated mice took 
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about 15 min to recover essentially normal behavior, whereas almost 2 hr had elapsed before 
cyanide intoxicated mice exhibited similar recovery (Table 10) and RotaRod experiments 
described below).  It appears from these observations that the part(s) of the central nervous system 
dealing with consciousness is (are) significantly more deeply affected by sub-lethal cyanide 
intoxication than is the case with sulfide.  The experimentally-established LD40 doses of NaHS 
and NaCN, 16 mg/kg and 5.0 mg/kg, respectively, represent a molar ratio of ~3:1 (total sulfide: 
total cyanide).  As the relevant pKas are 6.9 and 9.2 respectively,206, 207 this implies [H2S] ≅ [HCN] 
circulating in the bloodstreams at pH 7.4; that is, the toxicant species expected to be most readily 
membrane-permeable were administered at the same level.  This makes sense, given that we can 
anticipate the rate of diffusion of the toxicants from the bloodstream to depend upon mass action 
and the principle target molecule, cytochrome c oxidase, is similarly inhibited by sulfide and 
cyanide.98  In summary, while the pattern of sub-lethal narcosis clearly differs between the two 
toxicants, our present data are fully consistent with the notion that the two mechanisms of lethality 
are essentially analogous, with pulmonary function principally affected. 
Potential Antidotes to Sulfide Poisoning.  Doubts and conflicting reports have continued 
to persist regarding the usefulness of sodium nitrite as a sulfide antidote for almost 40 years.96, 209, 
215-217  Based on our recent experience with regard to cyanide and nitrite, we suspected that some 
of the confusion in the literature might stem from an incorrect understanding of how the antidotal 
action of nitrite might best be mechanistically explained.  The general consensus is that cyanide 
exerts its acute toxicity primarily on the central nervous system through inhibition of cytochrome 
c oxidase, with death primarily the result of interruption to the pulmonary nervous supply.130, 148  
We have shown that nitric oxide (NO) relieves the inhibition of cytochrome c oxidase by 
cyanide,59, 60 leading to the suggestion that the antidotal action of nitrite towards cyanide poisoning 
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involves the anion functioning as an NO donor to alleviate electron-transport chain inhibition by 
cyanide.61, 62  Consequently, we set out to investigate whether sodium nitrite might also be antidotal 
toward sulfide poisoning through a mechanism in which the anion acts as an NO donor.  We began 
with a prophylactic paradigm (Figure 18A).  Previously, 12 mg/kg NaNO2 was established as the 
optimal antidotal dose in the case of acute cyanide toxicity.61, 62  This same dose, however, resulted 
in only a modest improvement in survival of 79% (Figure 18B) for sulfide toxicity.  When 24 
mg/kg NaNO2 was administered 5 min before a 16 mg/kg NaHS dose, survival was significantly 
increased to 93% (Figure 18B) compared to 57% in the case of controls given no nitrite (Figure 
18B).  Several groups of authors have suggested that delivery of supplemental oxygen during 
treatment for sulfide poisoning may be beneficial218-221 and, indeed, while the supporting evidence 
is anecdotal, the idea can be rationalized on the basis that the known detoxification pathway of 
sulfide uses oxygen.96, 205  We investigated the matter experimentally.  Following prophylactic 
doses of NaNO2, mice were maintained under normoxic conditions for 5 min, then placed in a 
100% oxygen environment immediately after injections of NaHS.  Control animals were just given 
NaHS and placed in the 100% oxygen chamber.  Exposures to 100% oxygen were discontinued 
after 15 min or at time of death (< 15 min).  There was no detectable improvement in survival of 
mice provided with the supplemental oxygen following the toxicant dose (Figure 18B) compared 
to those maintained under normoxic conditions throughout (Figure 18B).  While this result could 
be considered negative, it is, nevertheless, important.  Faced with patients in respiratory distress, 
it is quite normal practice for emergency responders to provide supplemental oxygen if available.  
Therefore, it is comforting that our data show no effect of supplemental oxygen, neither good nor 
bad, suggesting that the protocol should at least do no harm in cases of sulfide intoxication. 
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Figure 18. Prophylactically administered NaNO2 ameliorates NaHS toxicity in mature and juvenile mice. 
A: Injection paradigm.  B:  Mice (Swiss-Webster males, 16-18 weeks of age) were given NaHS in saline (16 mg/kg, 
ip) and times until death recorded.  The duration of survival (breathing cessation) was measured from the time of the 
sulfide injection (t = 0).  Survival quotients are shown with surviving mice/total mice written above the bar.  NaNO2 
(12, or 24 mg/kg, ip) was given 5 min prior to NaHS injection.   Supplemental oxygen (100% O2) was administered 
for either 15 min, or until death, immediately after NaHS injections (* p ≤ 0.05 vs NaHS injection alone).  C:  Juvenile 
mice (Swiss-Webster males, 6-8 weeks old) were injected (ip) with either 16, 18, or 20 mg/kg NaHS and survival 
recorded as for adults.  In addition, 24 mg/kg NaNO2 was given 5 min before 18 mg/kg NaHS (* p ≤ 0.05 vs 18mg/kg 
NaHS injection). 
 
Unfortunately, in experiments where NaNO2 (24 mg/kg) was administered 1-2 min after 
the toxicant (NaHS, 16 mg/kg), there was no significant improvement in survival observed (data 
not shown).  While NaNO2 was not beneficial when administered after sulfide doses, we were able 
to confirm the results of Truong et al208 in which administration of hydroxycobalamin acetate (ip) 
at 2 min after the NaHS dose (ip) increased survival to 80% (data not shown).  We interpret these 
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observations to reinforce the idea that cobalamin binds sulfide circulating in the bloodstream, 
slowing the passage of the toxicant to the tissues in the critical 2-4 min period during which the 
majority of deaths were observed.  Nitrite, on the other hand, does not exert its primary action in 
the bloodstream (see below) and the NO released must reach inhibited mitochondria within tissues 
to reverse the effect of the toxicant.  As the maximal release of NO occurs about 5 min after ip 
injection61, this method of NaNO2 delivery is too slow for post-NaHS use in the current scenario 
and, ultimately, alternate methods (e.g. aerosol inhalation) will probably have to be considered. 
Sulfide Toxicity in Juvenile Mice.  It is of interest to determine if juveniles are more 
susceptible to the effects of sulfide.  To this end we carried out a series of experiments examining 
the dose response to sulfide and the efficacy of nitrite as an antidote in 6-8 week old mice.  As 
shown in Figure 18C, juveniles proved slightly more resistant to sulfide, as a dose of 18 mg/kg 
(Figure 18C) was needed to obtain a similar level of survival compared to adult mice exposed to 
16 mg/kg.  It is of interest to note that at 2 mg/kg more (20 mg/kg) survival dropped precipitously 
from 67% to 14%.  This kind of steep relationship was also observed in preliminary testing with 
adults (data not shown).  Survival was improved significantly upon the prophylactic administration 
NaNO2 (Figure 18C) at the same dose (24 mg/kg) as in the adults.  Also like the adults, those sub-
lethally intoxicated juvenile subjects recovered quickly (~15 min) and all deaths occurred within 
5 min of receiving the toxicant dose; none were observed in the 5 min to 24 hr time window. 
Recovery of Neuromuscular Function Following Acute Sulfide Intoxication.  There is 
anecdotal evidence in the occupational medicine literature for neurological dysfunction in humans 
following acute exposures to H2S.96, 106  To address this possibility experimentally, we employed 
an approach based on the RotaRod device – primarily a determinant of neuromuscular 
coordination, but there is also assessment of muscle strength, with a more limited cognitive 
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component.  The mice were trained 24 hours before the intoxication procedures and baseline 
peformance was established at 1 hr prior to administration of toxicant.  Following toxicant 
injections, mice were then tested every 15 min, up to 1 hr, and subsequently at 24 hrs (Figure 19A).  
There was no significant difference in RotaRod performance of mice (Figure 19B) given 16 mg/kg 
NaHS () 24 mg/kg NaNO2 () or NaNO2 + NaHS ().  In general, the animals improve with 
practice, so the increased performance between 15 min and 45 min post-intoxication should be 
taken to indicate a learning curve as it has a slope similar to that observed during the training 
period (Figure 19B).  These data show that all the animals have essentially recovered 
neuromuscular coordination at 15 min after administration of NaHS, irrespective of whether nitrite 
was given or not.  A comparison (Figure 19C) of the RotaRod performace of mice given 16 mg/kg 
NaHS () 5.0 mg/kg NaCN () or NaNO2 + NaCN () treated mice showed that the cyanide 
intoxicated mice had a longer recovery time (~2 hr) compared to sulfide (15 min).  Furthermore, 
while administering nitrite shortened the recovery time, the performance of these nitrite-treated 
and cyanide-intoxicated mice still clearly lagged behind that of the sulfide-intoxicated animals 
(Figure 19C).  Nevertheless, it is to be noted that, in the case of both toxicants, there was no 
indication of persistent impairment of neuromuscular coordination or readily apparent cognitive 
(learning/memory) issues as reported for humans – all the surviving animals rapidly made full 
recoveries as judged by the RotaRod testing and did not develop any latent problems at 24 hr. 
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Figure 19. RotaRodTM testing of neuromuscular coordination following NaHS/NaCN/NaNO2 exposures in 
adult Swiss Webster mice. 
A:  RotaRod testing paradigm:  Arrows indicate RotaRod testing times, lines with bars indicate injection times (all 
ip).  Mice were trained on the RotaRod 24 hr before injection and a baseline performance was obtained 1 hr before 
injection (Pre-ip).  Mice were tested every 15 min after injections for 1 hr to assess recovery. B:  Comparison of 
performance for injections of 16 mg/kg NaHS (), 24 mg/kg, NaNO2 () and 24 mg/kg NaNO2 injected 5 min prior 
to 16 mg/kg NaHS dose ().  C:  Comparison of performance for injections of 16 mg/kg NaHS (), 6.4 mg/kg NaCN 
(), 24 mg/kg NaNO2 injected 5 min prior to 6.4 mg/kg NaCN ().  Numbers of animals (in parentheses) used in 
each set of experiments:  NaHS (6), NaNO2 (8), NaNO2 + NaHS, (8), NaCN (9), NaNO2 + NaCN (10).  (* p ≤ 0.05 
vs controls) 
 
Nitrite-Dependent Release of NO in Blood and Heart Muscle.  We have previously 
shown that minority hemoglobin species in blood samples (HbNO, metHb and metHbS) can be 
quite accurately determined using EPR spectroscopy.61, 62   The addition of sodium nitrite to mice, 
followed by euthanasia with CO2 and sample preparation (see below) led to dose dependent (0-24 
mg/kg) EPR signals, identified as HbNO and metHb.  In general, the amount of HbNO observed 
in the blood (a maximum of 0.5 mM, or ~ 6% of the total hemoglobin) was roughly 2-3 times the 
amount of metHb (0.15 mM, or ~2% of the total hemoglobin).  Followed over time, the signal 
intensities peaked at 10-15 minutes and measurably persisted up to 1 hour after administration of 
the nitrite dose.61, 62  The presence of both signals could be construed as evidence for the presence 
of NO in the blood rather than nitrite (HbO2 + NO → metHb + nitrate; Hb + NO → HbNO) but as 
the signals were not present in the spectra of blood samples taken from control animals, they 
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clearly arose in a nitrite-dependent manner.  In the present study, mice were given NaNO2 (12-24 
mg/kg in saline, ip) then later euthanized in an atmosphere of CO2 starting at 7 minutes after the 
nitrite dose.  We chose this delay because previously the maximal level of NO-dependent EPR 
signals were found between 5 and 15 minutes following NaNO2 administration.  Within 2 min of 
starting euthanasia, blood had been withdrawn by cardiac puncture, 250 μL dispensed into an EPR 
tube and the sample cryogenically preserved by immersion in liquid nitrogen.  When required, 
NaHS (16 mg/kg in saline, ip) was administered either alone or 5 min following the nitrite dose 
(i.e. 2 min before commencing euthanasia). 
The EPR spectra of control blood samples, from animals given neither sulfide nor nitrite, 
exhibit only weak signals arising from transferrin at ~1600 gauss (not shown).  In samples drawn 
from mice given NaNO2, both metHb (~1100 gauss) and HbNO (~3400 gauss) EPR signals were 
readily observed (Figure 20A).  The HbNO exhibits a three-line hyperfine due to the interaction 
of the nuclear spin of the nitrogen atom in NO with the electron spin.222, 223  Most of the HbNO 
probably accumulates during euthanasia, as the animal will rapidly become systemically anaerobic 
before the blood sample can be drawn and cryogenically preserved.  Consequently, while the 
HbNO level contributes to the quantitative estimation of effective NO concentration at time of 
sacrifice, no other useful information can be deduced from these particular signals.  The blood of 
animals treated with NaHS alone, yielded EPR spectra that were essentially the same as controls, 
containing only very weak signals and certainly nothing that could be associated with the toxicant 
dose (Figure 20B).  On the other hand, the blood of mice administered sulfide 5 min after the nitrite 
exhibited EPR spectra that were interesting in a couple of respects.  First, the known EPR signal 
associated with metHbSH (rhombic in nature with features at 2736, 3057 (crossover) and 3715 
gauss61) was routinely observed (Figure 20C).  There are, however, three overlapping sets of EPR 
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signals present: metHb (~1100 gauss), HbNO (~3400 gauss) and the metHbSH signal.  To 
quantitate these signals we simulated the spectra using the program SpinCount (M. T. Hendrich, 
Carnegie Mellon University – see Methods) and the resulting signal intensities are presented in 
Table 11.  The concentration of metHbS detected was 0.13 mM, or < 2% of the total hemoglobin, 
which equates to 0.5 µmol in a mouse of total blood volume < 4 mL (0.13 mM x 4 mL = 0.52 
µmol).  Now, a 16 mg/kg dose of NaHS in a 45 g mouse equates to 12.9 µmol (16/56 x 40/1,000 
= 12.9 µmol).  Thus, only 4% of the total sulfide dose given was scavenged by the blood as 
metHbSH.  Interestingly, if nitrite was given to mice 2 min after administration of the sulfide, both 
reagents provided at the same doses as above, any EPR signals associated with the binding of HS– 
to metHb were weaker and in the majority of cases none were detected (e.g. Figure 20D) seemingly 
consistent with the rapid elimination of HS– from the bloodstream before nitrite can release NO 
and generate metHb.  Examination of samples of juvenile mouse blood drawn from animals 
subjected to the same nitrite/sulfide treatments as adults revealed no significant differences in the 
EPR signals observed (not shown). 
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Figure 20. EPR spectra (x-band, 10 K) of whole mouse blood. 
A:  EPR spectrum of drawn blood following dose of 24 mg/kg NaNO2 administered ip 5-10 min prior to sacrifice 
showing clear evidence for the generation of nitric oxide.  Signal (1) at ~1100 gauss: metHb;  signal (2) at ~3300 
gauss: HbNO.  The combined intensities of the metHb plus HbNO signals represents < 5% of the total heme present 
in the blood (~9 mM).  B:  Spectrum of blood following dose of 16 mg/kg NaHS.  This dose of NaHS roughly amounts 
to a maximal concentration of ~2.8 mM in the blood.  C:  Spectrum of blood following dose of 24 mg/kg of NaNO2 
(t = 0) and 16 mg/kg of NaHS at 2 min.  The signals at ~2700, 3060 and 3700 gauss all arise from metHbSH (designated 
signal 3) and represent < 3%  (~0.2 mM) of the total Hb (~200 mM).  D:  Spectrum of blood following NaHS injection 
2 min prior to NaNO2.  No metHbSH signals were detected. 
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Table 11. Quantitation of EPR signals (x-band, 10 K) observed in mouse tissue.
Mouse hearts were removed from animals exposed to either 24 mg/kg NaNO2 alone, 16 
mg/kg NaHS alone, or the nitrite/sulfide combinations immediately after euthanasia, flash frozen 
in liquid nitrogen and stored at -80 °C prior to preparation of EPR samples as described in the 
Methods.  EPR signals consistent with metmyoglobin (metMb) and nitrosylmyoglobin (MbNO) 
formation were observed in animals treated with nitrite (Figure 21A).  EPR signals of MbNO lack 
the three-line hyperfine pattern of HbNO and, thus, the two spectra are readily distinguishable (see 
Figures 20A and 21A).  There was very little sulfidometmyoglobin (metMbSH) signals present in 
any of the spectra obtained from the blood of animals given NaHS (Figures 21B-21D).  The level 
of metMb was diminished in samples where NaNO2 had been given before the NaHS (Figure 20C, 
Table 11) but any explanation of this could only be speculative in the absence of detectable 
metMbSH formation.  For practical purposes, the detection limit of single-scan EPR measurements 
is a few µM, so it is certainly the case that biologically significant levels of potentially EPR 
detectable species can arise, but remain below detection.  Thus, these data are not very informative 
regarding the movement of sulfide species into cells, but they do confirm significant trafficking of 
NO/nitrite from the bloodstream into the heart muscle.  Presumably, this also applies to other soft 
Whole Blood 
metHb (µM)       HbNO (µM)       metHbSH (µM) 
Minced Heart 
 metMb (µM)      MbNO (µM) 
Control < 5 0 0 < 2 0 
NaHS (16mg/kg) < 5 0 0 < 2 0 
NaNO2 (24 mg/kg) 90 (30) 190 (30) 0 15 (3) 50 (5) 
NaNO2 + NaHS* 
(*5 min delay) 
60 (30) 190 (40) 130 (30)   7 (2) 54 (3) 
EPR samples were made 7 min after injections (ip) to the mice (Swiss-Webster, 16-18 week old males) 
by either cardiac puncture (2 min after euthanasia) or by mincing the heart tissue and quickly freezing 
samples in EPR tubes for later analysis.  Values are means (3-6 samples) of signal concentrations 
determined either by integration or by signal simulation, with standard errors quoted in parentheses (see 
Methods). 
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vascularized tissues, but since most do not contain high levels of constitutive traps (like 
myoglobin) the assertion cannot be verified by our EPR methodology in such cases.  While tissues 
of the central nervous system are of prime importance in the present context, our EPR findings 
certainly do not exclude their efficient uptake of NO/nitrite and at least NO is known to cross the 
blood-brain barrier.224 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. EPR spectra (x-band, 10 K) of mouse heart tissue. 
A: EPR spectrum of minced heart tissue following dose of 24 mg/kg NaNO2 administered ip 5-10 min prior to sacrifice 
showing clear evidence for the generation of nitric oxide.  Signal (4) at ~1100 gauss: metMb;  signal (5) at ~3300 
gauss: MbNO.  The combined intensities of the metMb plus MbNO signals approximates to 100% of the total heme 
(~260 µM) present in the heart.  B:  Spectrum of heart tissue following dose of 16 mg/kg NaHS.  C:  Spectrum of 
heart tissue following dose of 24 mg/kg of NaNO2 (t = 0) and 16 mg/kg of NaHS at 2 min.  No signals due to metMbSH 
were observed.  D:  Spectrum of heart tissue following NaHS injection 2 min prior to NaNO2.  No metMbSH signals 
were detected. 
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Reactions with the Crucial Target of Sulfide Toxicity, Cytochrome c Oxidase.  In many 
cases, changes in oxidation state and substitution of ligands at the oxygen-binding (active site) 
heme a3 in cytochrome c oxidase can be conveniently followed by electronic absorption 
spectroscopy (e.g. Figure 22).  As prepared, the fully oxidized (“resting”) enzyme exhibits an 
absorption spectrum with two distinct features, a Soret band at 420-422 nm (Fig 22A, dot-dash 
trace) and a visible-region band at ~600 nm (Figure 22B, dot-dash trace).  Upon the addition of 
sulfide, using a 5-fold excess of NaHS over enzyme, the spectrum changes to yield a more 
prominent Soret band at 428 nm (Fig 22A, dotted trace) and an increased intensity of the ~600 nm 
band (Figure 22B, dotted trace).  It should be remembered that these absorption spectral envelopes 
(22A and 22B) result from two sets of overlapping signals arising from heme a and heme a3 (any 
CuA and CuB contributions are minimal).  This lack of resolution in the spectra means that while 
such measurements are very good indeed at revealing whether or not something has happened at 
either heme a or heme a3 (oxidation-reduction and/or ligand substitution) they do not necessarily 
reveal exactly which heme was involved, or exactly what happened chemically – this usually has 
to be inferred from other information.  It is quite clear from the absorption spectra that, following 
addition of sulfide, a new derivative of the enzyme has been formed, probably HS– (rather than S2– 
at pH 7.4) has bound to heme a3 of the enzyme, but the oxidations states of the metal cofactors 
remain unspecified.  Based on earlier studies,174 it was most likely that HS– became bound to ferric 
heme a3 with reduction of CuB – and, indeed, our own EPR measurements with samples prepared 
in parallel proved to be in keeping with this assertion (not shown).  Following exposure of the 
tentatively identified hydrosulfide adduct of the enzyme to excess NO gas, the 428 nm Soret band 
sharpened and increased in intensity (Figure 22A, dashed trace) while the visible-region band 
hardly changed (Figure 22B, dashed trace).  The new spectrum obtained after the NO addition is 
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reminiscent of that of a partially reduced-NO adduct of the enzyme, where NO is bound to ferrous 
heme a3 while heme a remains in the ferric form.59  Interestingly, upon the addition of a strong 
reductant (sodium dithionite) to the partially-reduced sulfide-inhibited NO adduct, a more 
complicated envelope was obtained, with two maxima at 428 nm and 442 nm (Figure 22A, solid 
trace) together with a two-fold stronger band at 603 nm in the visible region (Figure 22B, solid 
trace).  Absorption maxima at 442-444 nm and 603-605 nm are invariably associated with fully 
reduced derivatives of cytochrome c oxidase.  The lack of any great shift in the 428 nm band of 
the NO adduct upon the addition of dithionite confirms that NO was bound to a ferrous heme in 
both cases.  Also, the 428 nm and 442 nm features were slightly variable in relative intensity 
between samples (not shown) indicating that they represent two distinct chemical species (one 
associated with heme a, the other with heme a3) rather than being two bands in the spectrum of a 
single chromophore.  The present data do not definitively identify to which heme NO binds, but 
we assume this to be the oxygen binding site of heme a3; which in turn suggests the 442 nm band 
to arise from reduced heme a.  More importantly, the absorption spectra do unambiguously show 
that NO is able to displace the inhibitory ligand from the sulfide-inhibited enzyme.  Moreover, 
when oxygen was admitted to the closed vessel containing the NO adduct, the absorption spectrum 
reverted to that of the starting, fully-oxidized enzyme (not shown) confirming any NO inhibition 
to be transient and providing a mechanistic basis for nitrite-derived NO antagonizing sulfide 
inhibition of cytochrome c oxidase. 
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Figure 22. Electronic absorption spectra of cytochrome c oxidase derivatives showing displacement of HS– by 
NO. 
Samples were prepared in 100 mM aqueous potassium phosphate buffer, pH 7.4, 0.05 % lauryl maltoside, 25°C, 1.00 
cm pathlengths.  Dash-dot trace:  Cytochrome c oxidase as isolated (oxidized, resting), 5 µM in enzyme;  dotted 
trace:  partially-reduced sulfide adduct 5 µM in enzyme, 0.2 mM in NaHS, dashed trace: partially-reduced sulfide 
adduct plus NO, 5 µM in enzyme, 0.2 mM in NaHS, 1.9 mM (1.0 atm) NO; solid trace:  partially-reduced sulfide 
adduct plus NO, 5 mM in enzyme, 0.2 mM in NaHS, 1.9 mM (1.0 atm) NO, plus ~1 mM in Na2S2O4.  A:  Soret region 
380-470 nm.  B: Q (or α) band region 570-650 nm.
Amelioration of Sulfide Toxicity by Nitrite in Cultured Cells.  We have previously 
shown that proliferating (sub-confluent) bovine pulmonary artery endothelial cells (BPAEC) can 
be used to investigate changes in mitochondrial function within the cellular environment.133  
Furthermore, as BPAEC do not contain hemoglobin/myoglobin, it was possible to show with this 
cell line that NO antagonizes cell death due to cyanide in a manner that does not depend upon 
methemoglobin, or metmyoglobin, formation.60 Leavesley et al225 have reported a similar effect 
using NO donors in a neuronal line of cultured cells inhibited with KCN.  In the previous studies 
with BPAEC, we successfully used the metabolic indicator dye alamarBlue to monitor cell 
proliferation.  However, sulfide was found to interact directly with alamarBlue, reducing the dye 
and preventing its implementation in the current studies.  Instead, we used propidium iodide 
staining as a marker of cell death, having first established that propidium iodide did not react with 
sulfide.   Recent studies have shown that nitrite can be easily converted to NO in various 
122 
cells/tissues.55, 137, 226  Plated cells were covered with Parafilm and inoculations of reagents made 
by injections through the cover to slow down the loss rates of gaseous H2S and NO.  Compared to 
controls, application of NaNO2 did result in increased cell death after 1 hr (Figure23) which is not 
surprising, as the NO released will inhibit the mitochondrial electron-transport chain to some 
extent (i.e. transiently).  Addition of NaHS (alone) to the media resulted in considerably more cell 
death 1 hr later (Figure 23) showing the sulfide dose to be considerably more inhibitory/toxic than 
the nitrite-derived NO dose.  Most importantly, however, when the same doses of nitrite and sulfide 
were given together, their toxic effects did not combine additively, rather the level of cell death 
observed corresponded to that seen with nitrite alone (Figure 23).  In other words, nitrite is 
observed to ameliorate the sulfide toxicity.  These findings strongly support the proposition that 
methemoglobin formation by nitrite is not required for significant antidotal activity, but instead, 
NO generated from nitrite displaces bound sulfide from cytochrome c oxidase. 
Figure 23. Resistance of bovine pulmonary endothelial cells (BPAEC) to sulfide toxicity is increased in the 
presence of sodium nitrite. 
Effect of NaNO2 on BPAEC and BPAEC treated with NaHS.  BPAEC were plated and then covered with Parafilm 
just prior to experiments.  Aqueous solutions (in media) of both NaNO2 (1 mM) and NaHS (5 mM) were injected 
through the Parafilm into the cell media of wells while shaking the plates gently.  Plates were incubated at 37°C for 1 
hr and then treated with both SYBR-Green and propidium iodide dyes.   Cell counts were taken using a Zeiss IM 35 
fluorescent microscope and an Infinity 2 camera with the Infinity Analyze software. 
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Discussion 
It is widely accepted that the lethal acute toxicities of HCN and H2S are similar, cytochrome 
c oxidase within the central nervous system is the primary target for inhibition, and death results 
from respiratory paralysis.96, 148  We have found nothing, to date, that would lead us to suspect that 
any of these assertions might be incorrect.  It has also, however, previously been widely accepted 
that the antidotal action of sodium nitrite toward cyanide intoxication involves oxidation of 
hemoglobin to metHb, which then detoxifies cyanide through formation of cyanomethemoglobin 
(metHbCN).  This in turn frequently led to the tautological opinion that sodium nitrite was an 
undesirable choice for a cyanide antidote because it would result in methemoglobinemia in patients 
with already challenged respiratory function.227-229  Contrary to these hypotheses, our laboratory 
has shown in a series of studies that the nitrite anion probably functions as an NO donor able to 
reverse cyanide inhibition at cytochrome c oxidase and, at efficacious antidotal levels, metHb 
formation is minimal (< 2% total hemoglobin).59-62  In support of this position, Lavon has very 
recently shown that the administration of isosorbide dinitrate in rabbits ameliorates cyanide 
toxicity without any metHb formation.162  Now, in the present study of sulfide toxicity and its 
amelioration by nitrite, we have demonstrated an analogy.  Sodium nitrite can clearly be protective 
against acute sulfide toxicity in mice (Figures 18 & 19) while metHb accumulation in the blood is 
negligible (Fig 20).  Quantitation of the EPR data revealed that only 4% of the NaHS dose given 
to mice became trapped as metHbSH.  This is less than the experimental variability of the toxicant 
delivery, since our dose error was about ±1 mg/kg (of 16 mg/kg total) or ca. ±6%, not enough to 
explain the observed level of protection.  Using an approach suggested independently by Chen230 
and Way231 who, before our group, were the most vocal critics of the nitrite-metHb hypothesis, we 
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attempted to further suppress nitrite-dependent metHb formation with methylene blue.  Certainly, 
sodium nitrite was still fully protective against acute sulfide toxicity in mice also treated with 
methylene blue (data not shown) but we only found modest (< 20%) reduction in levels of metHb 
by EPR – in keeping with our position regarding the insignificance of metHb, but not adding much 
weight to the argument.  The current rather ambiguous results of the methylene blue experiment 
could be due to the relatively low levels of metHb formation we now obtain.  The present data 
obtained with isolated enzyme (Figure 22) and cultured cells (Figure 23) support the notion that 
nitrite-derived NO reversing the sulfide inhibition at cytochrome c oxidase is likely to be the 
principle antidotal mechanism. 
Our findings are that experimental animals acutely poisoned with sulfide (LD40 given 
intraperitoneally as an aqueous NaHS solution) either succumb within minutes (typically < 5 min) 
or recover fully (by RotaRod assay) within about 15 min (Figure 2) irrespective of whether antidote 
was given or not.  These observations seem to be in broad agreement with the recent report of 
Haouzi et al102 who also found following administration directly into the vasculature of sheep and 
rats at sub-lethal levels, free sulfide species reacted and disappeared from the bloodstream within 
1 minute.  In short, effects that can truly be described as “acute” are very rapid.  On the other hand, 
there are numerous accounts of suspected victims of H2S gas inhalation reaching the clinic 
exhibiting “acute symptoms” such as unconsciousness and respiratory difficulty.96, 106  Typically, 
these patients will have presented at the clinic approximately half an hour or more after collapse, 
many having received ventillatory support, and some succumb to the poisoning hours after the 
exposure.  This chain of events is quite unlike observations made with laboratory animals, 
suggesting additional and slower mechanisms of toxicity are important in real-world exposures.  
While inhibition of cytochrome c oxidase may represent the key acute toxic action of sulfide, it 
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has been suggested that sulfide may engage a broad range of other biological targets such as 
carbonic anhydrase,232 monoamine oxidase,233 cholinesterase and Na+/K+-ATPase.110  
Alternately, sulfide inhibition of mitochondrial electron-transport chains in various parts of the 
brain, which is probably not relieved by ventillatory support, may lead to damagingly low ATP 
levels – sometimes this is misleadingly referred to as “brain/tissue hypoxia” in relation to 
cyanide/sulfide toxicity, whereas “bioenergetic hypoxia” might be more appropriate as there will 
actually be net hyperoxic conditions due to suppressed oxidative phosphorylation.  Distinguishing 
between these possibilities will have to await further studies, but the current findings do reinforce 
the view from the experimental toxicologist’s perspective that clinical presentations of sulfide 
poisoning can never be accurately described as “acute” (the patient would either be dead, or require 
no treatment) instead, they represent a range of more complicated “post-acute” conditions. 
The current results (Figures 18 & 19) suggest that sodium nitrite may only be useful 
prophylactically and cannot be administered quickly enough to be of any antidotal value when 
given after toxicant dose.  However, the lengthy survival time of sulfide-poisoned human victims 
compared to the laboratory animals indicates that this need not be so.  There may be around half 
an hour or so, especially in the ambulance and before arrival at the clinic, during which time a 
beneficial intervention could be made with sodium nitrite, or other antidotes like decorporating 
agents.  NO crosses the blood-brain barrier and, consequently, nitrite administration may be a 
practical way to address the potential brain “bioenergetic” hypoxia during ventillatory support.  At 
this time, what is lacking is a good experimental paradigm for studying real-world exposures, 
which are almost all occupational accidents involving H2S gas inhalation for a duration of at least 
several minutes.  This is the first obvious limitation of the simple ip -injection approach we have 
adopted so far, which has such a short period of effect that meaningful testing of putative antidotes 
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post-toxicant delivery is impractical if at all possible.  At some point inhalation exposures of 
animals will be required to address some particular pulmonary issues, such as the lung edema 
commonly found at autopsy in humans 234 and which, so far, has not been evident in our animals.  
Nevertheless, there is some value in pursuing non-inhalation methods as some of the pulmonary 
issues are likely due to H2S acting as an irritant and it will be important to disentangle these from 
systemic toxic effects and their amelioration.  An equally important limitation of the present study 
is the use of a mouse model.  Humans and other larger mammals exposed to H2S tend to exhibit 
coma and death without the transient and reversible torpor, associated with bradycardia and 
hypopnea, observed for small animals like mice.  Perhaps this pattern of protective response helps 
the mice to avoid neurological sequelae in a manner not available to larger mammals.  
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Abstract 
Four cobalt-containing macrocyclic compounds previously shown to ameliorate cyanide 
toxicity have been comparatively evaluated with an acute sub-lethal toxicity model in conscious 
(un-anesthetized) adult male Swiss-Webster mice.  All of the compounds (the cobalt-corrins 
cobalamin and cobinamide, a cobalt-porphyrin, plus a cobalt-Schiff base macrocycle) given 5 min 
prior to the toxicant dose significantly decreased the righting-recovery time of cyanide-intoxicated 
mice, but the doses required for maximal antidotal effect varied.  Additionally, all of the 
compounds tested significantly reduced the righting-recovery time when administered at either 1 
or 2 min after cyanide intoxication, but none of the compounds tested significantly reduced the 
righting-recovery time when delivered 5 min after the toxicant dose.  Using the lowest effective 
dose of each compound determined during the first (prophylactic) set of experiments, 
neuromuscular recovery following cyanide intoxication in the presence/absence of the cobalt-
based antidotes was assessed by RotaRod® testing.  All the compounds tested accelerated recovery 
of neuromuscular coordination and no persistent impairment in any group, including those animals 
that received toxicant and no antidote, was apparent up to 2 weeks post-exposures.  The relative 
effectiveness of the cobalt compounds as cyanide antidotes are discussed and rationalized based 
upon the cyanide-binding stoichiometries and stability constants of the Co(III) cyano adducts, 
together with consideration of the rate constants for axial ligand substitutions by cyanide in the 
Co(II) forms. 
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Introduction 
Other compounds, including dicobalt ethylenediaminetetraacetate (Kelocyanor®) 235 and 
4-dimethylaminophenol 236, remain in use worldwide, but there are currently only two acceptable 
antidotes to cyanide poisoning available in the United States 237, 238.  The first, Nithiodote®, is a 
combination treatment of sodium nitrite and sodium thiosulfate 164; in which (i) the nitrite anion 
probably acts as a nitric oxide (NO) donor leading to the removal of cyanide bound to cytochrome 
c oxidase 62, 157 rather than simply being a methemoglobin generator and (ii) the thiosulfate reacts 
with free cyanide in a reaction catalyzed by the enzyme rhodanese leading to formation of the 
considerably less toxic thiocyanate anion (SCN–) 164. Intravenous infusion of sodium nitrite in the 
pre-hospital setting must be undertaken with caution, due to the likelihood of induced hypotension 
and methemoglobinemia, the latter being of particular concern if there has been any concomitant 
carbon monoxide poisoning through smoke inhalation 238, 239.  The second antidote, Cyanokit®, 
contains hydroxocobalamin (Cb), a vitamin B12 derivative (Figure 24A) 240.  Cb binds a single 
cyanide anion to its central cobalt(III) cation, with high affinity thereby acting as a scavenger of 
the toxicant in the bloodstream.  Unfortunately, while Cb appears to be efficacious and the safest 
available option for treating cyanide intoxication 241, 242, it is still a less than ideal antidote because 
it must first be dissolved (5 g solid in ~200 mL saline) before it can be intravenously infused (~15 
mL per min for almost 15 min in adults) 240. Particularly with regard to acute-poisonings/mass-
casualty situations, this slow administration is a significant problem as cyanide is such a quick-
acting toxicant. 
Cobinamide (Cbi) lacks the dimethylbenzimidazole nucleotide tail of Cb (Figure 24B) 
allowing for the binding of two cyanide anions to the cobalt ion and has been shown to be a 
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potentially better cyanide scavenger 243, 244.  We have recently demonstrated the cyanide 
scavenging ability of cobalt(III)meso-tetra(4-N-methylpyridinyl)porphine (CoTMPyP) (Figure 
24C) a water soluble metalloporphyrin complex 176, 245.  In addition, we have begun to investigate 
the cyanide binding and scavenging activities of Schiff-base macrocyclic compounds, including 
cobalt(III)2,12-dimethyl-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(7)2,11,13,15-pentaene 
(CoN4[11.3.1]) (Figure 24D) 69.  These smaller cobalt cations, CoTMPyP and CoN4[11.3.1] or 
similar, which are also able to bind two cyanide anions per cobalt, may be soluble at higher 
concentrations in the bloodstream than Cb and Cbi, resulting in improved cyanide-scavenging 
capabilities.  In this paper, to directly assess the relative merits of such cobalt-containing 
compounds (Table 12) as cyanide antidotes, we have undertaken a series of head-to-head 
comparative assays in mice, in which experiments with Cb were included as a benchmark. 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Structures of cobalt-containing compounds for comparison of cyanide scavenging abilities in mice. 
(A) Cobalamin (Vitamin B12),a FDA approved cyanide antidote, (B) cobinamide, the biological precursor to 
cobalamin, (C) CoTMPyP (Cobalt (II/III)meso-tetra(4-Nmethylpyridinyl)porphine), and (D) CoN4[11.3.1] (cobalt 
(II/III)(2,12-dimethyl-3,7,11,17-tetraazabicyclo-[11.3.1]heptadeca-1(7)2,11,13,15-pentaene). 
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Table 12. Selected Properties of the Cobalt-containing Trial Compounds. 
 
 
 
 
 
 
 
 
 
 
For this investigation, we chose an acute-toxicity model using intraperitoneal (ip) 
injections of NaCN (saline solutions) in adult male Swiss-Webster mice.  In this paradigm, which 
has previously been well-validated 22, 62, 156, 157 the mice are conscious and freely moving at the 
time of toxicant injection, avoiding the confounding influence of anesthesia present in some other 
animal protocols 62, 130.  The ameliorative capabilities of the compounds in question given both 
prophylactically and therapeutically have been compared.  Antidotal effects in the short term (< 
30 min) have been quantitatively assessed by observing shortening of recovery times following 
Property 
Hydroxocobalamin 
(Cb) 
Cobinamide 
(Cbi) CoTMPyP CoN4[11.3.1] 
Molecular masses  (of cations) 1329 990 678 317 
Comparative (estimated) costsa 1
b 63c ~0.8d < 0.2e 
Available sites for exogenous 
ligands 
1 2 2 2 
       Stability constantsf 105  M-1 109-1010  M-2 2 x 1011  M-2 > 107  M-2 g 
Rate constantsh > 102  M-1s-1 i > 103  M-1s-1  j 102 - 103  M-1s-1 k ~105  M-1s-1 l 
 aBased on the Sigma-Aldrich catalog (accessed on line October 2017) molar comparisons. bHydroxocobalamin 
hydrochloride $165/g (equating to $825 for a single adult dose). cComparing prices of cyanocobalamin and 
dicyanocobinamide, the sole derivative of the latter available at the time.  The Cbi was only available in mg 
quantities, so there is likely to be reduced cost associated with scaling up production; however, Cbi will remain 
many-fold more expensive than its precursor Cb as additional manufacturing steps (chemical modification, 
purification, recovery) are necessary. dCoTMPyP was not available, so this estimate is based on the mean of the 
pricing for cobalt(II)-5,10,15,20-tetraphenylporphine and cobalt(II)-5,10,15,20-tetrakis(4-
methoxyphenyl)porphine, two similar metalloporphyrins. eCoN4[11.3.1] is, so far as we are aware, not 
commercially available at this time (except by custom synthesis).  This estimate is based on the catalog prices of 
the starting materials multiplied by 10. fStability constants for cyano adducts in terms of total cyanide 
concentrations [HCN + CN–] for Co(III) forms at pH 7.4 and 25°C. gThe stability constant for the bis(cyano)Co(II) 
adduct was actually determined and found to be 3 x 105.  There are remarkably few studies reporting the stability 
constants of cyano complexes of transition-metal ions in different oxidation states.  However, based on available 
reliable data for (i) the hexacyanoferrate(II) and hexacyanoferrate(III) pair, plus (ii) the stepwise formation 
constants for some other polycyano complexes, we estimate the increase in the net stability constant for the Co(III) 
form of CoN4[11.3.1] to be at least an order of magnitude per cyano ligand:  3 x 105 multiplied by 102 = 3 x 107, 
or greater. hRate constants for cyanide binding to the Co(II) forms at pH 7.4 and 25 °C.  Where dicyano complexes 
are formed, it is often the case that the rate for only one ligand association can be observed, the other presumably 
being too fast to measure. iThe reported rate constant is for the Co(III) form (80 M-1s-1) hence that for the Co(II) 
form must be greater as Co(III) complexes are typically more substitution inert than their Co(II) counterparts. jThe 
rate constant for the largest (~90%) of two [cyanide]-dependent phases observed for the Co(III) form is 3 x 103 M-
1s-1, hence that for the Co(II) form must be greater. kTwo [cyanide]-dependent phases of comparable extent were 
observed. lPraekunatham et al, manuscript in preparation. 
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cyanide-induced unconsciousness (“righting recovery”).  Antidotal effects in the longer term (24 
hr – 2 weeks) have been quantitatively assessed by measuring the duration that the animals were 
able to remain in position on a rotating cylinder (RotaRod®) a test of neuromuscular coordination).  
The results suggest that the trial compounds all work by similar mechanisms and identify potential 
strengths/weaknesses of each in the pursuit of cobalt-containing compounds as antidotes to 
cyanide poisoning. 
 
Experimental Section 
Chemicals.  All non-gaseous reagents, obtained from Fisher or Sigma-Aldrich, were ACS 
grade or better and used without further purification.  Argon and nitrogen gases were purchased 
from Matheson Incorporated.  Previously described procedures were employed to prepare Cbi 246, 
CoTMPyP 245 and CoN4[11.3.1] 69.  Solutions of sodium cyanide in saline were prepared 
immediately prior to use in septum-sealed vials with minimized headspaces and volumetric 
transfers made with gastight syringes. 
Animal Exposures.  The University of Pittsburgh Institutional Animal Care and Use 
Committee (Protocol Number 13092637) approved all animal produces used in these experiments.  
The Division of Laboratory Animal Research of the University of Pittsburgh provided all 
veterinary care during this study.  With the exception of most animals exposed to sodium nitrite 
(see below), male Swiss-Webster mice weighing 35-40 g (6-7 weeks old) were purchased from 
Taconic, Hudson, NY, housed four per cage and allowed access to food and water ad libitum.  
Animals were allowed to adapt to their new environment for one week prior to carrying out 
experiments.  All animals were randomly assigned to experimental groups of predetermined size.  
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All solutions administered to mice were prepared by dilutions into sterilized saline in septum-
sealed vials using gastight syringes and were given by ~0.1 mL intraperitoneal (ip) injections.   
Similar procedures (Protocol Numbers 0808101 and 1008725) approved by the University 
of Pittsburgh Institutional Animal Care and Use Committee were employed in the case of the 
majority of mice treated with sodium nitrite.  Veterinary care was provided by the Division of 
Laboratory Animal Research of the University of Pittsburgh.  Male Swiss-Webster mice 16-20 
weeks old, weighing 40-45 g were purchased from Charles River Laboratories, Wilmington, MA.  
All solutions were prepared by dilutions into sterilized saline and administered through ∼0.1 mL 
intraperitoneal (ip) injections.  In general, a group of at least 4 mice were tested for each 
experimental point.  Efficacy was tested through the recovery of righting ability after NaNO2 (12 
mg/kg) was injected 2, 4, 8, 12, 16 or 20 min following the administration of NaCN (100 µmol/kg). 
Righting Recovery.  Following cyanide administration, the duration of time required for 
the recovery of righting ability in mice was measured following a simplification 157 of the 
procedure originally used by Crankshaw et al 156.  The toxicant (5 mg/kg NaCN) was administered 
to mice (ip) and they were then placed in a transparent but dark green-colored plastic tube (Kaytee 
CritterTrail, available from pet stores) in a supine position.  The time it took from the initial 
administration of the toxicant until the mouse flipped from the supine to a prone position in the 
plastic tube was taken as the endpoint (righting-recovery time).   
Prophylactic Dose-Response.  The established antidote (Cb) and potential prophylactic 
antidotes (Cbi, CoTMPyP or CoN4[11.3.1]) were injected (ip) into mice (n = 6-8 per dose) at levels 
of 30, 40, 45, 50 or 70 µmol/kg, 5 minutes before the administration (ip) of 100 µmol/kg NaCN.  
Control animals received cyanide alone. The righting-recovery times were recorded for mice that 
survived the cyanide intoxication.  A single injection of cyanide administered at this sub-lethal 
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dose typically results in a persistent state of unconsciousness within 1-2 min that can last for more 
than 25 min 62, 157 allowing for multiple measures of trial-compound efficacy given both 
prophylactically and therapeutically.  The lowest dose of each putative antidote (Cbi, CoTMPyP 
or CoN4[11.3.1]) having the maximal ameliorative response following prophylactic administration 
was determined.  Based on these results we then selected a single dose (“lowest dose having 
maximal antidotal effect”) for subsequently testing the therapeutic powers of the trial compounds.  
For comparison, Cb was given at 70 µmol/kg in these subsequent experiments (see below) as there 
was no maximal antidotal effect apparent for this compound in the experimental range. 
Therapeutic Time Response.  After determining the lowest doses having maximal 
antidotal effect for each putative antidote, mice (n = 6-8 per dose) were given 100 µmol/kg NaCN 
and subsequently (1, 2, or 5 min later) injected with either 50 µmol/kg CoN4[11.3.1] or, alternately, 
70 µmol/kg Cb, Cbi, or CoTMPyP.  Righting-recovery times were recorded for mice that survived 
the toxicant injections and, later, the same animals were used in the RotaRod assessments 
described below. 
RotaRod Testing.  The accelerating RotaRod® (Coulbourn Instruments, Whitehall, PA), 
a rotating cylindrical apparatus, was used to assess motor skill, learning and recovery subsequent 
to cyanide intoxication.  Well-established experimental protocols were followed 247, 248.  An 
individual trial was started by placing a mouse on the RotaRod device turning at 4 rpm.  
Subsequently, acceleration was varied linearly from 4 to 22 rpm over the course of 60 s.  Trials 
ended when the mouse either fell off, or had remained on the rotating cylinder for 60 s.  Latency 
to fall, and highest speed reached were recorded for each trial.  The animals were evaluated over 
a period of three consecutive days.  On the first day, each mouse was trained in a series of 8 
sequential trials on the RotaRod device.  The baseline motor performance was established on the 
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second day by determining the max speed (rpm) reached before each animal fell off the RotaRod 
apparatus, averaged over three trials.  On the second day, animals were tested in sets of 3 trials at 
15 min intervals (with one set of trials made prior to any injections) over a period of 2.5 hrs.  On 
the third day, 24 hr after the previous experiments, mice were tested again for a single set of 3 
trials to determine whether any latent longer-term differences between experimental groups had 
emerged.  A subset of the animals were further tested on the RotaRod apparatus up to 2 weeks 
following their injections.  Data were analyzed using 2-way ANOVA to determine the main effect 
of treatment and time with Tukey’s multiple-comparison test to determine the differences between 
groups. 
 
Results 
Comparison of the Prophylactic Effects of Cb, Cbi, CoTMPyP and CoN4[11.3.1] on 
Acute (Sub-Lethal) Cyanide Toxicity.  All of the cobalt containing compounds selected for 
comparison in this paper have been reported to be protective against acute cyanide poisoning 69, 
176, 237, 240, 245, but they have not previously all been tested in a head-to-head fashion in the same 
model system.  We chose to use the prophylactic administration of the cyanide scavenging 
compounds in mice as a starting point for comparing the efficacy of the four chosen compounds 
(Cb, Cbi, CoTMPyP and CoN4[11.3.1]) against cyanide toxicity.  In order to determine the lowest 
dose having maximal antidotal effect in each case, Swiss-Webster mice (age 7-8 weeks) were 
injected intraperitoneally (ip) with either 30, 40, 45, 50, or 70 µmol/kg of each cobalt compound 
to be tested, followed 5 min later by injection (ip) of NaCN (100 µmol /kg).  Control animals that 
received NaCN alone were “knocked down” (i.e. became unconscious) within 1-2 minutes, 20% 
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(16 of 82) died within 4 min of the toxicant delivery, and those that survived exhibited a mean 
righting recovery time of 24 ± 7 min (n = 66). 
All of the compounds employed in this prophylactic paradigm significantly decreased the 
righting recovery time of the cyanide-intoxicated mice, but the dose of each test compound 
required for the maximal effect (i.e. minimal recovery time) varied (Figure 25).  While the righting 
recovery time seemed to decrease as the Cb administered was increased from 30 to 50 µmol/kg, 
the only significantly effective dose was 70 µmol/kg (Figure 25A).  The righting recovery time 
was 9 ± 5 min (compared to 24 min for controls) and, in addition, 100% of the mice receiving this 
Cb dose (15 of 15) survived. Interestingly, Cb was the only antidotal compound of the four for 
which a majority of the mice (14 of 15) still experienced knock-down, even at the highest dose 
tested.  Lower doses of Cbi (45, 50 and 70 µmol/kg) compared to Cb significantly reduced the 
righting-recovery times of cyanide-intoxicated mice to 8 ± 8 min, 12 ± 10 min, and 5 ± 6 min, 
respectively (Figure 25B) – all the animals survived (16 of 16) and half experienced knock-down 
(8 of 16).  However, there was noticeably more variation within the Cbi-treated groups of mice 
compared to all the other groups, particularly in mice administered 45 or 50 µmol/kg Cbi, and the 
response was not strictly linear.  The most effective dose of Cb (70 µmol/kg), against cyanide 
intoxication, was ~1.6 times a similarly effective dose of Cbi (45 µmol/kg).  The lower effective 
dose of Cbi can be rationalized by consideration of its structure (Figure 24B) in which the loss of 
the dimethylbenzimidazole ribonucleotide tail of the Cb structure (Figure 24A) allows Cbi to bind 
two exogenous cyanide anions rather than only one. 
The other two compounds forming bicyano adducts, CoTMPyP and CoN4[11.3.1], were 
then tested. CoTMPyP significantly reduced the righting recovery time at all doses tested (Figure 
25C) with righting recovery times of 15 (± 10) min, 9 (± 7) min, 9 (± 5) min, 5 (± 4) min, and 1 (± 
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3) min for doses of 30, 40, 45, 50, and 70 µmol/kg, respectively.  The dose of Cb (70 µmol/kg) 
most effective against cyanide intoxication, was ~1.8 times a similarly effective dose of CoTMPyP 
(40 µmol/kg).  No deaths (100% survival) were observed when mice were administered either 45, 
50 or 70 µmol/kg CoTMPyP before cyanide intoxication.  Out of 13 mice that were administered 
70 µmol/kg of CoTMPyP, only two knocked-down. 
Finally, dose-response testing demonstrated that CoN4[11.3.1] administered at 45, 50, or 
70 µmol/kg significantly reduced the righting recovery time versus control mice to 5 (± 7), 3 (± 
4), 3 (± 3) min, respectively (Figure 25D) – all the animals survived (15 of 15) and about half 
experienced knock-down (7 of 15).  Since, we found that the average time of righting recovery is 
unchanged when the dose administered was increased from 50 to 70 µmol/kg, the lower dose (50 
µmol/kg) was chosen for the therapeutic experiments (see below).  The dose of Cb (70 µmol/kg) 
most effective against cyanide intoxication, was at least 1.6 times a similarly effective dose of 
CoN4[11.3.1] (45 µmol/kg) – this value could be up to 1.8 times (70 µmol/kg Cb:40 µmol/kg 
CoN4[11.3.1]) but for a single outlying point in the data (Figure 25D).   
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Figure 25. Dose-response profiles for prophylactically administered Cb, Cbi, CoTMPyP and CoN4[11.3.1] in 
cyanide-intoxicated male mice as determined by righting-recovery times. 
Swiss-Webster male mice (7-8 weeks of age) were injected (ip) with either Cb (A), Cbi (B), CoTMPyP (C) or 
CoN4[11.3.1] (D) 30, 40, 45, 50, and 70 µmol/kg in saline, 5 min before the administration of 100 µmol/kg NaCN (in 
saline).  Control animals received only 100 µmol/kg NaCN injections (open circles).  Righting recovery times were 
recorded and the medians and interquartile ranges are shown.  One-way ANOVA with Tukey’s multiple comparisons 
post-test was performed for each compound tested to determine the significance of the righting-recovery time as 
compared to controls. ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01 and *p ≤ 0.05. 
 
Comparison of the Therapeutic Effects of Cb, Cbi, CoTMPyP and CoN4[11.3.1] on 
Acute (Sub-Lethal) Cyanide Toxicity.  To examine the ability of the cobalt-containing 
compounds to ameliorate the effects of cyanide intoxication when given after the toxicant, Cb, 
Cbi, CoTMPyP, or CoN4[11.3.1] were administered at the maximally effective doses (as described 
above) to male Swiss-Webster mice (7-8 weeks of age) at either 1, 2, or 5 min after injection of 
NaCN (100 µmol/kg).  That is, all the cobalt compounds were administered at a dose of 70 
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µmol/kg, except for CoN4[11.3.1], which was given at a dose of 50 µmol/kg.  The righting-
recovery times following the cyanide injections were recorded and compared with the controls 
given NaCN only (Figure 26). 
The mean recovery times for animals given 70 µmol/kg Cb at 1 or 2 min after cyanide 
injections were found to be 11 ± 8 min and 14 ± 3 min, respectively (Figure 26A), longer than that 
observed when the same dose was prophylactically administered (9 ± 5 min, Figure 25A).  Mice 
receiving 70 µmol/kg Cbi at 1 or 2 min post-cyanide intoxication had righting-recovery times of, 
respectively, 7 ± 4 min and 11 ± 2 min, again longer than for the prophylactically administered 
dose (5 ± 6 min, Figure 25B).  CoTMPyP performed no better than Cb or Cbi in this therapeutic 
test (Figure 25C) exhibiting recovery times of 10 ± 7 min and 11 ± 6 min, for delivery of 70 
µmol/kg CoTMPyP at 1 and 2 min, respectively, after cyanide intoxication compared to 
prophylaxis (1 ± 3 min, Figure 25C).  Additionally, the majority (6/7) of mice tested knocked-
down when CoTMPyP was administered at 1 min after cyanide injections, comparable to the effect 
seen with both Cb and Cbi.  However, CoN4[11.3.1] performed better than the other compounds 
when given 1 min after cyanide intoxication (Figure 26D) with a righting recovery time of 4 ± 3 
min, comparable to its prophylaxis (3 ± 3 min, Figure 25D) even though a lower dose of the 
antidote (50 µmol/kg) was used.  When given 2 min after the toxicant, the mean righting-recovery 
time for CoN4[11.3.1] was 13 ± 6 min, no better than the other cobalt compounds at the same time 
point.  Additionally, when the CoN4[11.3.1] had been administered at 1 min after the cyanide 
injections, 4 of the 12 mice tested did not knock-down, a noteworthy improvement compared to 
the effects seen with the other compounds.   
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Figure 26. Therapeutic effects of cobalt-containing compounds in male mice after cyanide intoxication. 
Swiss-Webster mice were injected with either 70 µmol/kg of Cb (A), Cbi (B), CoTMPyP (C), or with 50 µmol/kg of 
CoN4[11.3.1] (D) at 1, 2, or 5 min  post cyanide intoxication.  NaCN given alone (100 µmol/kg) and with the test 
compounds (at the doses above) injected prophylactically at -5 min are included in each plot for comparison purposes. 
Righting-recovery times were recorded for each set of injections; the median and interquartile range are shown.  One-
way ANOVA with Tukey’s multiple comparisons post-test was performed for each compound tested to determine the 
significance of the righting-recovery time as compared to controls. ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01 and *p 
≤ 0.05.  #median and interquartile range are both equal to 0. 
In summary, all of the cobalt compounds tested significantly reduced the righting-recovery 
time when administered at either 1 or 2 min after cyanide intoxications, but none of the compounds 
tested had any measurable impact on the righting-recovery time when delivered 5 min after the 
cyanide administration (Figure 26).  Using exactly the same righting-recovery approach in sub-
lethally intoxicated mice (16-20 weeks of age) we have previously shown that sodium nitrite 
clearly is an effective cyanide antidote when given therapeutically more than 5 min after the 
toxicant dose 157.  Such is the significance of this earlier result that we present data collected from 
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the younger mice (7-8 weeks, closed diamonds) in this study along with the data previously 
published for the older mice here (Figure 27, solid circles) both for emphasis and as a positive 
control.  In terms of preventing knock-down and the shortest righting recovery observed, 
prophylactically administered CoTMPyP appeared to be the most effective of the cobalt 
compounds (Table 25).  Otherwise, CoN4[11.3.1] was the most efficacious of the cyanide 
scavengers tested by several criteria, not the least of which was that it performed comparably, or 
slightly better than the others, at lower relative dose. 
Figure 27. The ameliorative effect of NaNO2 on cyanide intoxication. 
Swiss-Webster mice (males, 16-20 weeks of age, solid circles and males 7-8 weeks of age, solid diamonds ) injected 
with NaCN (100 µmol/kg, ip) and then administered NaNO2 (12 mg/kg, ip) 2 to 20 min after cyanide. Control animals 
received NaCN only. Values represent means and standard deviations. In general, at least 4 animals per point were 
used, except for control (n = 17 for 16-20 weeks of age and n = 66 for mice of 7-8 weeks of age). One-way ANOVA 
with Tukey’s multiple comparisons post-test was performed to determine the significance of the righting-recovery 
time as compared to controls.*p ≤0.0001, **p ≤ 0.05 (16-20 week old mice) #p ≤0 .0001. ##p ≤ 0.01 (mice of 7-8 
weeks of age).   Solid circles (mice of 16-20 weeks of age) are reformatted data from Cambal et al. 
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Table 13. Distinguishing Animal Data for the Cobalt-containing Trial Compounds. 
 
Comparison of Neuromuscular Recovery in Mice Administered Acute (Sub-Lethal) 
Cyanide Doses (Controls) or Saline (Shams).  The RotaRod testing paradigm employed (Figure 
28A, see Experimental Methods for further details) involves measuring the duration that individual 
animals can remain in position walking on a rotating cylinder; any shortening of the observed 
duration following some experimental insult being taken as evidence of impairment.  While 
primarily a measurement of neuromuscular coordination 247, 248 the technique also routinely 
provides some assessment of learning capability and memory.  During the training periods (day 1, 
1 – 8 min; Figure 28B, 28C and 28D) the performance of all the animal groups increased steadily, 
indicating the mice were adapting to (i.e. learning) the test.  The trained performance was 
essentially maintained by 24 hr later with a very slight loss in the previous day’s level (pre-ip data 
sets, Figure 28B, 28C and 28D) and sham mice receiving saline solution without toxicant 
continued to adapt until reaching a plateau in their performance (open circles, day 2, 15 – 150 min; 
Assessment 
Controls 
(100 
µmol/kg 
NaCN) 
Hydroxocobalami
n 
(NaCN + Cb,       
70 µmol/kg) 
Cobinamide 
(NaCN + 
Cbi, 70 
µmol/kg) 
CoTMPyP 
(NaCN +    
70 µmol/kg) 
CoN4[11.3.1] 
(NaCN +        
50 µmol/kg) 
Prophylaxisa: Death/group 16/66 0/15 0/16 0/13 0/15 
Prophylaxis:                    
knock-downs/group 
66/66 
(100%) 14/15 (93%) 8/16 (50%) 2/13 (15%) 7/15 (47%) 
Prophylaxis: 
(5 min pre-NaCN): righting 
recovery time (min) 
 
24 
 
9 
 
5 
 
1 
 
3 
Prophylaxis:  
effectiveness ratiob N/A 1.0 1.6 1.8 1.7 
Therapeuticc: 
knock-downs/groupd N/A 4/4 (100%) 5/6 (83%) 6/7 (86%) 8/12 (67%) 
Therapeutic: 
righting recovery time (min)d N/A 11 7 10 4 
aPutative antidotes given 5 min before NaCN. 
b Relative to Cb (see text for explanation). 
cPutative andidotes given 1 min post NaCN administration 
dFor antidotal doses delivered at 1 min time points. 
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Figure 28B).  Control mice receiving only 100 µmol/kg NaCN were still completely incapacitated 
15 min after the toxicant dose, unable to remain on the rotating cylinder for any time at all, but 
then steadily improved over the next 2 hr (filled squares, day 2, 15 – 150 min; Figure 28B).  The 
performances of the sham and control animals remained indistinguishable 24 hr later (day 3, 24 hr 
points; Figure 28B).  A subset of these animals were evaluated at longer times post injections and, 
in fact, the performances of the sham and control animals subjected to training regimens remained 
indistinguishable at 48 hr, 1 week and 2 weeks after the intoxications (see Supporting Information). 
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Figure 28. Neuromuscular coordination comparison, using RotaRod testing, of Cb, Cbi, CoTMPyP and 
CoN4[11.3.1] amelioration following NaCN administration in male Swiss-Webster mice. 
(A) RotaRod testing paradigm: arrows indicate RotaRod testing times; lines with circles indicate injection times (all 
ip). Mice were trained on the RotaRod 24 h before injection, and a baseline performance was obtained 1 h before 
injection (Pre-ip). Mice were tested every 15 min after injections for 2.5 h (up to 150 min) and again at 24 h to assess 
recovery. One-way ANOVA with Tukey’s multiple comparisons post-tests were performed to determine the 
significance between controls and a particular compound tested or between compounds tested as noted. (B) 
Comparison of performance (maximum speed achieved) for injections of 100 μmol/kg NaCN (closed square) and 
saline control (open circle).  *p ≤ 0.001 vs saline control. (C) Comparison of performance (maximum speed achieved) 
for mice injected (ip) with 70 µmol/kg of Cb (closed circle), Cbi (open square), CoTMPyP (closed square) or 50 
µmol/kg CoN4[11.3.1] (open diamond). +p ≤ 0.01 vs Cbi. (D) Comparison of performance of mice (maximum speed 
achieved) injected with either 70 µmol/kg of Cb (closed circle), Cbi (open square), CoTMPyP (closed square) or 50 
µmol/kg CoN4[11.3.1] (open diamond) and 100 µmol/kg  cyanide. #p ≤ 0.05 for Cbi & NaCN vs Cbl & NaCN. 
Numbers of animals (in parentheses) used in each set of experiments are as follows: NaCN (16), saline (13), Cb (8), 
Cbi (8), CoTMPyP (6), CoN4[11.3.1] (7), Cb & NaCN (7), Cbi & NaCN (7), CoTMPyP & NaCN (6) and CoN4[11.3.1] 
& NaCN (7). 
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Comparison of Neuromuscular Recovery in Mice Administered Cb, Cbi, CoTMPyP 
and CoN4[11.3.1] Prior to Acute (Sub-Lethal) Cyanide Exposures.  Before testing any 
ameliorative capabilities, an initial set of experiments was performed in which the cobalt 
compounds were administered in the absence of cyanide to investigate the presence of possible 
undesirable side effects (Figure 28C).  Interestingly, the performance of mice on the RotaRod 
device was enhanced at 15 and 30 min after the administration of Cb (filled circles, Figure 28C, p 
< 0.01 compared to saline shams in Figure 28B); the effect being quite small, but reproducible 
over multiple days of testing.  In contrast, Cbi-treated mice had a significantly decreased rate of 
performance on the RotaRod device at 15 and 30 min post-cyanide administration (open squares, 
Figure 28C, p < 0.01 compared to saline shams in Figure 28B).  From about 90 min onwards, the 
data obtained for the animals treated with Cb, Cbi and the saline shams were indistinguishable 
(Figure 28C).   There were no significant differences in the entire experimental range from 15 min 
– 24 hr between the performances of either CoTMPyP- or CoN4[11.3.1]-treated animals (filled 
squares and open circles, Figure 28C) when compared to the performance of the sham mice 
injected with saline (Figure 28B). 
In a second set of experiments, animals were injected with the cobalt cyanide-scavenging 
compounds 5 min prior to the toxicant dose, then tested every 15 min for 2.5 hr and again at 24 hr 
(Figure 28D).  Mice administered 70 µmol/kg Cb (5 min before the toxicant dose) had significantly 
improved performance up to 105 min after the cyanide injection (filled circles, Figure 28D) when 
compared to mice receiving cyanide alone (filled squares, Figure 28B).  Interestingly, when 
comparing the performance of cyanide-challenged mice given the different antidotal compounds, 
the performance of the mice administered Cb was significantly improved compared to the others 
at the earliest time (15 min) after the cyanide intoxication (filled circles, Figure 28D).  Otherwise, 
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the performances of the cyanide-challenged mice administered Cb, Cbi, CoTMPyP, or 
CoN4[11.3.1] were not significantly different (Figure 28D).  Compared to the results for control 
animals given cyanide only (filled squares, Figure 28B) all the test compounds appeared to be 
significantly antidotal in mice in the 15 min to ~90 min window.  Consistent with a previous report 
69 there appears to be no persistent impairment of neuromuscular coordination detectable as judged 
by RotaRod testing at 24 hr in any group that received cyanide, irrespective of whether antidote 
was also given, or not (Figure 28B,C and D).  In fact, no impairment was observed at 2 weeks time 
post toxicant and/or antidote for any mice using the RotaRod testing (see Supporting Information). 
Importance of the Essentially Irreversible Kinetics of Antidotal Cyanide-Scavenging 
Compounds.  We have now repeatedly argued 69, 176 that the cobalt-based compounds Cb, Cbi, 
CoTMPyP and CoN4[11.3.1], even if administered in their Co(III) forms, are all quickly converted 
to Co(II) forms in circulating blood due to the presence of endogenous reductants such as 
ascorbate.  Following cyanide binding, however, the reduction potentials of the central cobalt ions 
become lowered to the extent that the cyanide adducts revert to oxidized forms.  This is crucially 
important because Co(III) complexes are typically more substitution inert than their Co(II) 
counterparts 118, 249, 250 and the cyanide forms are thus stabilized, so that they may be excreted 
rather than assist in systemic redistribution of the toxicant.  This point of view is, seemingly, 
reinforced by the observation that assimilation of the cobalamin cofactor in B12-dependent 
enzymes requires reductive decyanation of cyanocobalamin catalyzed by its chaperone 251.  As 
further demonstration of this principal, we undertook a set of experiments employing gallium 
nitrate as a trial antidote to both cyanide and sulfide (i.e. H2S/HS–) intoxication in mice.  Ga(III) 
is known to be a relatively safe ion when introduced into mammals, including humans, for other 
purposes 252, 253.  It is also well-known to form a stable complex with cyanide, but this is 
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substitution labile rather than inert 254, 255.  Accordingly, when attempts were made to investigate 
Ga(III) as a cyanide antidote in mice using the righting-recovery procedure, no effect was 
observed, beneficial or otherwise (Table 14).  On the other hand, the similarly acting mitochondrial 
poison sulfide 22, 256 forms a precipitate with Ga(III) 257.  This is not a readily reversible process 
and, consequently, Ga(III) was clearly efficacious in ameliorating sulfide intoxication (Table 14) 
in keeping with the suggestion that a degree of irreversibility associated  with the final adduct is a 
highly desirable characteristic for effective scavenging. 
 
Table 14. Effects of Ga(NO3)3 on Cyanide and Sulfide Toxicity in Swiss-Webster Mice. 
 
Discussion 
When given prophylactically, Cb, Cbi, CoTMPyP and CoN4[11.3.1] all clearly ameliorate 
the toxic effects of cyanide as assessed by righting recovery (Figure 25) and restoration of 
neuromuscular coordination (Figure 28D compared to filled squares in Figure 28B).  In all cases, 
including mice given only the toxicant, or only one of the cobalt compounds, recovery of normal 
neuromuscular function at 24 hr appeared complete (Figure 28B, 28C, 28D).  That is, there was 
no sign of any long-term impairment (up to 2 weeks), providing encouragement for the continued 
 Survivors/group (%) Time until deaths of non-survivors (min) 
5 mg/kg NaCN only (control) 50/66 (76%) ~3 
50 mg/kg Ga(NO3)3 given 1 min 
after NaCN 6/8 (75%) ~3 
18 mg/kg NaHS only (control) 16/24 (67%) < 4 
50 mg/kg Ga(NO3)3 given 1 min 
after NaHS 8/8 (100%) ——— 
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development of the latter three compounds as potential cyanide antidotes.  The slightly toxic effect 
detected in the case of Cbi at 15 and 30 min (open squares, Figure 28C) is, however, of some minor 
concern.  The value of these behavioral assessments of toxicity and antidote-dependent recovery 
with conscious mice should be fully appreciated – in addition to providing information not 
necessarily accessible with unconscious animals, such experiments avoid the well-known 
confounding complications of anesthesia 62, 130.  
In experiments where the putative antidotes were administered after the toxicant, Cbi, 
CoTMPyP and CoN4[11.3.1] (Figures 26B, 26C and 26D) all performed better than Cb (Figure 
26A).  Particularly if the lower dose is considered, CoN4[11.3.1] (Figure 26D, 50 µmol/kg) was 
measurably better than Cbi and CoTMPyP (Figures 26B and 26C, each 70 µmol/kg) as a 
therapeutic.  This lower effective dose of CoN4[11.3.1] could, of course, be of importance for 
treating higher levels of cyanide intoxication than would be possible with the other compounds.  
In relation to management of public health emergencies, there is currently some interest in 
stockpiling cyanide antidotes and, consequently, other factors may become important for ranking 
these cobalt compounds.  The relatively low cost of CoN4[11.3.1] (Table 12) should not be 
overlooked in this regard.  Also, however, the storage requirements for Cb and Cbi (biological 
materials) are that they be refrigerated (-20 °C) whereas we have stored CoTMPyP, CoN4[11.3.1] 
and similar complexes in darkened, screw-top vials at room temperature for months (years in some 
cases) without noticeable decomposition (assessed by mass spectrometry and spectral analysis) 
beyond some slow oxidation of Co(II) to Co(III). 
The stability constants (K) of all four cyano adducts (Table12) are large enough to ensure 
that the compounds are efficient cyanide scavengers.  For example, if Cb and cyanide are present 
in approximately equal quantities, K = 105 implies that > 99.99% of the cyanide will be bound to 
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the Co(III) center; alternately, if CoN4[11.3.1] and cyanide are present in approximately equal 
amounts, K = 3 x 105 (the lower end of the possible range – see footnote g to Table 12) implies 
that > 99.9% of the cyanide will be bound to the Co(II) center; in the other two cases, the stability 
constants are larger and even more of the cyanide will be scavenged.  Furthermore, since the rate 
constants for cyanide binding by the other three compounds are all similar or larger than that for 
Cb, we may argue that equilibrium is attainable in each case at fast enough rates that the relative 
efficacies of these compounds as antidotes should simply be given by the number of exogenous 
cyanide anions they can bind.  In other words, the antidotal capabilities of Cbi, CoTMPyP and 
CoN4[11.3.1] (all binding 2 CN– per Co(III)) should be comparable on a molar basis and they 
should be better than Cb (binding 1 CN– per Co(III)) by no more than a factor of approximately 2.  
In the present investigation, this is exactly what we find, the “effectiveness ratios” of Cbi, 
CoTMPyP and CoN4[11.3.1] compared to Cb are all approaching 2 (Table 13).  It requires 
comment that prophylactically administered Cbi has previously been reported to be 3-fold to 11-
fold more efficient than Cb as an in vivo cyanide scavenger in mice 244.  Certainly, the anesthesia 
used in this previous study may have influenced the results, but when the toxicant was given as 
NaCN solutions (ip injections) the 3-fold increased effectiveness of Cbi compared to Cb observed 
is not very different from the 2-fold increase we suggest here to be limiting.  Much more surprising 
is the finding that Cbi was 11-fold more effective than Cb when the toxicant dose was delivered 
as inhaled HCN.  This simply does not appear possible if the only relevant activity of Cbi is 
straightforward complexation of 2 CN– per Co(III); strongly suggesting that there must be some 
presently unrecognized aspect to the antidotal action of Cbi particularly associated with toxicant 
inhalation.  In the earlier study 244 the animals were given the antidotes 15 min before starting the 
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HCN dose which was then continued for a period of 30 min, so there was plenty of time for other 
processes to become involved. 
In the therapeutic experiments (Figure 26) where antidotes were given after the toxicant, 
the CoN4[11.3.1] performed best of the four when given 1 min after the cyanide (Table 13) perhaps 
reflecting its significantly faster reaction rate than the others (Table 12).  All the compounds were 
comparably effective when given up to 2 min after the cyanide, but if a delay of 5 min was allowed 
before giving antidote, none were effective (Figure 26).  We interpret this observation to indicate 
that within 5 min of receiving a cyanide dose the toxicant has bound to its molecular target, namely, 
cytochrome c oxidase in the mitochondria, and the cobalt-based scavengers are not able to reverse 
the inhibition of the enzyme as we have unambiguously demonstrated for at least Cb and Cbi 246.  
To the contrary, sodium nitrite clearly does work therapeutically if given as an antidote at times 
longer than 5 min after the cyanide dose (Figure 27).  It should be noted that the majority of these 
nitrite data were obtained employing older mice and from a different supplier compared to the 
other animal experiments.  The older control animals given no antidote exhibited a mean righting 
recovery time of 29 min, enabling effectiveness to be demonstrated if the nitrite was given up to 
20 min following the cyanide dose.  On the other hand, younger control animals given no antidote 
exhibited a mean righting recovery time of 24 min, enabling effectiveness to be demonstrated if 
the nitrite was given up to only about 15 min following the cyanide dose.  It is to be understood 
that the 15-20 window of effectiveness represents a limitation of the method, it does not necessarily 
mean that the nitrite would be ineffective if the therapeutic doses were to be delayed for more than 
20 min following a toxicant dose in some other poisoning scenario.  We have previously shown 
that nitric oxide (NO) is able to reverse cyanide inhibition of cytochrome c oxidase 59, 65 and used 
this observation to infer a plausible mechanism by which nitrite anion (acting as an NO donor) 
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may be antidotal toward cyanide intoxication independent of methemoglobin formation 62, 157.  
Therefore, unlike the cobalt-based scavengers, nitrite anion can reverse the toxic effect of cyanide 
at its principal molecular target by reversing the inhibition of cytochrome c oxidase; hence its 
broader window of action.  It follows that there are numerous experimental protocols that could 
inadvertently be undertaken that might misleadingly suggest cobalt-based scavengers (or any other 
cyanide-complexing compounds) can be of therapeutic benefit 5 min or more after the toxicant 
dose has ceased.  For instance, if a putative cyanide scavenger is given as a nitrite salt, or NO 
complex, then this really represents a combination therapy, not an unambiguous assessment of the 
scavenger.  Less obviously, any animal model in which cyanide scavengers are to be tested, but 
where there may be inflammation (with accompanying upregulation of inducible nitric oxide 
synthase), or where analgesics/anesthetics are employed (at least some of which are known 62 to 
behave like stimulators of endogenous NO production), a combination therapy is probably, if 
unintentionally, being investigated. 
We have previously shown 69, 176, 246 that the cobalt-based compounds Cb, Cbi, CoTMPyP 
and CoN4[11.3.1] are all quickly converted to Co(II) forms by reductants at the levels they are 
present in circulating blood, facilitating suitably rapid cyanide binding.  Upon binding cyanide, 
however, the reduction potentials of the central cobalt ions become lowered to the extent that the 
cyanide adducts become oxidized to stable forms that may be excreted.  Here, we have described 
a set of experiments (Table 11) employing gallium nitrate as a trial antidote to both cyanide and 
sulfide (i.e. H2S/HS–) providing further confirmation of the importance that the final adduct is 
essentially substitution inert – otherwise, the intended scavenger will only assist in the systemic 
redistribution of the toxicant.  The overall similarity in the relevant physicochemical properties 
(Table 12) of the cobalt compounds able to bind two cyanide anions per metal ion, namely Cbi, 
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CoTMPyP and CoN4[11.3.1] and the comparability of their performances in the antidotal trials 
(Table10) suggests that many cobalt complexes with four approximately equatorial nitrogen 
donors should display the necessary oxidation-reduction chemistry and ligand substitution 
characteristics suitable for application as cyanide scavengers.  Such compounds may, however, 
differ considerably the type of macromolecular biomolecules with which they interact.  That is, 
their relative toxicities will likely depend to some extent on the peripheral structures of their 
chelating ligands. 
 
Supplemental Materials and Figures 
Raw data for the righting recovery of cyanide intoxicated mice establishing prophylactic 
dose response, therapeutic time responses using Cbi, Cb, CoTMPyP and CoN4[11.3.1]. Raw data 
of RotaRod assessments for cyanide intoxicated mice and those treated with Cbi, Cbl, CoTMPyP. 
Mouse experiments were carried out as previously presented in the Experimental section.  
In addition to all individual data points used to make Figures 2, 3 and 5, we have included means 
and standard deviations of each data set.  
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Table 15. Raw data of the dose-response profiles for prophylactically administered Cb, Cbi, CoTMPyP and 
CoN4[11.3.1] in cyanide-intoxicated male mice as determined by righting-recovery times (as shown in Figure 
25). 
 
Swiss-Webster male mice (7-8 weeks of age) were injected (ip) with either Cb, Cbi, CoTMPyP or CoN4[11.3.1] 30, 
40, 45, 50, and 70 µmol/kg in saline, 5 min before the administration of 100 µmol/kg NaCN (in saline).  Cyanide 
intoxicated animals received 100 µmol/kg NaCN injections. 
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Table 16. Raw data of righting recovery times for therapeutic effects of cobalt-containing compounds in male 
mice after cyanide intoxication (as shown in Figure 26).  
Swiss-Webster mice were injected with either 70 µmol/kg of Cb, Cbi, CoTMPyP or with 50 µmol/kg of CoN4[11.3.1] 
at 1, 2, or 5 min  post cyanide intoxication.  NaCN given alone (100 µmol/kg) and with the test compounds (at the 
doses above) injected prophylactically at -5 min are included for comparison purposes.   
-5min +1min +2min +5min -5min +1min +2min +5min -5min +1min +2min +5min -5min +1min +2min +5min
1 20.5 5.0 17.0 8.0 15.5 14.0 16.0 9.0 14.5 0.0 0.0 22.0 7.5 0.0 7.0 15.0 20.0
2 34.5 5.0 0.0 22.0 22.5 0.0 0.0 10.5 16.5 0.0 20.0 5.5 32.0 0.0 0.0 9.8 22.5
3 22.0 8.5 9.5 12.0 21.5 10.0 7.0 12.0 17.0 0.0 14.0 13.0 19.0 0.0 6.0 9.5 30.0
4 30.0 6.5 18.0 14.5 17.0 0.0 9.5 13.5 19.0 11.0 14.0 13.0 21.0 0.0 4.5 19.0 19.5
5 24.0 18.0 13.5 0.0 6.0 26.0 0.0 8.5 5.5 18.0 0.0 6.5 6.5 22.0
6 23.0 19.5 0.0 4.0 0.0 4.0 9.0 7.0 6.0 20.5 26.0
7 24.0 9.0 0.0 0.0 6.0 8.0 0.0
8 25.5 0.0 21.0 0.0 0.0 0.0
9 20.5 5.5 7.0 0.0 8.0 6.5
10 22.0 9.0 0.0 0.0 0.0 4.0
11 23.5 7.5 0.0 0.0 7.5 7.0
12 9.5 8.0 4.5 0.0 6.5 0.0
13 17.0 15.0 6.0 7.0 4.0
14 25.0 7.0 0.0
15 35.5 7.0
16 25.5 0.0
17 17.5
18 22.0
19 24.0
20 32.0
21 25.5
22 17.5
23 11.0
24 25.0
25 23.0
26 6.5
27 29.0
28 26.0
29 25.0
30 27.0
31 25.5
32 29.0
33 28.0
34 15.0
35 13.5
36 30.0
37 16.0
38 30.0
39 25.0
40 28.0
41 34.0
42 29.0
43 27.0
44 9.0
45 13.0
46 23.0
47 31.0
48 33.0
49 21.0
50 25.0
51 23.0
52 27.0
53 23.5
54 34.0
Mean 23.8 9.0 11.1 14.0 19.1 4.8 7.1 11.3 18.6 1.3 9.5 11.3 19.5 3.2 4.0 13.4 23.3
Std. Dev. 6.7 5.5 8.3 5.1 3.4 6.2 5.4 1.9 4.4 3.4 6.9 6.2 8.7 3.7 3.1 5.7 4.0
Std. Error 0.9 1.5 4.2 2.3 1.7 1.5 2.2 1.0 2.0 0.9 2.6 2.5 3.9 1.0 0.9 2.3 1.6
CoN4[11.3.1]
Righting Recovery Time (min)
Mouse #
NaCN Cb Cbi CoTMPyP
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Table 17. Raw data for the neuromuscular coordination comparison, using RotaRod testing, of Cb, Cbi, 
CoTMPyP and CoN4[11.3.1] and of their amelioration following NaCN administration in male Swiss-Webster 
mice (as shown in Figure 28 B,C and D). 
Mice were trained on the RotaRod 24 h before injection, and a baseline performance was obtained 1 h before 
injection (Pre-ip). Mice were tested every 15 min after injections for 2.5 h to and again at 24 h to assess recovery 
A. Raw RotaRod data of mice injected (ip) with 70 µmol/kg of cobalamin (Cbl) cobinamide (Cbi), CoTMPyP
or 50 µmol/kg CoN4[11.3.1].
B. Raw RotaRod data of mice injected (ip) with 70 µmol/kg of cobalamin (Cbl) cobinamide (Cbi), CoTMPyP
or 50 µmol/kg CoN4[11.3.1].
Training 
Period
Mean
/ SD
Mean
/ SD
Mean
/ SD
Mean
/ SD
1-2 8.0 11.0 6.5 12.5 6.5 5.5 17.5 11.0 10±4 6.5 6.5 13.0 9.0 6.0 4.0 7.5 9.5 8±3 8.0 13.5 11.0 14.0 9.5 8.0 11±3 6.0 5.5 8.5 11.0 5.0 4.0 5.0 6±2
3-4 11.0 15.0 12.5 15.0 6.0 6.0 11.5 16.0 12±4 5.0 5.0 16.5 10.5 7.0 5.5 8.0 14.5 9±4 12.5 13.0 9.5 16.5 9.5 12.0 12±3 5.5 7.0 13.5 18.0 4.5 6.0 5.5 9±5
5-6 19.0 16.5 15.5 15.5 11.0 13.0 16.5 18.0 16±3 11.0 11.0 21.0 13.0 7.5 12.0 9.5 16.0 13±4 12.0 13.5 11.5 18.0 11.0 12.0 13±3 9.0 11.0 14.5 21.0 4.5 5.5 9.5 11±6
7-8 18.5 16.5 14.0 16.0 11.0 15.5 14.0 19.0 16±3 14.5 15.5 22.0 15.0 8.5 11.5 8.5 15.0 14±4 13.0 16.5 13.5 20.5 16.5 18.0 16±3 12.0 10.5 15.5 19.5 13.5 11.0 16.0 14±3
Pre-IP 17.7 11.0 15.7 9.7 14.0 11.3 14.7 19.7 14±3 14.3 13.3 19.0 12.3 8.0 14.0 9.0 14.7 13±3 9.3 18.3 13.0 18.3 18.3 16.3 16±4 14.0 12.7 13.0 15.7 16.0 10.7 11.3 13±2
Post-IP          
Recovery 
Period
15 22.0 22.0 21.0 17.0 14.0 13.3 19.3 22.0 19±4 11.0 8.7 21.0 5.3 6.7 10.7 12.3 9.0 11±5 5.3 14.0 9.7 20.3 19.7 13.7 14±6 15.0 15.3 8.7 17.3 13.0 14.0 10.0 13±3
30 22.0 20.3 21.7 22.0 14.0 18.3 20.7 22.0 20±3 13.7 18.0 13.3 4.7 12.3 14.3 11.3 15.0 13±4 10.0 21.7 10.0 22.0 22.0 13.3 17±6 21.0 20.3 12.0 18.0 10.7 15.7 12.3 16±4
45 21.7 17.3 22.0 21.3 13.0 14.3 22.0 22.0 19±4 13.7 16.0 21.7 8.7 14.0 14.3 17.3 20.0 16±4 7.7 19.3 9.7 22.0 22.0 8.0 15±7 21.3 17.0 16.3 17.0 16.0 15.0 6.7 16±4
60 20.5 22.0 22.0 22.0 12.0 14.0 22.0 22.0 20±4 9.7 16.0 22.0 13.0 8.7 13.7 17.0 17.0 15±4 10.3 20.7 11.7 21.3 14.7 10.7 15±5 21.7 22.0 16.0 13.0 8.7 13.7 4.3 14±6
75 21.7 19.3 22.0 22.0 9.3 11.3 21.3 22.0 19±5 11.0 17.0 22.0 14.7 10.7 14.0 19.3 21.0 16±4 12.0 21.3 10.7 22.0 17.3 17.3 17±5 21.3 19.7 13.0 13.7 13.3 8.7 14.7 15±4
90 19.0 20.7 22.0 18.3 8.3 15.0 18.7 19.0 18±4 8.3 22.0 21.0 14.7 13.3 13.7 20.7 22.0 17±5 10.7 17.7 9.3 21.0 14.7 12.3 14±4 19.7 18.7 11.0 15.0 11.7 14.7 11.3 15±4
105 16.3 20.3 21.3 20.7 7.3 14.7 17.0 13.0 16±5 7.3 13.0 21.3 14.3 9.0 11.3 18.3 22.0 15±5 8.7 12.7 11.0 22.0 17.0 19.7 15±5 18.3 19.7 16.3 22.0 9.3 9.7 6.7 15±6
120 20.0 21.3 20.3 21.3 9.3 13.0 16.3 19.3 18±4 10.3 16.0 21.0 12.0 12.3 14.3 16.3 21.7 15±4 11.0 21.0 11.3 19.0 13.0 18.3 16±4 19.3 17.0 16.3 22.0 9.0 8.7 11.0 15±5
135 20.0 20.3 22.0 21.7 9.0 15.3 14.3 17.3 17±4 11.0 16.3 22.0 13.7 11.3 18.0 13.3 22.0 16±4 11.7 22.0 13.0 17.0 11.7 13.7 15±4 15.7 19.3 15.0 22.0 10.3 9.3 12.0 15±5
150 14.7 19.3 22.0 20.3 8.0 16.3 17.3 17.0 17±4 13.0 15.3 22.0 13.7 11.0 18.3 13.3 22.0 16±4 11.7 22.0 13.7 19.3 12.0 21.0 17±5 20.0 16.7 15.3 22.0 13.7 8.7 13.7 16±4
24 hr 17.7 18.0 22.0 7.0 7.3 12.0 13.0 7.3 13±6 14.7 10.3 21.3 10.3 8.0 11.7 15.3 22.0 14±5 13.7 19.7 7.7 22.0 22.0 17.3 17±6 11.7 10.3 19.3 20.0 17.3 11.7 16.7 15±4
Cb Cbi
Maximum Speed Achieved (rpm)
CoTMPyP CoN4[11.3.1]
Training 
Period
Mean
/ SD
Mean
/ SD
1-2 10.5 9.5 7.5 11.5 8.0 5.0 7.0 8.0 8.5 4.0 7.5 6.5 16.5 8±3 9.0 5.5 5.5 6.5 6.5 8.5 11.0 5.5 6.0 7.0 8.5 8.0 6.0 8.5 10.5 10.5 8±2
3-4 17.0 10.5 13.5 14.0 13.5 8.0 7.5 11.5 13.5 6.0 9.5 10.5 20.0 12±4 13.5 13.0 6.5 5.5 11.0 13.5 10.5 5.5 10.5 8.0 15.0 13.5 15.0 12.5 11.0 14.0 11±3
5-6 17.5 10.5 19.0 18.0 14.0 8.0 9.0 18.0 14.0 4.5 13.0 11.0 22.0 14±5 15.5 12.0 7.5 8.5 15.5 16.5 15.0 8.0 14.0 9.5 12.5 15.0 10.5 13.0 14.0 20.0 13±3
7-8 17.0 10.5 17.0 18.0 16.0 16.0 8.5 21.0 13.0 6.5 14.5 14.0 22.0 15±5 15.5 12.0 12.5 14.0 14.0 12.5 17.0 11.0 21.5 10.0 12.5 17.0 15.5 16.0 16.5 21.0 15±3
Pre-IP 14.0 10.7 17.7 11.7 13.0 20.3 14.7 16.0 15.0 8.3 13.3 15.7 21.7 15±4 19.0 11.0 11.7 10.7 11.0 13.0 13.7 11.7 14.7 9.3 12.7 15.7 16.3 13.7 16.0 13.7 13±3
Post-IP 
Recovery 
Period
15 14.7 21.0 12.7 13.7 21.0 5.0 15.3 14.3 16.7 6.7 17.7 17.3 22.0 15±5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0±0
30 16.7 20.7 14.0 15.3 22.0 22.0 19.0 14.3 14.7 9.3 19.3 21.3 22.0 18±4 0.0 16.3 4.3 0.0 12.7 0.0 0.0 5.0 6.7 0.0 0.0 0.0 7.3 8.7 0.0 4.3 4±5
45 21.3 17.0 11.0 19.0 22.0 19.3 21.7 19.0 19.0 15.7 21.3 21.7 22.0 19±3 8.7 10.0 8.0 6.7 15.3 6.7 4.3 4.7 5.3 13.3 0.0 3.0 10.0 6.3 3.3 5.3 7±4
60 21.0 28.7 12.7 12.0 22.0 17.7 19.7 13.7 13.3 18.0 21.0 20.3 22.0 19±5 29.7 16.3 19.0 9.0 12.3 4.0 5.3 2.7 5.0 9.7 0.0 5.0 16.0 16.7 11.3 22.0 12±8
75 16.7 22.0 7.7 20.7 21.3 18.0 22.0 14.7 10.7 18.3 20.3 21.7 22.0 18±5 19.3 9.7 13.0 11.0 14.0 4.3 5.0 4.3 9.7 10.3 4.0 5.7 18.0 13.7 8.0 22.0 11±6
90 16.3 19.7 10.7 13.7 19.0 16.0 19.3 11.0 12.0 15.3 21.0 18.3 22.0 16±4 20.0 10.3 14.3 11.3 19.0 4.0 4.3 9.0 11.7 10.7 0.0 8.7 19.0 16.0 11.7 20.7 12±6
105 22.0 18.7 19.3 13.0 20.0 20.0 14.7 12.3 13.0 16.3 22.0 19.3 22.0 18±4 19.3 13.3 19.0 13.0 19.3 4.0 4.0 10.0 13.3 9.0 4.7 12.0 20.0 15.3 12.3 22.0 13±6
120 22.0 19.3 13.7 9.0 16.3 16.3 21.0 15.3 17.3 20.7 19.7 21.7 22.0 18±4 22.0 11.3 12.0 14.3 15.0 12.7 5.0 10.3 15.0 7.3 5.3 14.7 22.0 17.0 16.3 22.0 14±5
135 22.0 18.0 14.0 16.7 12.0 16.0 17.7 11.0 15.7 18.7 17.7 22.0 22.0 17±4 22.0 9.7 11.3 13.0 22.0 18.7 5.0 11.7 17.0 11.7 6.0 14.3 22.0 19.3 14.7 22.0 15±6
150 22.0 22.0 14.7 14.3 16.0 18.0 20.0 17.0 13.7 16.7 21.7 22.0 22.0 18±3 22.0 13.3 16.0 12.7 22.0 18.3 10.3 15.7 19.7 12.7 5.0 17.3 22.0 22.0 16.3 22.0 17±5
24 hr 18.0 16.3 11.7 17.3 6.3 18.0 10.3 7.0 10.3 12.7 13.3 15.0 22.0 14±5 18.0 13.3 12.7 9.0 21.7 16.0 13.7 9.7 17.0 10.7 4.3 20.0 20.3 20.0 22.0 17.3 15±5
Saline Control NaCN
Maximum Speed Achieved (rpm)
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C. Comparison of performance of mice injected with either 70 µmol/kg of cobalamin cobinamide, CoTMPyP
or 50 µmol/kg CoN4[11.3.1] (5 min before cyanide dose) and 100 µmol/kg  cyanide
D. Comparison of RotaRod performance of mice injected with either 70 µmol/kg of cobalamin cobinamide,
CoTMPyP or 50 µmol/kg CoN4[11.3.1] (given alone or 5 min before cyanide dose) and/or 100 µmol/kg
cyanide at 48 hours post injection.
The kinetics of the reaction of cyanide with Co(II)N4[11.3.1] (cobalt(II) 2,12-dimethyl-
3,7,11,17-tetraazabicyclo-[11.3.1]-heptadeca-1(7)2,11,13,15-pentaenyl cation) were determined 
using an Applied Photophysics laser-flash/stopped-flow spectrometer (LKS.60-SX.18MV-R 
system) to measure the rapid reaction kinetics and the resultant data was fit with the PC Pro-K 
software (!SX.18MV) provided by the manufacturer. All reactions were run under pseudo-first-
Training 
Period
Mean
/ SD
Mean
/ SD
Mean
/ SD
Mean
/ SD
1-2 12.5 17.0 7.0 7.5 7.5 7.5 6.0 9±4 18.5 10.0 8.5 4.5 5.5 5.5 10.0 9±5 10.0 10.5 8.5 5.5 11.0 9.0 9±2 7.5 6.0 5.0 12.0 6.5 10.5 8.0 8±3
3-4 14.5 19.0 9.5 15.0 13.0 11.5 9.0 13±3 16.5 18.5 12.0 6.0 10.0 8.0 14.0 12±5 17.0 13.5 8.0 8.0 14.5 12.5 12±4 9.0 9.0 7.0 11.5 6.0 10.0 13.5 9±3
5-6 10.0 19.0 12.5 16.5 16.0 16.5 13.0 15±3 17.0 22.0 11.0 10.0 10.5 12.0 12.5 14±4 22.0 20.0 13.0 16.0 14.0 15.5 17±4 9.0 13.0 11.5 15.5 15.0 13.5 18.0 14±3
7-8 14.5 21.5 14.0 20.5 15.5 17.0 15.5 17±3 16.5 20.0 14.0 5.0 10.0 13.5 13.5 13±5 22.0 22.0 18.5 21.0 13.5 15.0 19±4 10.5 15.5 11.0 22.0 18.5 16.0 19.5 16±4
Pre-IP 9.3 19.7 14.3 18.0 15.3 17.3 15.0 16±3 16.0 16.3 16.7 6.3 11.0 13.0 15.7 14±4 16.7 16.7 13.3 17.0 8.3 14.3 14±3 9.7 13.7 11.0 18.3 16.3 14.0 19.7 15±4
Post-IP          
Recovery 
Period
15 6.3 17.7 14.0 20.7 16.0 13.3 3.3 13±6 0.0 0.0 9.3 7.0 6.7 11.0 9.3 6±4 7.3 0.0 0.0 11.0 9.0 14.0 7±6 2.0 7.0 3.0 20.0 6.3 0.0 18.0 8±8
30 6.3 20.0 16.7 22.0 12.7 12.3 10.3 14±6 0.0 15.3 15.7 7.0 5.7 5.3 8.7 8±6 3.3 15.7 2.7 16.3 9.3 22.0 12±8 7.0 5.3 5.0 17.0 5.0 14.7 15.0 10±5
45 10.0 21.3 21.3 22.0 12.7 15.0 13.0 16±5 7.7 13.3 21.3 10.0 10.0 7.0 10.3 11±5 6.0 20.3 6.0 16.7 8.3 20.7 13±7 5.0 5.3 5.0 15.0 9.0 15.7 16.3 10±5
60 13.5 19.0 21.5 22.0 17.5 22.0 13.5 18±4 12.0 15.7 22.0 10.0 11.7 15.3 11.3 14±4 22.0 19.3 6.3 10.7 10.7 19.7 15±6 4.3 11.0 6.0 19.7 9.3 17.7 17.3 12±6
75 11.7 22.0 22.0 21.3 19.3 21.3 11.3 18±5 9.7 19.7 22.0 7.0 13.3 16.7 17.3 15±5 22.0 22.0 10.3 16.7 10.7 22.0 17±6 5.0 11.7 6.3 14.7 15.0 19.7 17.7 13±6
90 13.0 21.7 21.3 20.3 19.7 22.0 12.0 19±4 13.0 19.3 22.0 12.3 11.7 15.0 15.0 15±4 20.0 22.0 11.0 16.0 8.3 32.0 18±9 6.0 10.0 7.3 13.7 15.3 20.0 20.7 13±6
105 13.7 20.7 21.7 20.7 13.7 21.7 11.7 18±4 15.0 21.7 21.3 12.0 10.3 11.3 18.0 16±5 18.3 22.0 13.0 19.7 7.7 22.0 17±6 5.3 15.7 6.0 16.0 18.7 21.0 19.7 15±6
120 13.3 22.0 17.3 20.0 12.7 22.0 13.0 17±4 13.0 18.3 21.3 12.7 9.7 16.7 17.3 16±4 15.0 20.0 12.7 19.0 6.7 22.0 16±6 6.0 14.0 9.3 11.3 18.0 18.7 22.0 14±6
135 16.0 20.0 16.0 21.7 13.3 22.0 12.7 17±4 14.0 21.3 22.0 14.0 10.0 12.7 16.0 16±4 17.3 16.0 12.7 16.7 7.3 22.0 15±5 5.3 10.3 11.0 11.3 20.3 13.0 20.3 13±5
150 15.0 20.7 15.0 19.0 14.7 22.0 13.7 17±3 19.3 19.0 22.0 13.7 10.0 12.3 15.3 16±4 20.0 21.0 12.0 21.7 6.3 22.0 17±6 4.7 15.3 10.7 20.0 19.3 18.0 19.3 15±6
24 hr 10.3 22.0 18.3 20.7 9.7 19.7 8.7 16±6 14.0 13.0 21.3 10.0 7.7 12.0 13.3 13±4 18.7 21.3 10.3 19.7 6.3 18.0 16±6 8.0 11.0 7.3 20.0 12.0 18.0 11.0 12±5
Maximum Speed Achieved (rpm)
Cb + NaCN Cbi + NaCN CoTMPyP + NaCN CoN4[11.3.1] + NaCN
Table 17 Continued
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order conditions (4-16 mM potassium cyanide) following a decrease in absorbance at 462 nm (a 
band found in the absorption spectrum of Co(II)N4[11.3.1]) in phosphate buffer and at a 
thermostatically-controlled temperature. Both Co(II)N4[11.3.1] and potassium cyanide solutions 
were prepared anaerobically (using a Schlenk line), prior to loading into the stopped-flow 
spectrophotometer. Co(II)N4[11.3.1] was prepared in 100 mM potassium phosphate buffer and 
KCN was prepared in basic solution (1 mM NaOH) just prior to the reaction in order to prevent 
any loss of HCN. The final buffer (50 mM phosphate) pH was found to be pH 7.6, measured after 
the reaction occurred. The binding kinetics proved to be biphasic and very fast at 25°C, thus the 
reaction temperature was lowered to 10°C in order to better follow the absorbance changes. The 
first phase was still too rapid to be observed but the second phase was found to be linear in cyanide. 
This rate constant for the binding of cyanide to Co(II)N4[11.3.1] was obtained from linear fit of 
the individual observed rates to the cyanide concentrations (using Kaleidegraph software) and 
found to be 8.0 (±0.5) x 104 M-1 s-1 (pH 7.6, 50 mM potassium phosphate buffer, final pH and buffer 
concentrations) at 10°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Kinetics of cyanide binding to Co(II)N4[11.3.1] under anaerobic conditions. 
Linear dependence of the reaction of Co(II)N4[11.3.1]Br2 (0.6 mM) in sodium phosphate buffer (0.1 M, pH 7.4) with 
KCN (prepared in 1 mM NaOH, pH 11.6) at 10°C, anaerobic conditions (final pH = 7.6, 50 mM potassium phosphate). 
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Abstract 
Phosphine (PH3) poisoning continues to be a serious problem worldwide for which there 
is no antidote currently available.  An invertebrate model for examining potential toxicants and 
their putative antidotes has been used to determine if a strategy of using Au(I) complexes as 
phosphine scavenging compounds may be antidotally beneficial.  When Galleria mellonella larvae 
(or wax worms) were subjected to phosphine exposures of 4300 (±700) ppm●min over a 20 min 
time span, they become immobile (paralyzed) for ~35 min.  The administration of Au(I) complexes 
auro-sodium bisthiosulfate (AuTS), aurothioglucose (AuTG) and sodium aurothiomalate (AuTM) 
5 min prior to phosphine exposure resulted in a drastic reduction in the recovery time (0-4 min).  
When the putative antidotes were given 10 min after the phosphine exposure, all the antidotes were 
therapeutic, resulting in mean recovery times of 14, 17 and 19 min for AuTS, AuTG, AuTM, 
respectively.  Since AuTS proved to be the best therapeutic agent in the G. mellonella model, it 
was subsequently tested in mice using a behavioral assessment (pole-climbing test).  Mice given 
AuTS (50 mg/kg) 5 min prior to a 3200 (±500) ppm●min phosphine exposure exhibited behavior 
comparable to mice not exposed to phosphine.  However, when mice were given a therapeutic 
dose of AuTS (50 mg/kg) 1 min after a similar phosphine exposure, only a very modest 
improvement in performance was observed.  
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Introduction 
Worldwide, ingestion of pesticides is seemingly the most common method of suicide, 
accounting for approximately one third of all such deaths.258, 259 Since the early 1980s, particularly 
in parts of Asia, phosphine (PH3) released from pelleted phosphides has become increasingly used 
as the poison within this genre,260-265  yet there appears to be no antidote currently available.  
Throughout North America, phosphides (particularly of aluminum and zinc) are legally obtainable 
from many commercial outlets in pelleted form for use as rodenticides.  There are dozens of sub-
lethal occupational exposures annually in the U.S.266, 267 and occasional domestic accidents leading 
to fatalities in Canada and the U.S.;268, 269 but of greater public health concern is the possibility that 
phosphine may be deliberately put to malicious purposes, since the phosphide pellets release the 
toxic gas simply upon contact with mildly acidic water.  A key target for the acute toxic action of 
phosphine is believed to be the mitochondrion, seemingly by inhibition of cytochrome c oxidase 
(complex IV).270-274 Unfortunately, rigorous verification of this mechanism of action at the 
biochemical and cellular levels is lacking, representing a barrier to the rational development of 
possible antidotes.  Phosphine, however, is slow acting, relatively stable in vivo and a ligand much 
used in synthetic chemistry; it follows, therefore, that a scavenging approach employing metal ion 
complexes designed to bind phosphine ought to significantly ameliorate its toxicity. 
In this investigation, we studied a number of compounds that are commercially available 
and have previously been evaluated for their pharmacological activity and safety, although not as 
decorporating agents.  The essential desired activity we sought was the ability to rapidly bind 
phosphine with reasonably high affinity and, based on general inorganic principles,207, 275 we 
proposed that some gold(I) complexes should prove to be good candidate phosphine antidotes.  
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Phosphine is a “soft” ligand with a marked preference for binding in σ-donor/π-acceptor fashion 
to “soft” metal ions, typically 2nd and 3rd row transition metals in low oxidation states.  Gold in its 
univalent state, Au(I), is the softest metal ion and, given that Au(I) compounds have been widely 
used to treat rheumatoid arthritis for about a century, 276, 277we gave Au(I) complexes a high 
priority for investigation as potential phosphine-scavenging agents.  Non-life threatening side 
effects develop in about one third of patients given repeated high doses of Au(I) anti-arthritics, but 
these are usually minor and manageable/reversible.278, 279  Gold salts are about an order of 
magnitude more expensive than salts of most first-row transition metals, but this cost is still small 
in in comparison to that of the overall purified product. 
In addition, we have previously shown that Galleria mellonella larvae (caterpillars) can 
usefully be applied to the screening of antidotes for mitochondrial toxicants; namely, azide, 
cyanide and sulfide.280  Accordingly, we have employed G. mellonella larvae to find an exposure 
level to phosphine  gas useful for testing both the prophylactic and therapeutic effects towards 
phosphine of three Au(I) compounds (each in use for decades as anti-rheumatoid arthritis drugs278, 
279) namely, auro-bisthiosulfate (AuTS), sodium aurothiomalate (AuTM) and aurothioglucose 
(AuTG).  All of these compounds contain sulfide donors, keeping the gold in its reduced univalent 
state, lowering toxicity and promoting affinity for phosphine.  The outcomes of these experiments 
with the larvae were then used to guide the development of a protocol for testing the potential 
antidotes to phosphine in mice. 
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Experimental Section 
Reagents.  All chemicals, ACS grade or otherwise stated, were purchased from either 
Sigma-Aldrich or Fisher and used without additional purification. Aluminum phosphide (AlP) and 
argon gas purchased from American Elements (Los Angeles CA) and Matheson, respectively, 
were also used as supplied.  Gold compound solutions were prepared using phosphate-buffered 
saline (pH = 7.4).  Phosphine gas was generated through the reaction of either calcium phosphide 
(Ca3P2) or aluminum phosphide (AlP) with sulfuric acid. In the exposure of mice or G. mellonella 
larvae, 20 mL of 1.2 M sulfuric acid was added to ~0.5 g of Ca3P2 to slowly release phosphine in 
a closed container. The time-dependent variation in phosphine production was observed by 
infrared spectroscopy at 2,325 cm-1 (Thermo-Nicholet 6700 FT-IR) using Beer’s law to quantitate 
the measurements.  Calibration, was by a standard additions method using pure phosphine gas 
generated by the action of sulfuric acid on AlP, a more rapid reaction than that employed in the 
inhalation chamber.  The exposures to phosphine gas are reported as integrated concentration 
(ppm) × time (min) of phosphine exposure. 
Animal Studies – G. mellonella Larvae.  Larvae of the Greater Wax Moth, G. mellonella, 
were purchased from Vanderhorst Wholesale, Inc. (Saint Mary’s, Ohio) and were acclimated at 
25°C for six days. Larvae were randomly selected for groups of 10 organisms each. Groups were 
exposed to phosphine gas generated from calcium phosphide pellets using sulfuric acid in a sealed 
container (4.8 L volume) as above. In addition, a group of larvae were exposed to sulfuric acid 
only as an added control. Phosphine exposure lasted for 20 minutes and the atmosphere was 
pumped with a 30 mL syringe every 5 minutes in order to circulate the phosphine. After exposure, 
the wax worms were removed from the chamber and monitored for recovery from paralysis 
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(“knockdown”). Recovery was determined by the repeated performance of righting behavior as 
described by Frawley et al.280  Gold compounds and control solutions were administered at 
determined time points either before or after phosphine exposure. All injections were a maximum 
volume of 10 μL and into the most distal left abdominal proleg. Solutions were prepared with 
filtered PBS, which also served as the injection control. Organisms were monitored for immune 
activity signaled by a melanin-mediated color change.78 G. mellonella mitochondrial particles 
(mainly broken mitochondria) were prepared by cooling about 20 larvae to 4°C for 12 minutes.  
Larvae were then minced in 1 mL EDTA/KCL solution (154 mM KCl, 1 mM EDTA; pH adjusted 
to 6.8).159  The minced tissue was then gently homogenized using a glass homogenizer in 5 mL 
EDTA/KCl solution, filtered through cheesecloth and subsequently centrifuged at 1500 g, 4°C for 
8 min to collect mitochondrial particles.  The pellet obtained was then washed with 200 µL 
EDTA/KCl solution, suspended in 200 mL of the same solution and placed on ice subsequent to 
use in respirometric experiments. 
Animal Studies – Mouse Model.  The University of Pittsburgh Institutional Animal Care 
and Use Committee (Protocol Number 17091400) approved all animal protocols used in this study.  
The Division of Laboratory Animal Research of the University of Pittsburgh provided all 
veterinary care during these experiments.  Male Swiss-Webster (CFW) mice weighing 35-40 g (6-
7 weeks old) were purchased from Taconic, Hudson, NY, housed four per cage and allowed access 
to food and water ad lib.  Animals were allowed to adapt to their new environment for one week 
prior to carrying out experiments.  All animals were randomly assigned to experimental groups of 
predetermined size.  Animals, two at a time (one subject given test antidote, plus one control), 
were exposed to phosphine gas in a procedure that was otherwise identical to that used for the G. 
mellonella larvae (see above) for 15 min.  
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Following phosphine exposure, the duration of time required for the recovery of pole 
climbing in mice was measured following a procedure originated by Frawley et al.280  This test 
evaluates the ability of the mouse to climb a lightly roughened, twenty four inch pole (3/8” 
diameter) before and after exposure to a toxicant, as well as an evaluation of the recovery, post 
exposure when receiving a treatment. This test is based on the observed natural curiosity of the 
mouse to climb to the top of the pole, it is relatively simple, and requires minimal equipment.  The 
pole test was started at 20 minutes post toxicant exposure, or as soon the mouse righted itself, and 
continues every 10 minutes until the mouse was fully recovered.  Full recovery was assessed by 
the mouse scoring the highest rating possible (3), three times in a row.  Briefly, the pole was placed 
in the horizontal position (45° angle) and the mouse placed onto the end.  The pole was 
thengradually raised to the vertical position (through a 90° angle).  Once the mouse climbed to the 
top, or not, it was removed from the pole, scored and replaced in its bucket until the next trial.  The 
mice were scored by performance, receiving scores (see Supplementary information) from zero 
(fall off/ can’t grasp pole) to three (climbs to the top readily with no issues). 
The potential prophylactic antidote, AuTS, was injected (ip) into mice (3-6 animals) at 50 
mg/kg, 5 minutes before the exposure to phosphine.  Control animals received phosphine alone.  
In addition, the putative antidote (AuTS, 50 mg/kg) was given 1 min after the exposure of the mice 
to phosphine. 
Respirometric Experiments.  An Oxygraph O2k Polarographic instrument (Oroboros 
Instruments, Innsbruck, Austria), equipped with a Clark-type electrode for high-resolution 
respirometry was used to measure oxygen flux. Mitochondrial buffer, MiR05,35 (2.1 mL) was 
added to both chambers of the respirometer and allowed to equilibrate for 20 minutes at 25°C 
before adding ~100 µL of the mitochondrial particles (prepared as above).  Mitochondrial 
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respiration was then observed with the addition of cytochrome c (final concentration 10 µM), 
succinate (final concentration 10 mM) and rotenone (to prevent back reaction through complex I, 
final concentration 0.5 µM).  Phosphine was added in 25-100 µL increments to the respiring 
mitochondria particles from a saturated phosphine solution prepared by adding deoxygenated 
phosphate buffer to AlP in a septum-capped vial with minimal headspace.281 
Protein Isolations and Enzyme Assay.  Cytochrome c oxidase was prepared as previously 
described59 from intact bovine heart mitochondria using a modified Harzell-Beinert procedure 
(without the preparation of Keilin-Hartree particles).  The enzyme was determined to be 
spectroscopically pure if the 444 nm to 424 nm ratio for the reduced enzyme was 2.2 or higher.282  
Enzyme concentrations were determined as total heme a using the differential (absorption) 
extinction coefficient of ∆ε604 = 12 mM-1cm-1 for the reduced minus oxidized spectra of the 
mammalian and bacterial enzymes, respectively.283  Concentrations throughout are given on a per 
enzyme concentration basis (i.e. [heme a]/2).   
Steady-state kinetics were performed with the isolated enzyme as described by Nicholls et 
al.284  The concentration changes of the electron donor, bovine ferrocytochrome c, were monitored 
through its absorbance at 550 nm (minus 540 nm, an isosbestic point in the spectrum of cytochrome 
c) in the presence of excess sodium ascorbate (14.5 mM) in normoxic solution, 0.1 M potassium 
phosphate, pH 7.44, 0.02% laural maltoside (Anatrace).  The fractional oxidase activity, [E], was 
determined by the following equation: 
[E] = [c2+]0 x [c3+]t/[c3+]0 x [c2+]t.   
where [c2+]0 = fraction at time 0, [c3+]t = fraction at time t, [c3+]0 = fraction at time 0 and [c2+] = 
fraction at time 0.   
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Statistical Analysis.  Data was analyzed using Kaleidagraph software. A p-value ≤0.05 
was considered significant. 
 
Results 
Using G. mellonella as a Model for Testing Antidotes to Phosphine.  
We have previously shown that G. mellonella caterpillars provide a reasonable model for 
screening antidotes to cytochrome c oxidase toxicants, such as cyanide.280 Oxygen flux was 
initiated by adding cytochrome c, to replace any lost when the mitochondria were lysed, the 
electron donor succinate and rotenone (complex I inhibitor) to prevent backflow.  The 
respirometric inhibition (decreased oxygen flux, JO2) of G. mellonella mitochondrial particles280 
observed was quite linear (R2=0.95) with respect to micromolar phosphine additions as shown in 
Figure 30. 
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Figure 30. Respirometric response of G. mellonella mitochondrial particles titrated with PH3. 
Oxygen consumption was assessed in G. mellonella mitochondrial particles diluted in MiR05 respirometric solution 
(see Experimental Section for details).  The tissue suspension (2.1 mL) was allowed to equilibrate in chamber for ~10 
minutes prior to measuring oxygen consumption. Default respirometric settings of block temperature, 25°C; stir bar 
speed, 400 rpm and data recording, 2 s were used. All reagents/substrates quanitations are given as final 
concentrations.  Cytochrome c (10 µM), succinate (0.5 mM) and rotenone (0.5 µM) were added to the 2.1 mL of 
respirometric solution containing 100 µL of mitochondrial particles and the oxygen flux recorded over 5 min (JO2 of 
~140 pmol/s ● mL).  Subsequently, PH3 was added, from a saturated solution, resulting in PH3 concentrations of 12-
230 µM in the respirometer and the oxygen flux was followed until it was constant (~5 min). 
 
Exposure of G. mellonella larvae to phosphine in a closed container for 20 min caused ~ 
50% of the larvae to become immobile (paralyzed) and the time (known as the recovery time) until 
the paralyzed larvae regained their ability to move was then recorded.  Any larvae that were not 
immobilized were recorded as having a recovery time of zero.  A dose-response of this adjusted 
recovery time of the G. mellonella larvae exposed to phosphine (12-10,000 ppm●min) was 
subsequently determined (see Figure 31).  An exposure of 4300 (±700) ppm●min phosphine (over 
a 20 min time span) induced a state of paralysis that lasted ~35 min, a conveniently repeatable 
response.  
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Figure 31. Dose-response data for G. mellonella larvae exposed to varying amounts of PH3. 
The larvae were exposed to PH3 gas generated by the reaction of Ca3P2 with 20 mL of 1.2 M H2SO4 in a closed vessel 
(see Experimental section).  In sham controls, the addition of the same amount of acid to a reaction vessel (separated 
from the larvae) caused no change in the larval behavior. The time from which each larva ceased movement until 
movement began again (recovery time) was recorded. Each group of larvae (~10) were exposed to PH3 at 12 -10,000 
ppm●min.  Roughly 60% of control larvae were incapacitated and any larvae that did not knockdown were assigned 
recovery times of 0 min. The few larvae that had recovery times over 120 min were not scored. 
 
 
Once a reproducible recovery time for the larvae was obtained, putative antidotes at levels 
that showed no visible toxicity to the G. mellonella larvae (AuTS, 25 mg/kg; AuTM, 1g/kg; AuTG, 
1g/kg) were administered by injection into the most distal left abdominal proleg 10 min prior to 
exposure to phosphine gas.  All the gold complexes tested significantly decreased the mean time 
until the larvae recovered (AuTM 3(±3) min, AuTG 0 min, AuTS 2.1(±0.7) min; Figure 32A) and 
decreased the median time to be zero for all the antidotes when used prophylactically.  More 
impressively, when the antidotes were given to the larvae at 10 minutes after exposure to 
phosphine, all proved to also be effective when given therapeutically (mean times until recovery: 
AuTM, 19(±6) min, AuTG, 17(±6) min, AuTS, 15(±4) min; median times until recovery: AuTM, 
3 min, AuTG, 0 min, AuTS, 0 min; Figure 32B).   
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Figure 32. Prophylactic and therapeutic use of sodium aurothiomalate (AuTM), aurothioglucose (AuTG) and 
auro sodium bisthiosulfate hydrate (AuTS) against phosphine toxicity in G. mellonella larvae. 
Larvae were injected with each of the three putative antidotes (AuTM, 1g/kg; AuTG, 1 g/kg; AuTS, 25mg/kg) either 
5 min prior (A) or 10 min after (B) a PH3 exposure of 4300 (±700) ppm●min.  The mean time until recovery measured 
for each putative antidote vs control.  Roughly 60% of control larvae were incapacitated after PH3 exposure. Any 
larvae that did not knockdown were assigned recovery times of 0 min.  The few larvae that had recovery times over 2 
hours were scored as 120 min. In panel A (prophylactic testing) for each gold compound tested, p<0.005 when 
compared to control; in panel B (therapeutic testing, for each gold compound tested, p<0.01 when compared to 
controls.  The means for each group is shown as a bar. The median recovery times were 0 in all cases but the therapeutic 
administration of AuTM which resulted in a median recovery times of 3 min. 
 
Since it is difficult to isolate cytochrome c oxidase from G. mellonella larvae in large 
enough amounts in order to do steady-state turnover experiments and it has been shown that 
minimal differences between enzymes isolated from different species exist, the turnover 
experiments were performed with enzyme isolated from bovine hearts.  The steady-state turnover 
of oxygen by bovine cytochrome c oxidase was monitored by following the absorbance changes 
in cytochrome c, the oxidase electron donor, after providing a source of electrons for cytochrome 
c, sodium ascorbate (Figure 33A, open circles).   Once the steady-state was established, phosphine 
(to 100 µM) was added (at ~ 100 s) resulting in inhibition of the enzyme.  The resulting time course 
of the inhibition of cytochrome c oxidase was fit by a single exponential: [E]active = 0.87e-0.033t + 
0.13 (Figure 33B).  The inactivation rate was proportional to the phosphine concentration with a 
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kon calculated to be 3.3 x 103 M-1s-1 with 13% of the enzyme still active at the phosphine 
concentration of 100 µM.  This residual activity is proportional to the apparent Ki, which was 
determined to be 13 µM, similar to those previously reported.285   To test if the observed 
amelioration of phosphine toxicity by gold(I) complexes (Figure 32) could indeed be attributable 
to antagonism of cytochrome c oxidase activity, AuTS (300 µM) was added to the enzyme solution 
prior to the initiation of steady state conditions by addition of ascorbate (Figure 33A, closed 
diamonds).  When phosphine (100 µM) was subsequently added, the steady-state turnover was 
roughly 70% of that observed for the normally functioning enzyme. 
 
 
 
 
 
 
 
 
Figure 33. Cytochrome c oxidase steady state turnover: inhibition by phosphine and rescue by auro sodium 
bisthiosulfate hydrate (AuTS). 
Cytochrome c oxidase (0.194 µM) turnover was followed by observing the oxidation of reduced cytochrome c (14 
µM) monitored spectroscopically at A550 nm-A540 nm (T=25°C, 0.1 M sodium phosphate, pH 7.44, 0.02% lauryl 
maltoside) over time. Turnover was initiated by the addition of 1.45 mM sodium ascorbate.  (A) Representative plots 
for the addition of phosphine (100 µM, open circles) to the active enzyme.  Addition of 300 mM AuTS prior to 
ascorbate initiation of turnover (closed diamonds, symbols have been slightly offset so as to view both data sets) and 
subsequent addition of 100 µM phosphine.  (B) A single exponential fit (solid line) to the fraction of active enzyme 
vs. time (open circles) calculated according to Eq. 1 (see Experimental Section).  All reagents/quantities are given as 
final concentrations. 
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After screening the potential antidotes in G. mellonella larvae, a preliminary set of similar 
experiments were then carried out in mice.  Swiss-Webster mice were exposed to phosphine gas, 
produced by the same method as used with the G. mellonella larvae, in a closed container for 15 
min.  This dose of phosphine, 3200 (±500) ppm●min) did not cause the mice to “knockdown” but 
did induce a severely lethargic state (motionless in open field).  The mice were then examined by 
a pole-climbing behavioral assessment (see Supplemental Material section for details).  Mice were 
examined 5 days prior to the phosphine experiments in order to obtain a baseline and then subjected 
to the pole test starting immediately following their exposure to phosphine.  Mice given the AuTS 
antidote (50 mg/kg, previously determined to cause no change in behavior by pole testing and 
chosen based on the mean recovery time in G. mellonella) 5 min prior to the phosphine exposure 
performed as well as control mice that had never been exposed to phosphine (Figure 34A).  
However, when mice were exposed to phosphine and given the AuTS antidote 1 min after the 
toxicant exposure, the results of the pole test were less impressive with only a very modest 
improvement in performance (Figure 34B). 
 
 
Figure 34. Prophylactic and therapeutic use of aurobisthiosulfate (AuTS) in PH3 exposed mice. 
Mice were given 50 mg/kg AuTS intraperitoneally (closed circles) either 5 min before (A) or 1 min after (B) a PH3 
(closed squares) exposure of 3200 (±500) ppm●min (over a 15 min time period), The mice were examined using a 
behavioral assessment (pole climbing test, see Experimental section) to evaluate their response to the toxicant and 
putative antidote (AuTS). 
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Discussion 
It is intrinsically clear from the data (Figures 32) that, in the caterpillars, all three of the 
Au(I) compounds are highly effective antidotes for phosphine.  That is, the original concept has 
been at least circumstantially validated in a biological system; Au(I) complexes are indeed able to 
detoxify phosphine, presumably through scavenging (coordination) and decorporation.  Regarding 
the trials with mice, the compounds are certainly prophylactically effective (Figure 34A) but when 
administered after the toxicant, any beneficial effects were much more modest in these assays 
(Figure 34B).  This result should not, however, be taken to indicate that that the approach will 
ultimately prove to be of no therapeutic application for two main reasons.  First, it is presently 
unclear exactly why Au(I) complexes seem to be significantly therapeutic in the caterpillars 
(Figure 32B) but not the mice (Figure 34B).  The compounds may have significantly different 
pharmacodynamic/kinetic characteristics in the two organisms; in which case, there may be related 
structures exhibiting such properties more suitable for therapeutic use in mammals.  At this 
juncture, especially given that there is no antidote for phosphine currently available, any detectable 
ameliorative effect is encouraging.  Second, most human victims reach the clinic having ingested 
a phosphide salt and the exposure is ongoing as the phosphide continues to release phosphine gas 
through hydrolysis in the stomach.  Additionally, while phosphides are employed as fumigants in 
western countries, for indoor control of insects and outdoor control of rodents, it is not clear that 
their use is so effectively regulated worldwide.  The recent increase in the application of drones to 
crop-dusting operations, particularly in Asia, could conceivably lead to future exposures of larger 
human populations, either through accident or with malicious intent, not to mention the possibility 
of release by deliberate detonations.  Any individuals thus exposed to particulate phosphides 
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dispersed in air, will likely have infiltration of phosphide particles into the esophagus, airways and 
adhered to clothing.  In all such cases where slow and continuing release of phosphine gas is to be 
expected, the availability of effective prophylactics to prevent any further toxic dose exacerbating 
the condition of the victims could have life-saving consequences. 
The mechanism(s) through which phosphine exerts its toxicity is (are) seemingly 
complicated270, 286, 287 and remain incompletely delineated.288-290  We think it pertinent to consider 
if the present findings shed any light on these matters.  For almost half a century, mitochondria 
have been 274 and continue to be 291 identified as key targets for disruption by phosphine through 
inhibition  of cytochrome c oxidase.285, 292-295  In response to sub-lethal phosphine exposure, the 
G. mellonella larvae used in the current study exhibit dose-dependent (Figure 31) temporary 
paralysis (knockdown) from which they appear to fully recover.  This behavior is analogous to that 
obtained employing the bona fide cytochrome c oxidase inhibitors azide, cyanide and sulfide.280  
Consequently, while we have not set out to examine this particular question rigorously, our 
observations concerning the caterpillars do appear to be at least consistent with a mechanism of 
acute phosphine toxicity primarily involving inhibition of cytochrome c oxidase.  If this is so, then 
it follows that the different response to the antidotes of phosphine-challenged mice (Figure 34) 
compared to the caterpillars (Figure 32) is plausibly due to there being another toxic mechanism 
operating in the mice, that might not involve reversible inhibition of cytochrome c oxidase. 
In mammals, acute phosphine/phosphide poisoning is reported to lead to death by 
cardiopulmonary failure, with microscopically visible injury to myocardial tissue.287, 296  This 
shares some similarity with acute cyanide and sulfide toxicity in mammals, where death is also the 
result of cardiopulmonary collapse, but cyanide and sulfide act more rapidly38, 61 and principally 
on the central nervous system stimulating cardiopulmonary function.96, 148  The measured 
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inhibition constant (Ki = 13 µM) and on-rate (kon = 3.3 × 103 M-1s-1) for phosphine reacting with 
isolated cytochrome c oxidase (Figure 33) are, respectively, two orders of magnitude greater and 
three orders of magnitude slower than the corresponding reaction of the enzyme with cyanide,297 
in keeping with the less toxic nature of phosphine compared to cyanide.  It follows that lethal doses 
of inhaled phosphine may require prolonged exposure as recently reported,298-300 but there remains 
an observable difference between the behavior of phosphine and the better characterized 
mitochondrial toxicants in mammals, again suggesting that there could be at least one other toxic 
mechanism in play, possibly non-mitochondrial.  Rahimi et al.301 have recently shown that 
phosphine poisoning in rats can be ameliorated through blood transfusion, clearly implicating 
some component of the blood/vasculature as a target for the toxicant.  This finding seems to be in 
keeping with earlier observations302, 303 that hemolysis and methemoglobinemia may correlate with 
severity of outcome in aluminum phosphide-poisoned human patients.  There is a paucity of 
information regarding the reaction of phosphine with hemoglobin and red blood cells, the available 
literature now being more than twenty-five years old.304, 305   Further effort in this area now appears 
to be warranted.  
 
Supplemental Material and Figures 
Raw data for the pole climbing (see Experimental Section for details) assessment of phosphine 
intoxicated mice establishing prophylactic and therapeutic responses using auro-bisthiosulfate 
(AuTS, 50 mg/kg) (see Table 18). Raw data for the recovery assessment of G. mellonella larvae 
after exposures of phosphine along with the prophylactic and therapeutic administration of putative 
antidotes Au(I) complexes auro-bisthiosulfate (AuTS), sodium aurothiomalate (AuTM) and 
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aurothioglucose (AuTG).  When Galleria mellonella larvae (or wax worms) were subjected to PH3 
exposures of 4300 (±700) ppm●min over a 20 min time span, they become immobile (paralyzed) 
for ~35 min.  The administration of Au(I) complexes auro-sodium bisthiosulfate hydrate (AuTS), 
sodium aurothiomalate (AuTM) and aurothioglucose (AuTG) 5 min prior to PH3 exposure resulted 
in a drastic reduction in the recovery time (0-4 min).  When the putative antidotes were given 10 
min after the PH3 exposure, all the antidotes were therapeutic, resulting in recovery times of 19, 
17 and 14 min for AuTM, AuTG and AuTS, respectively. 
Raw data for the pole climbing (see Materials and Methods for details) assessment of 
phosphine intoxicated mice establishing prophylactic and therapeutic responses using auro-
bisthiosulfate (AuTS, 50 mg/kg) (see Table 18) 
 
Table 18. Raw data of the responses of phosphine-intoxicated male mice and the putative antidote AuTS as 
determined by a pole-climbing test (as shown in Figure 33).   
 
 
Swiss-Webster male mice (7-8 weeks of age) were exposed phosphine gas, 3200 (±500) 
ppm min for 15 min (see controls).  Mice were administered 50 mg/kg AuTS either 5 min before 
  Pole Test Score at Time Point 
  
Time 
(min) 10 20 30 60 90 120 
- 5 min 
mouse 1 3 3 3 3 3 3 
mouse 2 3 3 3 3 3 3 
mouse 3 3 3 3 3 3 3 
+ 1 min 
mouse 4 3 3 3 3 3 3 
mouse 5 1 1 2 2 1 2 
mouse 6 1 1 1 1 1 1 
controls 
mouse 7 2 2 3 3 3 3 
mouse 8  1 1 1 1 1 1 
mouse 9  1 3 3 3 3 3 
moue 10 1 1 1 1 1 1 
mouse 11 2 2 1 2 2 3 
mouse 12 0 0 0 0 0 0 
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phosphine gas or 1 min after the mice were exposed to phosphine.  Mice were exposed in pairs: 1 
control and 1 given the antidote. 
Table 19. Dose-response recovery times of G. mellonella larvae in response to increasing Phosphine exposures 
as shown in Figure 31. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i [PH3] 
ppm•min
Recover
y T (min) i
[PH3] 
ppm•min
Recover
y T (min)
1 12.2 0 51 4362.5 0
2 12.2 0 52 4362.5 0
3 12.2 0 53 4362.5 7
4 12.2 0 54 4362.5 14
5 12.2 0 55 4362.5 17
6 12.2 0 56 4362.5 22
7 12.2 0 57 4362.5 29
8 12.2 0 58 4362.5 60
9 12.2 0 59 4362.5 100
10 12.2 0 60 4362.5 100
11 73.1 0 61 5447 0
12 73.1 0 62 5447 0
13 73.1 0 63 5447 16
14 73.1 0 64 5447 22
15 73.1 0 65 5447 41
16 73.1 0 66 5447 90
17 73.1 0 67 5447 100
18 73.1 0 68 5447 100
19 73.1 0 69 5447 100
20 73.1 0 70 5447 100
21 219.3 0 71 6287.8 0
22 219.3 0 72 6287.8 0
23 219.3 0 73 6287.8 8
24 219.3 0 74 6287.8 100
25 219.3 0 75 6287.8 100
26 219.3 0 76 6287.8 100
27 219.3 0 77 6287.8 100
28 219.3 0 78 6287.8 100
29 219.3 0 79 6287.8 100
30 219.3 4 80 6287.8 100
31 438.7 0 81 7835.4 100
32 438.7 0 82 7835.4 100
33 438.7 0 83 7835.4 100
34 438.7 0 84 7835.4 100
35 438.7 0 85 7835.4 100
36 438.7 0 86 7835.4 100
37 438.7 0 87 7835.4 100
38 438.7 0 88 7835.4 100
39 438.7 0 89 7835.4 100
40 438.7 0 90 7835.4 100
41 3265.8 0 91 10187.3 100
42 3265.8 0 92 10187.3 100
43 3265.8 0 93 10187.3 100
44 3265.8 0 94 10187.3 100
45 3265.8 0 95 10187.3 100
46 3265.8 0 96 10187.3 100
47 3265.8 0 97 10187.3 100
48 3265.8 0 98 10187.3 100
49 3265.8 20 99 10187.3 100
50 3265.8 20 100 10187.3 100
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Table 20. Dose-response recovery times of G. mellonella larvae in response to prophylactic and therapeutic 
treatment with Au(I) complexes auro-bisthiosulfate (AuTS, 25 mg/kg), sodium aurothiomalate (AuTM, 1g/kg) 
 
No 
Treatment 
Control
PBS 
Injection 
Control
AuTM 
Injection 
Control 
(1000ppm)
AuTG 
Injection 
Control 
(1000ppm)
AuTS 
Injection 
Control 
(25ppm)
PH3 4300 
(±700) 
ppm●min
Prophylactic 
PBS
Post 
Exposure 
PBS
Prophylactic 
AuTM 
(1000ppm)
Prophylactic 
AuTG 
(1000ppm)
Prophylactic 
AuTS 
(25ppm)
Post 
Exposure 
AuTM 
(1000ppm)
Post 
Exposure 
AuTG 
(1000ppm)
Post 
Exposure 
AuTS 
(25ppm)
H2SO4 
Control
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 5 0
0 0 0 0 0 0 0 0 0 0 0 5 0
0 0 0 0 0 0 0 0 0 0 0 7 0
0 0 0 0 0 0 0 0 0 0 0 11 0
0 0 0 0 0 0 6 0 0 0 0 14 0
0 0 0 0 0 0 8 0 0 0 0 14 0
0 0 0 0 0 0 9 0 0 0 0 21 0
0 0 0 0 0 0 9 0 0 0 0 84 0
0 0 0 0 0 0 10 0 0 0 0 120 0
0 0 0 0 0 0 10 0 0 0 0 120 0
0 0 0 0 0 0 10 0 0 0 0 120 0
0 0 0 0 0 0 11 0 0 0 0 0
0 0 0 0 0 0 12 0 0 0 0 0
0 0 0 0 0 0 12 0 0 7 0 0
0 0 0 0 0 0 13 0 0 7 0 0
0 0 0 0 0 0 13 0 0 9 0 0
0 0 0 0 0 0 16 0 0 10 2 0
0 0 0 0 0 0 17 0 0 12 2 0
0 0 0 0 0 0 24 0 0 13 5 0
0 0 0 0 0 0 35 6 0 14 5 0
0 0 0 0 0 0 40 6 0 15 7 0
0 0 0 0 0 51 8 0 7 0
0 0 0 0 0 79 8 0 7 0
0 0 0 0 0 120 8 0 10 0
0 0 0 0 0 120 8 0 10 0
0 0 0 0 0 120 8 0 10 1
0 0 0 0 0 120 8 0 10 2
0 0 0 0 0 120 10 0 10 5
0 0 0 0 0 120 0 6 10 5
0 0 0 0 0 120 0 40 10 5
0 0 0 0 0 120 10 120 11 5
0 0 0 0 0 11 13 7
0 0 0 0 0 11 14 7
0 0 0 0 0 13 16 9
0 0 0 0 0 14 16 9
0 0 0 0 0 19 19 9
0 0 0 0 20 20 11
0 0 0 0 23 20 11
0 0 0 0 23 20 21
0 0 0 0 31 20 27
0 0 0 0 34 23 27
0 0 0 0 86 26 47
0 0 0 5 115 35 51
0 0 0 5 120 43 55
0 0 0 6 120 50 61
0 0 0 6 120 71 61
0 0 0 7 120 74 94
0 0 0 7 120 93 120
0 0 0 7 120 93 120
0 0 0 7 120 93 120
0 0 0 8 120 117 120
0 0 0 8 120 120
0 0 0 9 120 120
0 0 0 9 120 120
0 0 0 9 120 120
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No 
Treatment 
Control
PBS 
Injection 
Control
AuTM 
Injection 
Control 
(1000ppm)
AuTG 
Injection 
Control 
(1000ppm)
AuTS 
Injection 
Control 
(25ppm)
PH3 4300 
(±700) 
ppm●min
Prophylactic 
PBS
Post 
Exposure 
PBS
Prophylactic 
AuTM 
(1000ppm)
Prophylactic 
AuTG 
(1000ppm)
Prophylactic 
AuTS 
(25ppm)
Post 
Exposure 
AuTM 
(1000ppm)
Post 
Exposure 
AuTG 
(1000ppm)
Post 
Exposure 
AuTS 
(25ppm)
H2SO4 
Control
0 0 0 9 120 120
0 0 0 10 120 120
0 0 0 10 120 120
0 0 0 11 120 120
0 0 0 11 120 120
0 0 0 11 120 120
0 0 0 11 120 120
0 0 11 120 120
0 0 11 120 120
0 0 11 120 120
0 0 12 120 120
0 0 12 120 120
0 0 12 120 120
0 0 12 120 120
0 0 13 120 120
0 0 14 120 120
0 0 14 120 120
0 0 16 3
0 0 17 5
0 0 17 7
0 0 17 19
0 0 18 0
0 0 19 0
0 0 20 0
0 0 20 0
0 0 20 0
0 0 22 120
0 0 22
0 0 22
0 0 24
0 0 25
0 0 29
0 0 30
0 0 30
0 0 31
0 0 31
0 0 38
0 0 40
0 0 40
0 0 41
0 0 45
0 0 45
0 0 57
0 0 60
0 0 60
0 0 60
0 0 64
0 0 66
0 0 67
0 0 70
0 0 80
0 0 82
0 0 87
0 0 90
0 0 98
0 0 103
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
0 0 120
Table 20 continued 
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